{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 292337, "items": [{"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:04:35Z", "timestamp": 1574111075419}, "reference-count": 0, "publisher": "American Chemical Society (ACS)", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Biochemistry"], "published-print": {"date-parts": [[1999, 1]]}, "DOI": "10.1021/bi981727r", "type": "journal-article", "created": {"date-parts": [[2002, 7, 26]], "date-time": "2002-07-26T05:32:19Z", "timestamp": 1027661539000}, "page": "1300-1309", "source": "Crossref", "is-referenced-by-count": 50, "title": ["Overexpression and Functional Characterization of Kinin Receptors Reveal Subtype-Specific Phosphorylation\u2020,\u2021"], "prefix": "10.1021", "volume": "38", "author": [{"given": "Andree", "family": "Blaukat", "sequence": "first", "affiliation": []}, {"given": "Kerstin", "family": "Herzer", "sequence": "additional", "affiliation": []}, {"given": "Christian", "family": "Schroeder", "sequence": "additional", "affiliation": []}, {"given": "Michael", "family": "Bachmann", "sequence": "additional", "affiliation": []}, {"given": "Norman", "family": "Nash", "sequence": "additional", "affiliation": []}, {"given": "Werner", "family": "M\u00fcller-Esterl", "sequence": "additional", "affiliation": []}], "member": "316", "container-title": ["Biochemistry"], "language": "en", "link": [{"URL": "https://pubs.acs.org/doi/pdf/10.1021/bi981727r", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 9]], "date-time": "2019-10-09T04:49:40Z", "timestamp": 1570596580000}, "score": 68.86053, "issued": {"date-parts": [[1999, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1999, 1]]}, "issue": "4"}, "alternative-id": ["10.1021/bi981727r"], "URL": "http://dx.doi.org/10.1021/bi981727r", "ISSN": ["0006-2960", "1520-4995"], "issn-type": [{"value": "0006-2960", "type": "print"}, {"value": "1520-4995", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T09:03:16Z", "timestamp": 1574154196151}, "reference-count": 58, "publisher": "Wiley", "issue": "1", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 4595, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Andrologia"], "published-print": {"date-parts": [[2003, 2]]}, "DOI": "10.1046/j.1439-0272.2003.00533.x", "type": "journal-article", "created": {"date-parts": [[2003, 3, 11]], "date-time": "2003-03-11T02:23:40Z", "timestamp": 1047349420000}, "page": "17-23", "source": "Crossref", "is-referenced-by-count": 46, "title": ["Structure and signalling pathways of kinin receptors"], "prefix": "10.1111", "volume": "35", "author": [{"given": "A.", "family": "Blaukat", "sequence": "first", "affiliation": []}], "member": "311", "reference": [{"key": "b18_32", "author": "Abd Alla S", "volume": "268", "first-page": "17277", "year": "1993", "journal-title": "J Biol Chem"}, {"key": "b13_33", "DOI": "10.1074/jbc.271.44.27382", "doi-asserted-by": "publisher"}, {"key": "b36_34", "DOI": "10.1074/jbc.274.37.26079", "doi-asserted-by": "publisher"}, {"key": "b37_35", "DOI": "10.1038/35024095", "doi-asserted-by": "publisher"}, {"key": "b38_36", "DOI": "10.1038/nm0901-1003", "doi-asserted-by": "publisher"}, {"key": "b54_37", "author": "Adomeit A", "volume": "19", "first-page": "5289", "year": "1999", "journal-title": "Mol Cell Biol", "DOI": "10.1128/MCB.19.8.5289", "doi-asserted-by": "crossref"}, {"key": "b8_38", "DOI": "10.1016/S0162-3109(98)00037-X", "doi-asserted-by": "publisher"}, {"key": "b2_39", "author": "Bhoola KD", "volume": "44", "first-page": "1", "year": "1992", "journal-title": "Pharmacol Rev"}, {"key": "b45_40", "DOI": "10.1210/er.17.6.698", "doi-asserted-by": "publisher"}, {"key": "b24_41", "DOI": "10.1074/jbc.271.50.32366", "doi-asserted-by": "publisher"}, {"key": "b29_42", "author": "Blaukat A", "volume": "382", "first-page": "135", "year": "2001", "journal-title": "Biol Chem", "DOI": "10.1515/BC.2001.020", "doi-asserted-by": "crossref"}, {"key": "b25_43", "DOI": "10.1021/bi981727r", "doi-asserted-by": "publisher"}, {"key": "b57_44", "DOI": "10.1016/S0014-5793(99)00613-4", "doi-asserted-by": "publisher"}, {"key": "b28_45", "DOI": "10.1128/MCB.20.18.6837-6848.2000", "doi-asserted-by": "publisher"}, {"key": "b23_46", "DOI": "10.1074/jbc.M107024200", "doi-asserted-by": "publisher"}, {"key": "b40_47", "author": "Bohm SK", "volume": "322", "first-page": "1", "year": "1997", "journal-title": "Biochem J", "DOI": "10.1042/bj3220001", "doi-asserted-by": "crossref"}, {"key": "b39_48", "author": "Brass LF", "volume": "78", "first-page": "581", "year": "1997", "journal-title": "Thromb Haemost"}, {"key": "b27_49", "author": "Burch RM", "volume": "84", "first-page": "6374", "year": "1987", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.84.18.6374", "doi-asserted-by": "crossref"}, {"key": "b56_50", "DOI": "10.1074/jbc.273.2.685", "doi-asserted-by": "publisher"}, {"key": "b55_51", "DOI": "10.1038/36362", "doi-asserted-by": "publisher"}, {"key": "b50_52", "DOI": "10.1038/379557a0", "doi-asserted-by": "publisher"}, {"key": "b49_53", "author": "Dikic I", "volume": "30", "first-page": "369", "year": "1999", "journal-title": "Cell Biochem Biophys", "DOI": "10.1007/BF02738120", "doi-asserted-by": "crossref"}, {"key": "b48_54", "DOI": "10.1038/383547a0", "doi-asserted-by": "publisher"}, {"key": "b21_55", "DOI": "10.1074/jbc.274.42.29603", "doi-asserted-by": "publisher"}, {"key": "b20_56", "DOI": "10.1074/jbc.273.5.2617", "doi-asserted-by": "publisher"}, {"key": "b47_57", "author": "Flemming I", "volume": "76", "first-page": "522", "year": "1995", "journal-title": "Circ Res", "DOI": "10.1161/01.RES.76.4.522", "doi-asserted-by": "crossref"}, {"key": "b30_58", "DOI": "10.1074/jbc.274.25.17901", "doi-asserted-by": "publisher"}, {"key": "b00_59", "author": "Graness A", "volume": "327", "first-page": "147", "year": "1997", "journal-title": "Biochem J", "DOI": "10.1042/bj3270147", "doi-asserted-by": "crossref"}, {"key": "b53_60", "DOI": "10.1074/jbc.273.48.32016", "doi-asserted-by": "publisher"}, {"key": "b46_61", "DOI": "10.1074/jbc.273.4.1839", "doi-asserted-by": "publisher"}, {"key": "b17_62", "author": "Haasemann M", "volume": "147", "first-page": "3882", "year": "1991", "journal-title": "J Immunol"}, {"key": "b12_63", "DOI": "10.1074/jbc.270.35.20591", "doi-asserted-by": "publisher"}, {"key": "b15_64", "DOI": "10.1074/jbc.271.47.29746", "doi-asserted-by": "publisher"}, {"key": "b16_65", "DOI": "10.1074/jbc.271.44.27382", "doi-asserted-by": "publisher"}, {"key": "b34_66", "DOI": "10.1042/0264-6021:3510257", "doi-asserted-by": "publisher"}, {"key": "b44_67", "DOI": "10.1074/jbc.M007396200", "doi-asserted-by": "publisher"}, {"key": "b31_68", "author": "Liebmann C", "volume": "382", "first-page": "49", "year": "2001", "journal-title": "Biol Chem", "DOI": "10.1515/BC.2001.008", "doi-asserted-by": "crossref"}, {"key": "b4_69", "DOI": "10.1139/cjpp-75-6-725", "doi-asserted-by": "publisher"}, {"key": "b35_70", "DOI": "10.1074/jbc.M909490199", "doi-asserted-by": "publisher"}, {"key": "b33_71", "DOI": "10.1042/0264-6021:3430335", "doi-asserted-by": "publisher"}, {"key": "b43_72", "author": "Mathis SA", "volume": "50", "first-page": "128", "year": "1996", "journal-title": "Mol Pharmacol"}, {"key": "b5_73", "author": "McEachern AE", "volume": "88", "first-page": "7724", "year": "1991", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.88.17.7724", "doi-asserted-by": "crossref"}, {"key": "b7_74", "DOI": "10.1016/S0162-3109(99)00062-4", "doi-asserted-by": "publisher"}, {"key": "b14_75", "author": "Nardonne J", "volume": "91", "first-page": "4417", "year": "1994", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.91.10.4417", "doi-asserted-by": "crossref"}, {"key": "b6_76", "DOI": "10.1016/S0167-4781(98)00163-8", "doi-asserted-by": "publisher"}, {"key": "b26_77", "author": "Nishizuka Y", "volume": "258", "first-page": "607", "year": "1992", "journal-title": "Science", "DOI": "10.1126/science.1411571", "doi-asserted-by": "crossref"}, {"key": "b11_78", "DOI": "10.1126/science.289.5480.739", "doi-asserted-by": "publisher"}, {"key": "b22_79", "DOI": "10.1074/jbc.274.18.12738", "doi-asserted-by": "publisher"}, {"key": "b19_80", "DOI": "10.1021/bi011600t", "doi-asserted-by": "publisher"}, {"key": "b41_81", "DOI": "10.1074/jbc.272.23.14638", "doi-asserted-by": "publisher"}, {"key": "b52_82", "author": "Prenzel N", "volume": "402", "first-page": "884", "year": "1999", "journal-title": "Nature", "DOI": "10.1038/47260", "doi-asserted-by": "crossref"}, {"key": "b3_83", "author": "Regoli D", "volume": "71", "first-page": "556", "year": "1993", "journal-title": "Can J Physiol Pharmacol", "DOI": "10.1139/y93-079", "doi-asserted-by": "crossref"}, {"key": "b9_84", "author": "Schill WB", "volume": "24", "first-page": "69", "year": "1992", "journal-title": "Andrologia", "DOI": "10.1111/j.1439-0272.1992.tb02613.x", "doi-asserted-by": "crossref"}, {"key": "b1_85", "author": "Sethi T", "volume": "51", "first-page": "3621", "year": "1991", "journal-title": "Cancer Res"}, {"key": "b42_86", "DOI": "10.1074/jbc.274.13.8539", "doi-asserted-by": "publisher"}, {"key": "b10_87", "DOI": "10.1071/RD00014", "doi-asserted-by": "publisher"}, {"key": "b32_88", "DOI": "10.1006/bbrc.1998.8574", "doi-asserted-by": "publisher"}, {"key": "b51_89", "DOI": "10.1074/jbc.272.40.24767", "doi-asserted-by": "publisher"}], "container-title": ["Andrologia"], "language": "en", "deposited": {"date-parts": [[2018, 2, 2]], "date-time": "2018-02-02T07:13:12Z", "timestamp": 1517555592000}, "score": 40.02055, "issued": {"date-parts": [[2003, 2]]}, "references-count": 58, "journal-issue": {"published-print": {"date-parts": [[2003, 2]]}, "issue": "1"}, "alternative-id": ["10.1046/j.1439-0272.2003.00533.x"], "URL": "http://dx.doi.org/10.1046/j.1439-0272.2003.00533.x", "relation": {"cites": []}, "ISSN": ["0303-4569", "1439-0272"], "issn-type": [{"value": "0303-4569", "type": "print"}, {"value": "1439-0272", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T21:29:59Z", "timestamp": 1575494999377}, "reference-count": 38, "publisher": "American Society for Pharmacology & Experimental Therapeutics (ASPET)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Mol Pharmacol"], "published-print": {"date-parts": [[2014, 9]]}, "DOI": "10.1124/mol.114.093179", "type": "journal-article", "created": {"date-parts": [[2014, 6, 26]], "date-time": "2014-06-26T00:22:43Z", "timestamp": 1403742163000}, "page": "263-274", "source": "Crossref", "is-referenced-by-count": 10, "title": ["Subtype-Specific Mechanisms for Functional Interaction between \u03b16\u03b24* Nicotinic Acetylcholine Receptors and P2X Receptors"], "prefix": "10.1124", "volume": "86", "author": [{"given": "Walrati", "family": "Limapichat", "sequence": "first", "affiliation": []}, {"given": "Dennis A.", "family": "Dougherty", "sequence": "additional", "affiliation": []}, {"given": "Henry A.", "family": "Lester", "sequence": "additional", "affiliation": []}], "member": "36", "published-online": {"date-parts": [[2014, 6, 25]]}, "reference": [{"key": "2019081413483431000_86.3.263.1", "DOI": "10.1038/nn.3155", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.2", "DOI": "10.1016/j.neuron.2010.09.029", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.3", "doi-asserted-by": "crossref", "first-page": "1246", "DOI": "10.1523/JNEUROSCI.23-04-01246.2003", "article-title": "Intracellular cross talk and physical interaction between two classes of neurotransmitter-gated channels", "volume": "23", "author": "Bou\u00e9-Grabot", "year": "2003", "journal-title": "J Neurosci"}, {"key": "2019081413483431000_86.3.263.4", "DOI": "10.1074/jbc.M307772200", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.5", "DOI": "10.1074/jbc.M410223200", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.6", "DOI": "10.1146/annurev.biophys.33.110502.132703", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.7", "DOI": "10.1113/jphysiol.2005.088435", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.8", "DOI": "10.1038/35039519", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.9", "DOI": "10.1074/jbc.M111.263673", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.10", "DOI": "10.1074/jbc.M111.322610", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.11", "DOI": "10.1152/ajpgi.00048.2009", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.12", "DOI": "10.1111/j.1365-2982.2010.01505.x", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.13", "DOI": "10.1016/j.neuron.2008.09.009", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.14", "DOI": "10.1124/mol.107.039180", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.15", "DOI": "10.1007/s00424-006-0078-1", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.16", "DOI": "10.1085/jgp.20028535", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.17", "DOI": "10.1113/jphysiol.2004.064568", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.18", "DOI": "10.1124/jpet.104.075069", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.19", "DOI": "10.1016/j.neuropharm.2014.01.010", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.20", "doi-asserted-by": "crossref", "first-page": "917", "DOI": "10.1096/fj.11-195883", "article-title": "Nicotinic acetylcholine receptors in dorsal root ganglion neurons include the \u03b16\u03b24* subtype.", "volume": "26", "author": "Hone", "year": "2011", "journal-title": "FASEB J"}, {"key": "2019081413483431000_86.3.263.21", "DOI": "10.1016/j.neuropharm.2008.06.067", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.22", "DOI": "10.1074/jbc.M113.509356", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.23", "DOI": "10.1074/jbc.M111.231324", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.24", "DOI": "10.1523/JNEUROSCI.0561-05.2005", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.25", "DOI": "10.1038/35019066", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.26", "doi-asserted-by": "crossref", "first-page": "740", "DOI": "10.1523/JNEUROSCI.14-02-00740.1994", "article-title": "ATP-activated current and its interaction with acetylcholine-activated current in rat sympathetic neurons", "volume": "14", "author": "Nakazawa", "year": "1994", "journal-title": "J Neurosci"}, {"key": "2019081413483431000_86.3.263.27", "DOI": "10.1523/JNEUROSCI.5189-04.2005", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.28", "DOI": "10.3389/fncel.2013.00233", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.29", "DOI": "10.1111/j.1469-7793.1998.783bj.x", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.30", "DOI": "10.1074/jbc.M110.165282", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.31", "DOI": "10.1113/jphysiol.1975.sp010925", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.32", "DOI": "10.1038/243404a0", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.33", "DOI": "10.1038/35039526", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.34", "DOI": "10.1111/j.1471-4159.2007.04640.x", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.35", "DOI": "10.1124/mol.106.027326", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.36", "DOI": "10.1016/j.tips.2004.07.008", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.37", "DOI": "10.1016/j.bbrc.2008.07.096", "doi-asserted-by": "publisher"}, {"key": "2019081413483431000_86.3.263.38", "DOI": "10.1111/j.1469-7793.1998.685ba.x", "doi-asserted-by": "publisher"}], "container-title": ["Molecular Pharmacology"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1124/mol.114.093179", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 8, 14]], "date-time": "2019-08-14T20:49:46Z", "timestamp": 1565815786000}, "score": 28.847965, "issued": {"date-parts": [[2014, 6, 25]]}, "references-count": 38, "journal-issue": {"published-online": {"date-parts": [[2014, 7, 25]]}, "published-print": {"date-parts": [[2014, 9]]}, "issue": "3"}, "alternative-id": ["10.1124/mol.114.093179"], "URL": "http://dx.doi.org/10.1124/mol.114.093179", "relation": {"cites": []}, "ISSN": ["0026-895X", "1521-0111"], "issn-type": [{"value": "0026-895X", "type": "print"}, {"value": "1521-0111", "type": "electronic"}], "subject": ["Molecular Medicine", "Pharmacology"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T15:40:26Z", "timestamp": 1574178026382}, "reference-count": 20, "publisher": "Elsevier", "isbn-type": [{"value": "9780121828097", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2005]]}, "DOI": "10.1016/s0076-6879(05)04036-x", "type": "book-chapter", "created": {"date-parts": [[2006, 1, 18]], "date-time": "2006-01-18T15:33:45Z", "timestamp": 1137598425000}, "page": "411-422", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Assay and Functional Properties of the Tyrosine Kinase Pyk2 in Regulation of Arf1 Through ASAP1 Phosphorylation"], "prefix": "10.1016", "author": [{"given": "Anamarija", "family": "Kruljac\u2010Letunic", "sequence": "first", "affiliation": []}, {"given": "Andree", "family": "Blaukat", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Methods in Enzymology", "GTPases Regulating Membrane Dynamics"], "deposited": {"date-parts": [[2019, 1, 19]], "date-time": "2019-01-19T04:25:52Z", "timestamp": 1547871952000}, "score": 27.49641, "issued": {"date-parts": [[2005]]}, "ISBN": ["9780121828097"], "references-count": 20, "URL": "http://dx.doi.org/10.1016/s0076-6879(05)04036-x", "ISSN": ["0076-6879"], "issn-type": [{"value": "0076-6879", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:30:07Z", "timestamp": 1574112607468}, "publisher-location": "New Jersey", "reference-count": 0, "publisher": "Humana Press", "isbn-type": [{"value": "1592597548", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1385/1-59259-754-8:283", "type": "book-chapter", "created": {"date-parts": [[2004, 2, 9]], "date-time": "2004-02-09T19:31:09Z", "timestamp": 1076355069000}, "page": "283-298", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Identification of G-Protein-Coupled Receptor Phosphorylation Sites by 2D Phosphopeptide Mapping"], "prefix": "10.1007", "author": [{"given": "Andree", "family": "Blaukat", "sequence": "first", "affiliation": []}], "member": "297", "container-title": ["Receptor Signal Transduction Protocols"], "deposited": {"date-parts": [[2013, 1, 3]], "date-time": "2013-01-03T13:41:17Z", "timestamp": 1357220477000}, "score": 26.845146, "issued": {"date-parts": [[null]]}, "ISBN": ["1592597548"], "references-count": 0, "URL": "http://dx.doi.org/10.1385/1-59259-754-8:283"}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T00:27:11Z", "timestamp": 1574468831943}, "reference-count": 65, "publisher": "Elsevier BV", "issue": "8", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2012, 8, 1]], "date-time": "2012-08-01T00:00:00Z", "timestamp": 1343779200000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"DOI": "10.13039/100000002", "name": "National Institutes of Health", "doi-asserted-by": "crossref", "award": ["HL36473", "HL60678", "DK41431"]}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cellular Signalling"], "published-print": {"date-parts": [[2012, 8]]}, "DOI": "10.1016/j.cellsig.2012.04.002", "type": "journal-article", "created": {"date-parts": [[2012, 4, 12]], "date-time": "2012-04-12T23:18:54Z", "timestamp": 1334272734000}, "page": "1619-1631", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Characterization of dual agonists for kinin B1 and B2 receptors and their biased activation of B2 receptors"], "prefix": "10.1016", "volume": "24", "author": [{"given": "Xianming", "family": "Zhang", "sequence": "first", "affiliation": []}, {"given": "Jessica L.", "family": "Lowry", "sequence": "additional", "affiliation": []}, {"given": "Viktor", "family": "Brovkovych", "sequence": "additional", "affiliation": []}, {"given": "Randal A.", "family": "Skidgel", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Cellular Signalling"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0898656812001179?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0898656812001179?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 24]], "date-time": "2018-11-24T04:54:31Z", "timestamp": 1543035271000}, "score": 24.35994, "issued": {"date-parts": [[2012, 8]]}, "references-count": 65, "journal-issue": {"published-print": {"date-parts": [[2012, 8]]}, "issue": "8"}, "alternative-id": ["S0898656812001179"], "URL": "http://dx.doi.org/10.1016/j.cellsig.2012.04.002", "ISSN": ["0898-6568"], "issn-type": [{"value": "0898-6568", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T07:34:47Z", "timestamp": 1575099287059}, "reference-count": 50, "publisher": "SAGE Publications", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Biomol Screen"], "published-print": {"date-parts": [[2003, 10]]}, "DOI": "10.1177/1087057103257555", "type": "journal-article", "created": {"date-parts": [[2003, 10, 16]], "date-time": "2003-10-16T19:29:57Z", "timestamp": 1066332597000}, "page": "500-510", "source": "Crossref", "is-referenced-by-count": 17, "title": ["Comparative Analysis of Functional Assays for Characterization of Agonist Ligands at G Protein-Coupled Receptors"], "prefix": "10.1177", "volume": "8", "author": [{"given": "Anke", "family": "Niedernberg", "sequence": "first", "affiliation": []}, {"given": "Sorin", "family": "Tunaru", "sequence": "additional", "affiliation": []}, {"given": "Andree", "family": "Blaukat", "sequence": "additional", "affiliation": []}, {"given": "Bruce", "family": "Harris", "sequence": "additional", "affiliation": []}, {"given": "Evi", "family": "Kostenis", "sequence": "additional", "affiliation": []}], "member": "179", "reference": [{"key": "atypb1", "unstructured": "1. Wilson S, Bergsma DJ, Chambers JK, et al: Orphan G-protein-coupled receptors: the next generation of drug targets? Br J Pharmacol 1998;125: 1387-1392 .", "DOI": "10.1038/sj.bjp.0702238", "doi-asserted-by": "crossref"}, {"key": "atypb2", "unstructured": "2. Civelli O, Nothacker HP, Saito Y, et al: Novel neurotransmitters as natural ligands of orphan G-protein-coupled receptors . Trends Neurosci 2001;24: 230-237 .", "DOI": "10.1016/S0166-2236(00)01763-X", "doi-asserted-by": "crossref"}, {"key": "atypb3", "unstructured": "3. Lee DK, George SR, Evans JF, et al: Orphan G protein coupled receptors in the CNS . Curr Opin Pharmacol 2001;1: 31-39 .", "DOI": "10.1016/S1471-4892(01)00003-0", "doi-asserted-by": "crossref"}, {"key": "atypb4", "unstructured": "4. Howard AD, McAllister G, Feighner SD, et al: Orphan G protein coupled receptors and natural ligand discovery . Trends Pharmacol Sci 2001;22: 132-140 .", "DOI": "10.1016/S0165-6147(00)01636-9", "doi-asserted-by": "crossref"}, {"key": "atypb5", "unstructured": "5. Lefkowitz RJ: The superfamily of heptahelical receptors . Nat Cell Biol 2000;2: E133-E136 .", "DOI": "10.1038/35017152", "doi-asserted-by": "crossref"}, {"key": "atypb6", "unstructured": "6. Bockaert P, Pin JP: Molecular tinkering of G protein-coupled receptors: an evolutionary success . EMBO J 1999;18: 1723-1729 .", "DOI": "10.1093/emboj/18.7.1723", "doi-asserted-by": "crossref"}, {"key": "atypb7", "unstructured": "7. Bourne HR: How receptors talk to trimeric G proteins . Curr Opin Cell Biol 1997;9: 134-142 .", "DOI": "10.1016/S0955-0674(97)80054-3", "doi-asserted-by": "crossref"}, {"key": "atypb8", "unstructured": "8. Hamm HE, Gilchrist A: Heterotrimeric G proteins . Curr Opin Cell Biol 1996;8: 189-196 .", "DOI": "10.1016/S0955-0674(96)80065-2", "doi-asserted-by": "crossref"}, {"key": "atypb9", "unstructured": "9. Berman DM, Wilkie TM, Gilman AG: GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits . Cell 1996;86: 445-452 .", "DOI": "10.1016/S0092-8674(00)80117-8", "doi-asserted-by": "crossref"}, {"key": "atypb10", "unstructured": "10. Druey KM, Blumer KJ, Kang VH, et al: Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family . Nature 1996;379: 742-746 .", "DOI": "10.1038/379742a0", "doi-asserted-by": "crossref"}, {"key": "atypb11", "unstructured": "11. Hunt TW, Fields TA, Casey PJ, et al: RGS10 is a selective activator of G alpha i GTPase activity . Nature 1996;383: 175-177 .", "DOI": "10.1038/383175a0", "doi-asserted-by": "crossref"}, {"key": "atypb12", "unstructured": "12. Watson N, Linder ME, Druey KM, et al: RGS family members: GTPase-activating proteins for heterotrimeric G-protein alpha-subunits . Nature 1996;383: 172-175 .", "DOI": "10.1038/383172a0", "doi-asserted-by": "crossref"}, {"key": "atypb13", "unstructured": "13. Hilf G, Gierschik P, Jakobs KH: Muscarinic acetylcholine receptor-stimulated binding of guanosine 5'-O-(3-thiotriphosphate) to guanine-nucleotide-binding proteins in cardiac membranes . Eur J Biochem 1989;186: 725-731 .", "DOI": "10.1111/j.1432-1033.1989.tb15266.x", "doi-asserted-by": "crossref"}, {"key": "atypb14", "unstructured": "14. Adham N, Ellerbrock B, Hartig P, et al: Receptor reserve masks partial agonist activity of drugs in a cloned rat 5-hydroxytryptamine1B receptor expression system . Mol Pharmacol 1993;43: 427-433 ."}, {"key": "atypb15", "unstructured": "15. Stanton JA, Beer MS: Characterization of a cloned human 5-HT1A receptor cell in using [35S]GTP gamma S binding . Eur J Pharmacol 1997;320: 267-275 .", "DOI": "10.1016/S0014-2999(96)00914-4", "doi-asserted-by": "crossref"}, {"key": "atypb16", "unstructured": "16. Audinot V, Beauverger P, Lahaye C, et al: Structure-activity relationship studies of melanin-concentrating hormone (MCH)-related peptide ligands at SLC-1, the human MCH receptor . J Biol Chem 2001;276: 13554-13562 .", "DOI": "10.1074/jbc.M010727200", "doi-asserted-by": "crossref"}, {"key": "atypb17", "unstructured": "17. Clapham DE, Neer EJ: G protein \u03b2\u03b3 subunits . Annu Rev Pharmacol Toxicol 1997;37: 167-203 .", "DOI": "10.1146/annurev.pharmtox.37.1.167", "doi-asserted-by": "crossref"}, {"key": "atypb18", "unstructured": "18. Conklin BR, Farfel Z, Lustig KD, Julius D, Bourne HR: Substitution of three amino acids switches receptor specificity of Gq alpha to that of Gi alpha . Nature 1993;363: 274-276 .", "DOI": "10.1038/363274a0", "doi-asserted-by": "crossref"}, {"key": "atypb19", "unstructured": "19. Kostenis E: Is G\u03b116 the optimal tool for fishing ligands of orphan G protein coupled receptors? Trends Pharmacol Sci 2001;22: 560-564 .", "DOI": "10.1016/S0165-6147(00)01810-1", "doi-asserted-by": "crossref"}, {"key": "atypb20", "unstructured": "20. Kostenis E: Potentiation of GPCR-signaling via membrane targeting of G protein \u03b1 subunits . J Rec Signal Trans 2002;22: 267-281 .", "DOI": "10.1081/RRS-120014601", "doi-asserted-by": "crossref"}, {"key": "atypb21", "unstructured": "21. Offermanns S, Simon M: G\u03b115 and G\u03b116 couple a wide variety of receptors to phospholipase C . J Biol Chem 1995;270: 15175-15180 .", "DOI": "10.1074/jbc.270.25.15175", "doi-asserted-by": "crossref"}, {"key": "atypb22", "unstructured": "22. Marinissen MJ, Gutkind JS: G protein coupled receptors and signaling networks: emerging paradigms . Trends Pharmacol Sci 2001;22: 368-376 .", "DOI": "10.1016/S0165-6147(00)01678-3", "doi-asserted-by": "crossref"}, {"key": "atypb23", "unstructured": "23. Niedernberg A, Scherer C, Busch AE, et al: Comparative analysis of human and rat S1P5 (edg8): differential expression profiles and sensitivities to antagonists . Biochem Pharmacol 2002;7402: 1-8 .", "DOI": "10.1016/S0006-2952(02)01289-3", "doi-asserted-by": "crossref"}, {"key": "atypb24", "unstructured": "24. Baubet V, Le Mouellic H, Campbell AK, et al: Chimeric green fluorescent protein-aequorin as bioluminescent Ca2+ reporters at the single-cell level . Proc Natl Acad Sci U S A 2000;97: 7260-7265 .", "DOI": "10.1073/pnas.97.13.7260", "doi-asserted-by": "crossref"}, {"key": "atypb25", "unstructured": "25. Blaukat A, Barac A, Cross MJ, et al: G protein-coupled receptor-mediated mitogen-activated protein kinase activation through cooperation of G\u03b1q and G\u03b1isignals . Mol Cell Biol 2000;20: 6837-6848 .", "DOI": "10.1128/MCB.20.18.6837-6848.2000", "doi-asserted-by": "crossref"}, {"key": "atypb26", "unstructured": "26. Im D-S, Clemens J, MacDonald TL, Lynch KR: Characterization of the human and mouse sphingosine 1-phosphate receptor, S1P5(EDG8): structure-activity relationship of sphingosine 1-phosphate receptors . Biochem 2001;40: 14053-14060 .", "DOI": "10.1021/bi011606i", "doi-asserted-by": "crossref"}, {"key": "atypb27", "unstructured": "27. Lee JWM, Joshi S, Chan JSC, et al: Differential coupling of \u03bc, \u03b4- and \u03ba-opioid receptors to G\u03b116-mediated stimulation of phospholipase C . J Neurochem 1998;70: 2203-2211 .", "DOI": "10.1046/j.1471-4159.1998.70052203.x", "doi-asserted-by": "crossref"}, {"key": "atypb28", "unstructured": "28. Peralta EG, Ashkenazi A, Winslow JW, et al: Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes . Nature 1988;334: 434-437 .", "DOI": "10.1038/334434a0", "doi-asserted-by": "crossref"}, {"key": "atypb29", "unstructured": "29. Sternweis PC: The active role of beta gamma in signal transduction . Curr Opin Cell Biol 1994;2: 198-203 .", "DOI": "10.1016/0955-0674(94)90136-8", "doi-asserted-by": "crossref"}, {"key": "atypb30", "unstructured": "30. Kostenis E, Degtyarev MY, Conklin BR, et al: The N-terminal extension of G\u03b1q is critical for constraining the selectivity of receptor coupling . J Biol Chem 1997;272: 19107-19110 .", "DOI": "10.1074/jbc.272.31.19107", "doi-asserted-by": "crossref"}, {"key": "atypb32", "unstructured": "32. Brinkmann V, Davis MD, Heise CE, et al: The immune modulator FTY720 targets sphingosine 1-phosphate receptors . J Biol Chem 2002;277: 21453-21457 .", "DOI": "10.1074/jbc.C200176200", "doi-asserted-by": "crossref"}, {"key": "atypb33", "unstructured": "33. Kotani M, Mollereau C, Detheux M, et al: Functional characterization of a human receptor for neuropeptide FF and related peptides . Br J Pharmacol 2001;133: 138-144 .", "DOI": "10.1038/sj.bjp.0704038", "doi-asserted-by": "crossref"}, {"key": "atypb34", "unstructured": "34. Kohama T, Olivera A, Edsall L, et al: Molecular cloning and functional characterization of murine sphingosine kinase . J Biol Chem 1998;37: 23722-23728 .", "DOI": "10.1074/jbc.273.37.23722", "doi-asserted-by": "crossref"}, {"key": "atypb35", "unstructured": "35. Ryu Y, Takuwa N, Sugimoto N, et al: Sphingosine 1-phosphate, a platelet derived lysophospholipid mediator, negatively regulates cellular rac activity and cell migration in vascular smooth muscle cells . Circulation Res 2002;90: 325-332 .", "DOI": "10.1161/hh0302.104455", "doi-asserted-by": "crossref"}, {"key": "atypb36", "unstructured": "36. Amatruda TT III, Gerard NP, Gerard C, et al: Specific interactions of chemoattractant factor receptors with G-proteins . J Biol Chem 1993;268: 10139-10144 ."}, {"key": "atypb37", "unstructured": "37. Shum JK, Allen RA, Wong YH: The human chemoattractant complement C5a receptor inhibits cyclic AMP accumulation through Gi and Gz proteins . Biochem Biophys Res Commun 1995;208: 223-229 .", "DOI": "10.1006/bbrc.1995.1327", "doi-asserted-by": "crossref"}, {"key": "atypb38", "unstructured": "38. Elshourbagy NA, Ames RS, Fitzgerald LR, et al: Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor . J Biol Chem 2000;275: 25965-25971 .", "DOI": "10.1074/jbc.M004515200", "doi-asserted-by": "crossref"}, {"key": "atypb39", "unstructured": "39. Liu Q, Schonbrunn A: Agonist-induced phosphorylation of somatostatin receptor subtype 1 (sst1). Relationship to desensitization and internalization . J Biol Chem 2001;276: 3709-3717 .", "DOI": "10.1074/jbc.M008873200", "doi-asserted-by": "crossref"}, {"key": "atypb40", "unstructured": "40. Hukovic N, Rocheville M, Kumar U, Sasi R, Khare S, Patel YC. Agonist-dependent up-regulation of human somatostatin receptor type 1 requires molecular signals in the cytoplasmic C-tail . J Biol Chem 1999;274: 24550-24558 .", "DOI": "10.1074/jbc.274.35.24550", "doi-asserted-by": "crossref"}, {"key": "atypb41", "unstructured": "41. Saito Y, Nothacker HP, Wang Z, et al: Molecular characterization of the melanin-concentrating-hormone receptor . Nature 1999;400: 265-269 .", "DOI": "10.1038/22321", "doi-asserted-by": "crossref"}, {"key": "atypb42", "unstructured": "42. Holst B, Hastrup H, Raffetseder U, et al: Two active molecular phenotypes of the tachykinin NK1 receptor revealed by G-protein fusions and mutagenesis . J Biol Chem 2001;276: 19793-19799 .", "DOI": "10.1074/jbc.M100621200", "doi-asserted-by": "crossref"}, {"key": "atypb43", "unstructured": "43. Le Poul E, Hisada S, Mizuguchi Y, et al: Adaptation of aequorin functional assay to high throughput screening . J Biomol Screen 2002;7: 57-65 .", "DOI": "10.1089/108705702753520341", "doi-asserted-by": "crossref"}, {"key": "atypb44", "unstructured": "44. Boyer JL, Graber SG, Waldo GL, et al: Selective activation of phospholipase C by recombinant G-protein \u03b1-and \u03b2\u03b3-subunits . JBiolChem 1994;269: 2814-2819 ."}, {"key": "atypb45", "unstructured": "45. Yamazaki Y, Kon J, Sato K, et al: Edg-6 as a putative sphingosine 1-phosphate receptor coupling to Ca2+ signalling pathway . Biochem Biophys Res Commun 2000;268: 583-589 .", "DOI": "10.1006/bbrc.2000.2162", "doi-asserted-by": "crossref"}, {"key": "atypb46", "unstructured": "46. Englert M, Quitterer U, Klotz KN: Effector coupling of stably transfected human A3 adenosine receptors in CHO cells . Biochem Pharmacol 2002;64: 61-65 .", "DOI": "10.1016/S0006-2952(02)01071-7", "doi-asserted-by": "crossref"}, {"key": "atypb47", "unstructured": "47. Perez DM, Hwa J, Gaivin R, et al: Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor . Mol Pharmacol 1996;49: 112-122 ."}, {"key": "atypb48", "unstructured": "48. Kenakin T, Onaran O: The ligand paradox between affinity and efficacy: can you be there and not make a difference? Trends Pharmacol Sci 2002;23: 275-280 .", "DOI": "10.1016/S0165-6147(02)02036-9", "doi-asserted-by": "crossref"}, {"key": "atypb49", "unstructured": "49. Kenakin T: Agonist-specific receptor conformations . Trends Pharmacol Sci 1997;18: 416-417 .", "DOI": "10.1016/S0165-6147(97)90673-8", "doi-asserted-by": "crossref"}, {"key": "atypb50", "unstructured": "50. Kukkonen JP, Jansson CC, Akerman KE: Agonist trafficking of Gi/o-mediated \u03b12A-adrenoceptor responses in HEL 92.1.7 cells . Br J Pharmacol 2001;132: 1477-1484 .", "DOI": "10.1038/sj.bjp.0703964", "doi-asserted-by": "crossref"}, {"key": "atypb51", "unstructured": "51. Kukkonen JP, Nasman J, Akerman KE: Modelling of promiscuous receptor-Gi/Gs-protein coupling and effector response . Trends Pharmacol Sci 2001; 22: 616-622 .", "DOI": "10.1016/S0165-6147(00)01864-2", "doi-asserted-by": "crossref"}], "container-title": ["Journal of Biomolecular Screening"], "language": "en", "deposited": {"date-parts": [[2018, 3, 16]], "date-time": "2018-03-16T22:09:56Z", "timestamp": 1521238196000}, "score": 24.226255, "issued": {"date-parts": [[2003, 10]]}, "references-count": 50, "journal-issue": {"published-print": {"date-parts": [[2003, 10]]}, "issue": "5"}, "alternative-id": ["10.1177/1087057103257555"], "URL": "http://dx.doi.org/10.1177/1087057103257555", "relation": {"cites": []}, "ISSN": ["1087-0571", "1552-454X"], "issn-type": [{"value": "1087-0571", "type": "print"}, {"value": "1552-454X", "type": "electronic"}], "subject": ["Biotechnology", "Analytical Chemistry", "Molecular Medicine", "Biochemistry", "Pharmacology", "Drug Discovery"]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T18:03:23Z", "timestamp": 1576778603614}, "reference-count": 49, "publisher": "Elsevier BV", "issue": "6", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2018, 9, 1]], "date-time": "2018-09-01T00:00:00Z", "timestamp": 1535760000000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "start": {"date-parts": [[2018, 8, 22]], "date-time": "2018-08-22T00:00:00Z", "timestamp": 1534896000000}, "delay-in-days": 0, "content-version": "vor"}], "funder": [{"name": "National Cancer Institute of the National Institutes of Health", "award": ["P01CA132681", "R01CA170820", "F31CA200242", "R01EB017206"]}], "content-domain": {"domain": ["biophysj.org", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Biophysical Journal"], "published-print": {"date-parts": [[2018, 9]]}, "DOI": "10.1016/j.bpj.2018.08.018", "type": "journal-article", "created": {"date-parts": [[2018, 8, 22]], "date-time": "2018-08-22T21:57:27Z", "timestamp": 1534975047000}, "page": "1116-1129", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Computational Model of Chimeric Antigen Receptors Explains Site-Specific Phosphorylation Kinetics"], "prefix": "10.1016", "volume": "115", "author": [{"given": "Jennifer A.", "family": "Rohrs", "sequence": "first", "affiliation": []}, {"given": "Dongqing", "family": "Zheng", "sequence": "additional", "affiliation": []}, {"given": "Nicholas A.", "family": "Graham", "sequence": "additional", "affiliation": []}, {"given": "Pin", "family": "Wang", "sequence": "additional", "affiliation": []}, {"given": "Stacey D.", "family": "Finley", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Biophysical Journal"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0006349518309706?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0006349518309706?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 10, 22]], "date-time": "2019-10-22T19:46:46Z", "timestamp": 1571773606000}, "score": 19.973497, "issued": {"date-parts": [[2018, 9]]}, "references-count": 49, "journal-issue": {"published-print": {"date-parts": [[2018, 9]]}, "issue": "6"}, "alternative-id": ["S0006349518309706"], "URL": "http://dx.doi.org/10.1016/j.bpj.2018.08.018", "relation": {"has-preprint": [{"id-type": "doi", "id": "10.1101/262527", "asserted-by": "object"}]}, "ISSN": ["0006-3495"], "issn-type": [{"value": "0006-3495", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Computational Model of Chimeric Antigen Receptors Explains Site-Specific Phosphorylation Kinetics", "name": "articletitle", "label": "Article Title"}, {"value": "Biophysical Journal", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.bpj.2018.08.018", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "\u00a9 2018 Biophysical Society.", "name": "copyright", "label": "Copyright"}]}, {"institution": {"name": "bioRxiv", "place": ["-"], "acronym": ["-"]}, "indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T00:05:48Z", "timestamp": 1575245148309}, "posted": {"date-parts": [[2018, 2, 8]]}, "group-title": "Systems Biology", "reference-count": 47, "publisher": "Cold Spring Harbor Laboratory", "content-domain": {"domain": [], "crossmark-restriction": false}, "accepted": {"date-parts": [[2018, 6, 20]]}, "abstract": "<jats:title>Abstract</jats:title><jats:p>Chimeric antigen receptors (CARs) have recently been approved for the treatment of hematological malignancies, but our lack of understanding of the basic mechanisms that activate these proteins has made it difficult to optimize and control CAR-based therapies. In this study, we use phospho-proteomic mass spectrometry and mechanistic computational modeling to quantify the <jats:italic>in vitro</jats:italic> kinetics of individual tyrosine phosphorylation on a variety of CARs. We show that each of the ten tyrosine sites on the CD28-CD3\u03b6 CAR is phosphorylated by LCK with distinct kinetics. The addition of CD28 at the N-terminal of CD3\u03b6 increases the overall rate of CD3\u03b6 phosphorylation. Our computational model identifies that LCK phosphorylates CD3\u03b6 through a mechanism of competitive inhibition. This model agrees with previously published data in the literature and predicts that phosphatases in this system interact with CD3\u03b6 through a similar mechanism of competitive inhibition. This quantitative modeling framework can be used to better understand CAR signaling and T cell activation.</jats:p>", "DOI": "10.1101/262527", "type": "posted-content", "created": {"date-parts": [[2018, 2, 12]], "date-time": "2018-02-12T16:06:32Z", "timestamp": 1518451592000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Computational model of chimeric antigen receptors explains site-specific phosphorylation kinetics"], "prefix": "10.1101", "author": [{"given": "Jennifer A.", "family": "Rohrs", "sequence": "first", "affiliation": []}, {"given": "Dongqing", "family": "Zheng", "sequence": "additional", "affiliation": []}, {"given": "Nicholas A.", "family": "Graham", "sequence": "additional", "affiliation": []}, {"given": "Pin", "family": "Wang", "sequence": "additional", "affiliation": []}, {"ORCID": "http://orcid.org/0000-0001-6901-3692", "authenticated-orcid": false, "given": "Stacey D.", "family": "Finley", "sequence": "additional", "affiliation": []}], "member": "246", "reference": [{"issue": "9", "key": "2019071819090371000_262527v2.1", "doi-asserted-by": "crossref", "first-page": "566", "DOI": "10.1038/nrc.2016.97", "article-title": "Engineered T cells: The promise and challenges of cancer immunotherapy", "volume": "16", "year": "2016", "journal-title": "Nat Rev Cancer [Internet]"}, {"key": "2019071819090371000_262527v2.2", "DOI": "10.1177/1535370215584936", "doi-asserted-by": "publisher"}, {"issue": "12", "key": "2019071819090371000_262527v2.3", "doi-asserted-by": "crossref", "first-page": "818", "DOI": "10.1038/nrd.2017.249", "article-title": "Second anticancer CAR T therapy receives FDA approval", "volume": "16", "year": "2017", "journal-title": "Nat Rev Drug Discov [Internet]"}, {"issue": "5", "key": "2019071819090371000_262527v2.4", "doi-asserted-by": "crossref", "first-page": "301", "DOI": "10.1038/nrd.2017.84", "article-title": "CAR T therapies drive into new terrain", "volume": "16", "year": "2017", "journal-title": "Nat Rev Drug Discov [Internet]"}, {"issue": "4", "key": "2019071819090371000_262527v2.5", "doi-asserted-by": "crossref", "first-page": "843", "DOI": "10.1038/mt.2010.24", "article-title": "Case report of a serious adverse event following the administration of t cells transduced with a chimeric antigen receptor recognizing ERBB2", "volume": "18", "year": "2010", "journal-title": "Mol Ther [Internet]"}, {"key": "2019071819090371000_262527v2.6", "DOI": "10.1016/S0140-6736(14)61403-3", "doi-asserted-by": "publisher"}, {"key": "2019071819090371000_262527v2.7", "DOI": "10.1158/1078-0432.CCR-13-2627", "doi-asserted-by": "publisher"}, {"key": "2019071819090371000_262527v2.8", "unstructured": "Harris DT , Hager M V , Smith SN , Stone JD , Kruger P , Lever M , et al. Comparison of T Cell Activities Mediated by Human TCRs and CARs That Use the Same Recognition Domains. J Immunol. 2018;", "DOI": "10.4049/jimmunol.1700236", "doi-asserted-by": "crossref"}, {"key": "2019071819090371000_262527v2.9", "DOI": "10.1038/sj.onc.1208074", "doi-asserted-by": "publisher"}, {"issue": "22", "key": "2019071819090371000_262527v2.10", "doi-asserted-by": "crossref", "first-page": "8655", "DOI": "10.1128/MCB.00168-06", "article-title": "Lck Regulates the Threshold of Activation in Primary T Cells, While both Lck and Fyn Contribute to the Magnitude of the Extracellular Signal-Related Kinase Response", "volume": "26", "year": "2006", "journal-title": "Mol Cell Biol [Internet]"}, {"issue": "6", "key": "2019071819090371000_262527v2.11", "doi-asserted-by": "crossref", "first-page": "766", "DOI": "10.1016/j.immuni.2010.05.011", "article-title": "Constitutively active Lck kinase in T cells drives antigen receptor signal transduction", "volume": "32", "year": "2010", "journal-title": "Immunity [Internet]"}, {"key": "2019071819090371000_262527v2.12", "unstructured": "Chakraborty AK , Weiss A. Insights into the initiation of TCR signaling. Nat Immunol [Internet. 2014 Sep 19 [cited 2015 Jul 29];15Chakrabo(9):798\u2013807. Available from: http://www.nature.com/ni/journal/v15/n9/abs/ni.2940.html#affil-auth", "DOI": "10.1038/ni.2940", "doi-asserted-by": "crossref"}, {"issue": "1", "key": "2019071819090371000_262527v2.13", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1111/j.1600-065X.2008.00753.x", "article-title": "The structure, regulation, and function of ZAP-70", "volume": "228", "year": "2009", "journal-title": "Immunol Rev [Internet]"}, {"issue": "377", "key": "2019071819090371000_262527v2.14", "first-page": "1", "article-title": "The catalytic activity of the kinase ZAP-70 mediates basal signaling and negative feedback of the T cell receptor pathway", "volume": "8", "year": "2015", "journal-title": "Sci Signal"}, {"issue": "5", "key": "2019071819090371000_262527v2.15", "doi-asserted-by": "crossref", "first-page": "1063", "DOI": "10.1002/eji.1830260516", "article-title": "The protein interactions of the immunoglobulin receptor family tyrosine-based activation motifs present in the T cell receptor zeta subunits and the CD3 gamma, delta and epsilon chains", "volume": "26", "year": "1996", "journal-title": "Eur J Immunol [Internet]"}, {"issue": "5376", "key": "2019071819090371000_262527v2.16", "doi-asserted-by": "crossref", "first-page": "572", "DOI": "10.1126/science.281.5376.572", "article-title": "Fidelity of T Cell Activation Through Multistep T Cell Receptor Phosphorylation", "volume": "281", "year": "1998", "journal-title": "Science (80-) [Internet]"}, {"key": "2019071819090371000_262527v2.17", "DOI": "10.1016/j.bpj.2016.03.024", "doi-asserted-by": "publisher"}, {"issue": "3", "key": "2019071819090371000_262527v2.18", "doi-asserted-by": "crossref", "first-page": "e1003004", "DOI": "10.1371/journal.pcbi.1003004", "article-title": "Systems model of T cell receptor proximal signaling reveals emergent ultrasensitivity", "volume": "9", "year": "2013", "journal-title": "PLoS Comput Biol [Internet]"}, {"issue": "8", "key": "2019071819090371000_262527v2.19", "first-page": "a002436", "article-title": "An enigmatic tail of CD28 signaling", "volume": "2", "year": "2010", "journal-title": "Cold Spring Harb Perspect Biol [Internet]"}, {"issue": "3", "key": "2019071819090371000_262527v2.20", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.1038/ni761", "article-title": "Regulation of Lck activity by CD4 and CD28 in the immunological synapse", "volume": "3", "year": "2002", "journal-title": "Nat Immunol [Internet]"}, {"key": "2019071819090371000_262527v2.21", "DOI": "10.1128/MCB.20.22.8409-8419.2000", "doi-asserted-by": "publisher"}, {"issue": "13", "key": "2019071819090371000_262527v2.22", "doi-asserted-by": "crossref", "first-page": "E1594", "DOI": "10.1073/pnas.1503286112", "article-title": "Combinatorial proteomic analysis of intercellular signaling applied to the CD28 T-cell costimulatory receptor", "volume": "112", "year": "2015", "journal-title": "Proc Natl Acad Sci U S A [Internet]"}, {"issue": "4 Pt 1", "key": "2019071819090371000_262527v2.23", "first-page": "255", "article-title": "Phosphorylation of each of the distal three tyrosines of the CD28 cytoplasmic tail is required for CD28-induced T cell IL-2 secretion", "volume": "48", "year": "1996", "journal-title": "Tissue Antigens [Internet]"}, {"issue": "11", "key": "2019071819090371000_262527v2.24", "doi-asserted-by": "crossref", "first-page": "2732", "DOI": "10.1002/eji.1830241124", "article-title": "CD28 signal transduction: tyrosine phosphorylation and receptor association of phosphoinositide-3 kinase correlate with Ca(2+)-independent costimulatory activity", "volume": "24", "year": "1994", "journal-title": "Eur J Immunol [Internet]"}, {"issue": "6", "key": "2019071819090371000_262527v2.25", "doi-asserted-by": "crossref", "first-page": "935", "DOI": "10.1016/S1074-7613(01)00244-8", "article-title": "CD28 as a molecular amplifier extending TCR ligation and signaling capabilities", "volume": "15", "year": "2001", "journal-title": "Immunity [Internet]"}, {"key": "2019071819090371000_262527v2.26", "DOI": "10.1093/intimm/dxh120", "doi-asserted-by": "publisher"}, {"key": "2019071819090371000_262527v2.27", "unstructured": "Kersh BEN , Kersh GJ , Allen PM. Partially Phosphorylated T Cell Receptor Zeta Molecules Can Inhibit Inhibit T Cell Activation. J Exp Med. 1999;190(11).", "DOI": "10.1084/jem.190.11.1627", "doi-asserted-by": "crossref"}, {"issue": "2", "key": "2019071819090371000_262527v2.28", "doi-asserted-by": "crossref", "first-page": "133", "DOI": "10.1038/nsmb.2762", "article-title": "In vitro membrane reconstitution of the T-cell receptor proximal signaling network", "volume": "21", "year": "2014", "journal-title": "Nat Struct Mol Biol [Internet]"}, {"issue": "3", "key": "2019071819090371000_262527v2.29", "doi-asserted-by": "crossref", "first-page": "351", "DOI": "10.1007/s12195-016-0438-7", "article-title": "Predictive Model of Lymphocyte-Specific Protein Tyrosine Kinase (LCK) Autoregulation", "volume": "9", "year": "2016", "journal-title": "Cell Mol Bioeng"}, {"issue": "37", "key": "2019071819090371000_262527v2.30", "doi-asserted-by": "crossref", "first-page": "16113", "DOI": "10.1073/pnas.1010580107", "article-title": "Mammalian endoplasmic reticulum stress sensor IRE1 signals by dynamic clustering", "volume": "107", "year": "2010", "journal-title": "Proc Natl Acad Sci U S A [Internet]"}, {"issue": "September", "key": "2019071819090371000_262527v2.31", "first-page": "8392", "article-title": "Production of high-titer helper-free retroviruses by transient transfection (retroviral packaing cells/gene therapy)", "volume": "90", "year": "1993", "journal-title": "Cell Biol"}, {"key": "2019071819090371000_262527v2.32", "DOI": "10.1007/978-1-59745-525-1_5", "doi-asserted-by": "publisher"}, {"issue": "17", "key": "2019071819090371000_262527v2.33", "doi-asserted-by": "crossref", "first-page": "6704", "DOI": "10.1158/0008-5472.CAN-10-0460", "article-title": "Identification of optimal drug combinations targeting cellular networks: integrating phospho-proteomics and computational network analysis", "volume": "70", "year": "2010", "journal-title": "Cancer Res [Internet]"}, {"issue": "4", "key": "2019071819090371000_262527v2.34", "doi-asserted-by": "crossref", "first-page": "862", "DOI": "10.1110/ps.3870102", "article-title": "Mass spectrometric analysis of the kinetics of in vivo rhodopsin phosphorylation", "volume": "11", "year": "2002", "journal-title": "Protein Sci [Internet]"}, {"issue": "1", "key": "2019071819090371000_262527v2.35", "doi-asserted-by": "crossref", "first-page": "169", "DOI": "10.1084/jem.183.1.169", "article-title": "The SH3 domain of p56lck binds to proline-rich sequences in the cytoplasmic domain of CD2", "volume": "183", "year": "1996", "journal-title": "J Exp Med [Internet]"}, {"issue": "3", "key": "2019071819090371000_262527v2.36", "doi-asserted-by": "crossref", "first-page": "375", "DOI": "10.1084/jem.190.3.375", "article-title": "Proline residues in CD28 and the Src homology (SH)3 domain of Lck are required for T cell costimulation", "volume": "190", "year": "1999", "journal-title": "J Exp Med [Internet]"}, {"issue": "29", "key": "2019071819090371000_262527v2.37", "doi-asserted-by": "crossref", "first-page": "E5891", "DOI": "10.1073/pnas.1701990114", "article-title": "Ionic CD3-Lck interaction regulates the initiation of T-cell receptor signaling", "volume": "114", "year": "2017", "journal-title": "Proc Natl Acad Sci [Internet]"}, {"issue": "SUPPL. 1", "key": "2019071819090371000_262527v2.38", "first-page": "777", "article-title": "RegPhos: A system to explore the protein kinase-substrate phosphorylation network in humans", "volume": "39", "year": "2011", "journal-title": "Nucleic Acids Res"}, {"issue": "11", "key": "2019071819090371000_262527v2.39", "doi-asserted-by": "crossref", "first-page": "1023", "DOI": "10.1038/80930", "article-title": "Phosphorylation of T cell receptor zeta is regulated by a lipid dependent folding transition", "volume": "7", "year": "2000", "journal-title": "Nat Struct Biol [Internet]"}, {"key": "2019071819090371000_262527v2.40", "DOI": "10.1126/scisignal.aaf6029", "doi-asserted-by": "publisher"}, {"issue": "13", "key": "2019071819090371000_262527v2.41", "doi-asserted-by": "crossref", "first-page": "2423", "DOI": "10.1084/jem.20120790", "article-title": "Local changes in lipid environment of TCR microclusters regulate membrane binding by the CD3e cytoplasmic domain", "volume": "209", "year": "2012", "journal-title": "J Exp Med [Internet]"}, {"key": "2019071819090371000_262527v2.42", "DOI": "10.1111/j.1742-4658.2007.05653.x", "doi-asserted-by": "publisher"}, {"key": "2019071819090371000_262527v2.43", "DOI": "10.1016/S0968-0004(96)20026-X", "doi-asserted-by": "publisher"}, {"key": "2019071819090371000_262527v2.44", "unstructured": "Ferrell JE , Ha SH. Ultrasensitivity part II\u25a1: multisite phosphorylation, stoichiometric inhibitors, and positive feedback. 2014;39(11).", "DOI": "10.1016/j.tibs.2014.09.003", "doi-asserted-by": "crossref"}, {"issue": "March", "key": "2019071819090371000_262527v2.45", "first-page": "eaaf1292", "article-title": "T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition", "volume": "4", "year": "2017", "journal-title": "Science (80-)"}, {"key": "2019071819090371000_262527v2.46", "volume": "270", "first-page": "2369", "year": "2003", "article-title": "Investigation of the kinetics and order of tyrosine phosphorylation in the T-cell receptor zeta chain by the protein tyrosine kinase Lck", "journal-title": "Eur J Biochem", "DOI": "10.1046/j.1432-1033.2003.03604.x", "doi-asserted-by": "crossref"}, {"issue": "7", "key": "2019071819090371000_262527v2.47", "first-page": "3839", "article-title": "Multiple modes of interaction between Lck and CD28", "volume": "174", "year": "2005", "journal-title": "J Immunol [Internet]"}], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1101/262527", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 7, 19]], "date-time": "2019-07-19T02:15:55Z", "timestamp": 1563502555000}, "score": 22.941154, "issued": {"date-parts": [[2018, 2, 8]]}, "references-count": 47, "URL": "http://dx.doi.org/10.1101/262527", "relation": {"cites": []}, "subtype": "preprint"}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T04:16:26Z", "timestamp": 1574136986564}, "reference-count": 34, "publisher": "Walter de Gruyter GmbH", "issue": "9", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2003, 1, 28]]}, "DOI": "10.1515/bc.2003.147", "type": "journal-article", "created": {"date-parts": [[2004, 9, 7]], "date-time": "2004-09-07T07:39:22Z", "timestamp": 1094542762000}, "source": "Crossref", "is-referenced-by-count": 8, "title": ["Kinin-B1 Receptors in Ischaemia-Induced Pancreatitis: Functional Importance and Cellular Localisation"], "prefix": "10.1515", "volume": "384", "author": [{"given": "J. F.", "family": "Kuebler", "sequence": "first", "affiliation": []}, {"given": "E.", "family": "Schremmer-Danninger", "sequence": "additional", "affiliation": []}, {"given": "K. D.", "family": "Bhoola", "sequence": "additional", "affiliation": []}, {"given": "A. A.", "family": "Roscher", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Messmer", "sequence": "additional", "affiliation": []}, {"given": "T. F.", "family": "Hoffmann", "sequence": "additional", "affiliation": []}], "member": "374", "reference": [{"key": "p_1", "author": "Ahluwalia A.", "volume": "156", "first-page": "269", "year": "1996", "journal-title": "J. Immunol."}, {"key": "p_2", "DOI": "10.1038/sj.bjp.0701534", "doi-asserted-by": "publisher"}, {"key": "p_3", "DOI": "10.1074/jbc.272.17.11420", "doi-asserted-by": "publisher"}, {"key": "p_4", "author": "Bassi D.", "volume": "179", "first-page": "257", "year": "1994", "journal-title": "J. Am. Coll. Surg."}, {"key": "p_5", "DOI": "10.1515/BC.2001.013", "doi-asserted-by": "publisher"}, {"key": "p_6", "author": "Bhoola K.D.", "volume": "44", "first-page": "1", "year": "1992", "journal-title": "Pharmacol. Rev."}, {"key": "p_7", "author": "Bloechle C.", "volume": "274", "first-page": "G42", "year": "1998", "journal-title": "Am. J. Physiol."}, {"key": "p_8", "DOI": "10.1016/0162-3109(96)00055-0", "doi-asserted-by": "publisher"}, {"key": "p_9", "DOI": "10.1016/0090-6980(95)00050-K", "doi-asserted-by": "publisher"}, {"key": "p_10", "author": "Dendorfer A.", "volume": "432", "first-page": "R99", "year": "1996", "journal-title": "Pfl\u00fcger's Arch."}, {"key": "p_11", "author": "Griesbacher T.", "volume": "108", "first-page": "405", "year": "1993", "journal-title": "Hoe 140. Br. J. Pharmacol.", "DOI": "10.1111/j.1476-5381.1993.tb12817.x", "doi-asserted-by": "crossref"}, {"key": "p_12", "DOI": "10.1007/BF00169391", "doi-asserted-by": "publisher"}, {"key": "p_13", "author": "Hall J.M.", "volume": "28", "first-page": "1", "year": "1997", "journal-title": "Gen. Pharmacol.", "DOI": "10.1016/S0306-3623(96)00174-7", "doi-asserted-by": "crossref"}, {"key": "p_14", "DOI": "10.1016/0162-3109(96)00074-4", "doi-asserted-by": "publisher"}, {"key": "p_15", "DOI": "10.1038/sj.bjp.0704462", "doi-asserted-by": "publisher"}, {"key": "p_16", "DOI": "10.1007/BF02576782", "doi-asserted-by": "publisher"}, {"key": "p_17", "DOI": "10.1006/jsre.1996.0187", "doi-asserted-by": "publisher"}, {"key": "p_18", "DOI": "10.1016/0162-3109(96)00066-5", "doi-asserted-by": "publisher"}, {"key": "p_19", "DOI": "10.1002/bjs.1800830213", "doi-asserted-by": "publisher"}, {"key": "p_20", "DOI": "10.1002/(SICI)1097-0029(19970601)37:5/6<557::AID-JEMT16>3.0.CO;2-P", "doi-asserted-by": "publisher"}, {"key": "p_21", "DOI": "10.1097/00006676-199610000-00011", "doi-asserted-by": "publisher"}, {"key": "p_22", "author": "Klar E.", "volume": "9", "first-page": "85", "year": "1990", "journal-title": "Int. J. Microcirc. Clin. Exp."}, {"key": "p_23", "DOI": "10.1139/cjpp-75-6-725", "doi-asserted-by": "publisher"}, {"key": "p_24", "DOI": "10.1111/j.1469-7793.2001.0069m.x", "doi-asserted-by": "publisher"}, {"key": "p_25", "DOI": "10.1016/0014-2999(89)90661-4", "doi-asserted-by": "publisher"}, {"key": "p_26", "author": "Pruneau D.", "volume": "111", "first-page": "1029", "year": "1994", "journal-title": "Br. J. Pharmacol.", "DOI": "10.1111/j.1476-5381.1994.tb14847.x", "doi-asserted-by": "crossref"}, {"key": "p_27", "author": "Regoli D.", "volume": "55", "first-page": "855", "year": "1977", "journal-title": "Can. J. Physiol. Pharmacol.", "DOI": "10.1139/y77-115", "doi-asserted-by": "crossref"}, {"key": "p_28", "DOI": "10.1097/00006676-199601000-00012", "doi-asserted-by": "publisher"}, {"key": "p_29", "DOI": "10.1016/0026-2862(77)90028-0", "doi-asserted-by": "publisher"}, {"key": "p_30", "DOI": "10.1016/0014-2999(95)00347-N", "doi-asserted-by": "publisher"}, {"key": "p_31", "DOI": "10.1006/bbrc.1997.7999", "doi-asserted-by": "publisher"}, {"key": "p_32", "DOI": "10.1016/0162-3109(96)00060-4", "doi-asserted-by": "publisher"}, {"key": "p_33", "DOI": "10.1016/0076-6879(95)48043-9", "doi-asserted-by": "publisher"}, {"key": "p_34", "DOI": "10.1097/00003246-200004000-00035", "doi-asserted-by": "publisher"}], "container-title": ["Biological Chemistry"], "link": [{"URL": "https://www.degruyter.com/view/j/bchm.2003.384.issue-9/bc.2003.147/bc.2003.147.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 7, 26]], "date-time": "2018-07-26T21:18:50Z", "timestamp": 1532639930000}, "score": 22.348173, "issued": {"date-parts": [[2003, 1, 28]]}, "references-count": 34, "journal-issue": {"issue": "9"}, "URL": "http://dx.doi.org/10.1515/bc.2003.147", "relation": {"cites": []}, "ISSN": ["1431-6730"], "issn-type": [{"value": "1431-6730", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T07:59:13Z", "timestamp": 1574409553576}, "publisher-location": "Dordrecht", "reference-count": 17, "publisher": "Springer Netherlands", "isbn-type": [{"value": "9789401073530", "type": "print"}, {"value": "9789400919129", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1990]]}, "DOI": "10.1007/978-94-009-1912-9_37", "type": "book-chapter", "created": {"date-parts": [[2011, 10, 15]], "date-time": "2011-10-15T03:19:30Z", "timestamp": 1318648770000}, "page": "289-293", "source": "Crossref", "is-referenced-by-count": 0, "title": ["5-Hydroxytryptamine1A Receptors: Pharmacological and Functional Characterization"], "prefix": "10.1007", "author": [{"given": "A. J.", "family": "Sleight", "sequence": "first", "affiliation": []}, {"given": "S. J.", "family": "Peroutka", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "37_CR1", "doi-asserted-by": "crossref", "first-page": "220", "DOI": "10.1111/j.1471-4159.1981.tb02397.x", "volume": "36", "author": "N.W. Pedigo", "year": "1981", "unstructured": "Pedigo, N.W., Yamamura. H.I. and Nelson, D.L. (1981) \u2018Deter mination of multiple [3H]-5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain\u2019, J. Neurochem., 36, 220\u2013226.", "journal-title": "J. Neurochem."}, {"key": "37_CR2", "doi-asserted-by": "publisher", "first-page": "85", "DOI": "10.1016/0006-8993(86)90902-9", "volume": "376", "author": "D Hoyer", "year": "1986", "unstructured": "Hoyer, D., Pazos, A., Probst, A. and Palacios, J.M. (1986) \u2018Serotonin receptors in the human brain: I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites\u2019, Brain Res., 376, 85\u201396.", "journal-title": "Brain Res"}, {"key": "37_CR3", "doi-asserted-by": "crossref", "first-page": "453", "DOI": "10.1021/jm00154a005", "volume": "29", "author": "E.J. Lloyd", "year": "1986", "unstructured": "Lloyd, E.J. and Andrews, P.R. (1986) common structural model for central nervous system drugs and their receptors\u2019, J. Med. Chem., 29, 453\u2013462.", "journal-title": "J. Med. Chem."}, {"key": "37_CR4", "doi-asserted-by": "crossref", "first-page": "1087", "DOI": "10.1021/jm00401a007", "volume": "31", "author": "M. Hibert", "year": "1988", "unstructured": "Hibert, M., Gittos, M.W., Middlemiss, D.N., Mir, A.K. and Fozard, J.R. (1988) Graphics computer-aided receptor mapping as a predictive tool for drug design: Development of potent, selective and stereospecific ligands for the 5-HT1A receptor1, J. Med. Chem., 31, 1087\u20131094.", "journal-title": "J. Med. Chem."}, {"key": "37_CR5", "doi-asserted-by": "crossref", "first-page": "1943", "DOI": "10.1016/0006-2952(86)90725-2", "volume": "35", "author": "J.R. Schlegel", "year": "1986", "unstructured": "Schlegel, J.R. and Peroutka, S.J. (1986) \u2018Nucleotide interactions with 5-HT1A binding sites directlv labeled by [3H]-8-hydroxy-2-(di-n-propylamino)tetralin ([3H]-8-OH-DPAT)\u2019, Biochem. Pharmacol., 35, 1943\u20131949.", "journal-title": "Biochem. Pharmacol."}, {"key": "37_CR6", "first-page": "248", "volume": "238", "author": "M. Vivo", "year": "1986", "unstructured": "De Vivo, M. and Maayani, S. (1986) \u2018Characterization of the 5-hydroxytryptamine1A receptor-mediated inhibition of forskolin- stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes\u2019, J. Pharmacol. Exp. Ther., 238, 248\u2013253.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "37_CR7", "doi-asserted-by": "crossref", "first-page": "255", "DOI": "10.1016/0014-2999(88)90199-9", "volume": "154", "author": "A.J. Sleight", "year": "1988", "unstructured": "Sleight, A.J., Marsden, C.A., Palfreyman, M.G. Mir, A.K. and Lovenberg, W. (1988) \u2018Chronic MAO A and MAO B inhibition decreases the 5-HT1A receptor mediated inhibition of forskolin- stimulated adenylate cyclase\u2019, Eur. J. Pharmacol., 154, 255\u2013261.", "journal-title": "Eur. J. Pharmacol."}, {"key": "37_CR8", "author": "GK Aghajanian", "first-page": "141", "year": "1987", "unstructured": "Aghajanian, G.K., Sprouse, J.S. and Rasmussen, K. (1987) Physiology of the midbrain serotonin system1, in H.Y. Meltzer (ed.), Psychopharmacology: The Third Generation of Progress, Raven Press, New York, pp. 141\u2013149.", "volume-title": "Psychopharmacology: The Third Generation of Progress"}, {"key": "37_CR9", "doi-asserted-by": "crossref", "first-page": "271", "DOI": "10.1016/0014-2999(84)90714-3", "volume": "106", "author": "M.D. Tricklebank", "year": "1984", "unstructured": "Tricklebank, M.D., Forler, C. and Fozard, J.R. (1984) \u2018The involvement of subtypes of the 5-HT1 receptor and of the cate- cholaminergic systems in the behavioural response to 8-hydroxy- 2-(di-n-propylamino)tetralin in the rat\u2019, Eur. J. Pharmacol., 106, 271\u2013282.", "journal-title": "Eur. J. Pharmacol."}, {"key": "37_CR10", "unstructured": "Dourish, C.T., Hutson, P.H. and Curzon, G. (1985) \u2018Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-0H-DPAT)\u2019, Psychopharmacology, 86, 197\u2013204.", "DOI": "10.1007/BF00431709", "doi-asserted-by": "crossref"}, {"key": "37_CR11", "doi-asserted-by": "crossref", "first-page": "347", "DOI": "10.1016/0014-2999(86)90445-0", "volume": "129", "author": "P.H. Hutson", "year": "1986", "unstructured": "Hutson, P.H., Dourish, C.T. and Curzon, G. (1986) \u2018Neurochemical and behavioural evidence for the modulation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors\u2019, Eur. J. Pharmacol., 129, 347\u2013352.", "journal-title": "Eur. J. Pharmacol."}, {"key": "37_CR12", "doi-asserted-by": "crossref", "first-page": "377", "DOI": "10.1016/0361-9230(85)90005-X", "volume": "15", "author": "C.T. Dourish", "year": "1985", "unstructured": "Dourish, C.T., Hutson, P.H. and Curzon, G. (1985) \u2018Characteristics of feeding induced by the serotonin agonist 8-hydroxy-2- (di-n-propylamino) tetralin (8-OH-DPAT)\u2019, Brain Res. Bull., 15, 377\u2013384.", "journal-title": "Brain Res. Bull."}, {"key": "37_CR13", "author": "EC Tompkins", "first-page": "5", "year": "1980", "unstructured": "Tompkins, E.C., Clemento, A.J., Taylor, D.P. and Perlach, J.L. Jr. (1980) Inhibition of aggressive behaviour in rhesus monkeys by buspirone\u2019, Res. Commun. Psychol. Psychiat. Behav., 5, 337\u2013352.", "volume-title": "Inhibition of aggressive behaviour in rhesus monkeys by buspirone\u2019, Res. Commun. Psychol"}, {"key": "37_CR14", "doi-asserted-by": "crossref", "first-page": "1184", "DOI": "10.1176/ajp.136.9.1184", "volume": "136", "author": "HL Goldberg", "year": "1979", "unstructured": "Goldberg, H.L. and Finnerty, R.J. (1979) \u2018The comparative efficacy of buspirone and diazepam in the treatment of anxiety\u2019, Am. J. Psychiat., 136, 1184\u20131187.", "journal-title": "Am. J. Psychiat"}, {"key": "37_CR15", "doi-asserted-by": "publisher", "first-page": "299", "DOI": "10.1016/0014-2999(82)90265-5", "volume": "83", "author": "S Hjorth", "year": "1982", "unstructured": "Hjorth, S. and Carlsson, A. (1982) Buspirone: Effects on central monoaminergic transmission-possible relevance to animal experimental and clinical findings\u2019, Eur. J. Pharmacol., 83, 299\u2013303.", "journal-title": "Eur. J. Pharmacol"}, {"key": "37_CR16", "doi-asserted-by": "publisher", "first-page": "265", "DOI": "10.1016/0014-2999(87)90357-8", "volume": "134", "author": "GA Kennett", "year": "1987", "unstructured": "Kennett, G.A., Dourish, C.T. and Curzon, G. (1987) \u2018Antidepressant -like action of 5-HT1 agonists and conventional antidepressants in an animal model of depression\u2019, Eur. J. Pharmacol., 134, 265\u2013274.", "journal-title": "Eur. J. Pharmacol"}, {"key": "37_CR17", "doi-asserted-by": "publisher", "first-page": "432", "DOI": "10.1097/00005344-198804000-00008", "volume": "11", "author": "HN Doods", "year": "1988", "unstructured": "Doods, H.N., Boddeke, H.W.G.M., Kalkman, H.O., Hoyer, D., Mathy, M-J. and van Zwieten, P.A. (1988) \u2018Central 5-HT1A receptor and the mechanism of the central hypotensive effect of (+)8-0H-DPAT, DP-5-CT, R28935 and Urapidil\u2019, J. Cardiovascular Pharmacol., 11, 432\u2013437.", "journal-title": "J. Cardiovascular Pharmacol."}], "container-title": ["Serotonin"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-94-009-1912-9_37", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 5]], "date-time": "2019-11-05T12:23:34Z", "timestamp": 1572956614000}, "score": 21.919062, "issued": {"date-parts": [[1990]]}, "ISBN": ["9789401073530", "9789400919129"], "references-count": 17, "URL": "http://dx.doi.org/10.1007/978-94-009-1912-9_37", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:25:01Z", "timestamp": 1574490301967}, "reference-count": 42, "publisher": "Wiley", "issue": "7", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 7458, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1995, 4]]}, "DOI": "10.1111/j.1476-5381.1995.tb13372.x", "type": "journal-article", "created": {"date-parts": [[2012, 7, 20]], "date-time": "2012-07-20T09:41:45Z", "timestamp": 1342777305000}, "page": "1471-1477", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Characterization of kinin receptors modulating neurogenic contractions of the mouse isolated vas deferens"], "prefix": "10.1111", "volume": "114", "author": [{"given": "Jonny", "family": "Maas", "sequence": "first", "affiliation": []}, {"given": "Giles A.", "family": "Rae", "sequence": "additional", "affiliation": []}, {"given": "Juan P.", "family": "Huidobro-Toro", "sequence": "additional", "affiliation": []}, {"given": "Jo\u00e3o B.", "family": "Calixto", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2012, 7, 19]]}, "reference": [{"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "227", "DOI": "10.1016/0304-3940(90)90308-V", "article-title": "Bradykinin facilitates the purinergic motor component of the rat bladder neurotransmission", "volume": "113", "author": "ACEVEDO", "year": "1990", "journal-title": "Neurosci. Lett."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "48", "DOI": "10.1111/j.1476-5381.1959.tb00928.x", "article-title": "Some quantitative uses of drug antagonists", "volume": "14", "author": "ARUNLAKSHANA", "year": "1959", "journal-title": "Br. J. Pharmacol. Chemother."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB3|cit3", "first-page": "59P", "article-title": "Characterization of bradykinin receptors in the electrically-stimulated rat vas deferens", "volume": "108", "author": "ASGHAR", "year": "1993", "journal-title": "Br. J. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB4|cit4", "first-page": "1", "article-title": "Bioregulation of kinins: kallikreins, kininogens, and kininases", "volume": "44", "author": "BHOOLA", "year": "1992", "journal-title": "Pharmacol. Rev."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "591", "DOI": "10.1111/j.1476-5381.1984.tb16523.x", "article-title": "Further evidence for the existence of two receptor sites for bradykinin responsible for the diphasic effect in the rat isolated duodenum", "volume": "83", "author": "BOSCHCOV", "year": "1984", "journal-title": "Br. J. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB6|cit6", "author": "BURCH", "first-page": "19", "year": "1993", "volume-title": "Molecular Biology and Pharmacology of Bradykinin Receptors"}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1016/0024-3205(92)90395-6", "article-title": "Bradykinin induced biphasic responses in the rat isolated stomach fundus: Functional evidence for a novel bradykinin receptor", "volume": "50", "author": "CALIXTO", "year": "1992", "journal-title": "Life Sci."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB8|cit8", "first-page": "902", "article-title": "Mechanisms involved in the contractile responses of kinins in rat portal vein rings: mediation by B1 and B2 receptors", "volume": "268", "author": "CAMPOS", "year": "1994", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB9|cit9", "author": "COLLIER", "first-page": "409", "year": "1970", "volume-title": "Handbook of Experimental Pharmacology. Bradykinin, Kallidin and Kallikrein", "DOI": "10.1007/978-3-642-46222-1_19", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1111/j.1476-5381.1993.tb13791.x", "article-title": "Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse", "volume": "110", "author": "CORR\u00c9A", "year": "1993", "journal-title": "Br J. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1016/0014-2999(89)90499-8", "article-title": "Involvement of postjunctional purinergic mechanisms in the facilitatory action of bradykinin in neurotransmission in the rat vas deferens", "volume": "160", "author": "DONOSO", "year": "1989", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "825", "DOI": "10.1111/j.1476-5381.1992.tb09064.x", "article-title": "ATP overflow from the mouse isolated vas deferens", "volume": "105", "author": "DRAKE", "year": "1992", "journal-title": "Br. J. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "293", "DOI": "10.1111/j.1476-5381.1992.tb14248.x", "article-title": "Bradykinin receptors in the guinea-pig taenia caeci are similar to proposed BK3 receptors in the guinea-pig trachea and are blocked by Hoe 140", "volume": "105", "author": "FIELD", "year": "1992", "journal-title": "DBr. J. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB14|cit14", "first-page": "339", "article-title": "Log-normal distribution of equieffective doses of norepinephrine and acetylcholine in several tissues", "volume": "181", "author": "FLEMING", "year": "1972", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "393", "DOI": "10.1016/0014-2999(92)90397-M", "article-title": "Analysis of the antagonistic action of HOE 140 and other novel bradykinin analogues in the guinea-pig ileum", "volume": "211", "author": "GRIESBACHER", "year": "1992", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "131", "DOI": "10.1016/0163-7258(92)90016-S", "article-title": "Bradykinin receptors: pharmacological properties and biological roles", "volume": "56", "author": "HALL", "year": "1992", "journal-title": "Pharmacol. Ther."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "376", "DOI": "10.1016/0165-6147(93)90096-3", "article-title": "Receptor subtypes or species homologues: relevance to drug discovery", "volume": "14", "author": "HALL", "year": "1993", "journal-title": "Trends Pharmacol. Sci."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB18|cit18", "first-page": "1", "article-title": "Differential pharmacology of cloned human and mouse B2 bradykinin receptors", "volume": "45", "author": "HESS", "year": "1994", "journal-title": "Mol. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "769", "DOI": "10.1111/j.1476-5381.1991.tb12248.x", "article-title": "Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies", "volume": "102", "author": "HOCK", "year": "1991", "journal-title": "Br. J. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "305", "DOI": "10.1016/0014-2999(86)90250-5", "article-title": "Pre- and postsynaptic bradykinin responses in the rat vas deferens: asymmetric distribution of the postsynaptic effect", "volume": "121", "author": "HUIDOBRO-TORO", "year": "1986", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "365", "DOI": "10.1111/j.1476-5381.1983.tb09402.x", "article-title": "An electrophysiological study of presynaptic \u03b12-adrenoceptors in the vas deferens of the mouse", "volume": "78", "author": "ILLES", "year": "1983", "journal-title": "Br. J. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB22|cit22", "author": "KENAKIN", "first-page": "344", "year": "1993", "volume-title": "Pharmacologic Analysis of Drug-Receptor Interaction"}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "1465", "DOI": "10.1111/j.1476-5381.1993.tb13986.x", "article-title": "Prejunctional modulation of noradrenaline release in mouse and rat vas deferens: contribution of P1- and P2- purinoceptors", "volume": "110", "author": "KURZ", "year": "1993", "journal-title": "Br. J. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB24|cit24", "first-page": "305", "article-title": "Recent advances toward novel bradykinin antagonists", "volume": "17", "author": "KYLE", "year": "1992", "journal-title": "Drugs of the Future"}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB25|cit25", "first-page": "5", "article-title": "A survey of bradykinin receptors and their antagonists", "volume": "2", "author": "KYLE", "year": "1993", "journal-title": "Curr. Opin. Invest. Drugs"}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "297", "DOI": "10.1111/j.1476-5381.1991.tb12169.x", "article-title": "New, long-acting, potent bradykinin antagonist", "volume": "102", "author": "LEMBECK", "year": "1991", "journal-title": "Br. J. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB27|cit27", "first-page": "608", "article-title": "Identification of pre- and postsynaptic bradykinin receptor sites in the vas deferens: evidence for different structural prerequisites", "volume": "241", "author": "LLONA", "year": "1987", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "2585", "DOI": "10.1016/0024-3205(91)90616-J", "article-title": "Bradykinin modulates the release of noradrenaline from vas deferens nerve terminals", "volume": "48", "author": "LLONA", "year": "1991", "journal-title": "Life Sci."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "495", "DOI": "10.1038/267495a0", "article-title": "Endogenous opioid peptides: multiple agonists and receptors", "volume": "267", "author": "LORD", "year": "1977", "journal-title": "Nature"}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB30|cit30", "author": "MANZINI", "year": "1992", "volume-title": "International Symposium on Substance P and Related Peptides (Shizuoka, Japan, 3-6 November), S104"}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB31|cit31", "author": "MARCEAU", "first-page": "33", "year": "1991", "volume-title": "Bradykinin Antagonists: Basic and Clinical Research"}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB32|cit32", "doi-asserted-by": "crossref", "first-page": "157", "DOI": "10.1016/0014-2999(93)90197-P", "article-title": "Analysis of the mechanisms underlying the biphasic responses to bradykinin in circular muscle from guinea-pig ileum", "volume": "241", "author": "MEDEIROS", "year": "1993", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB33|cit33", "first-page": "171P", "article-title": "Hoe 140: a novel bradykinin analogue that is a potent antagonist at both B2 and B3 receptors in vitro", "volume": "102", "author": "PERKINS", "year": "1991", "journal-title": "Br. J. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "PL83", "DOI": "10.1016/0024-3205(90)90191-S", "article-title": "Effects of endothelins on nervemediated contractions of the mouse vas deferens", "volume": "47", "author": "RAE", "year": "1990", "journal-title": "Life Sci."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB35|cit35", "first-page": "1", "article-title": "Pharmacology of bradykinin and related kinins", "volume": "32", "author": "REGOLI", "year": "1980", "journal-title": "Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "115", "DOI": "10.1016/0014-2999(92)90661-M", "article-title": "Pharmacological characertization of a new highly potent B2 receptor antagonist (Hoe 140: D-Arg-[Hyp3,Thi5,D-Tic7,Oic8] bradykinin)", "volume": "210", "author": "RHALEB", "year": "1992", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "305", "DOI": "10.1016/0014-2999(87)90120-8", "article-title": "Bradykinin receptor antagonists used to characterize the heterogeneity of the bradykinin-induced responses in rat vas deferens", "volume": "142", "author": "RIFO", "year": "1987", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.1016/0306-4522(86)90184-3", "article-title": "Neuropeptide Y -A cotransmitter with noradrenaline and adenosine 5\u2032triphosphate in the sympathetic nerves of the mouse vas deferens? A biochemical, physiological and electropharmacological study", "volume": "18", "author": "STJ\u00c4RNE", "year": "1986", "journal-title": "Neurosci. Lett."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "333", "DOI": "10.1016/0143-4179(87)90007-2", "article-title": "Characterization of pre- and postjunctional receptors for neurokinins in the rat vas deferens", "volume": "9", "author": "TOUSIGNANT", "year": "1987", "journal-title": "Neuropeptides"}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB40|cit40", "doi-asserted-by": "crossref", "first-page": "227", "DOI": "10.1016/0014-2999(93)91000-D", "article-title": "Comparative actions of new highly potent bradykinin receptor antagonists in the guinea-pig trachea", "volume": "239", "author": "TRIFILIEFF", "year": "1993", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB41|cit41", "doi-asserted-by": "crossref", "first-page": "760", "DOI": "10.1007/BF00169686", "article-title": "Effects of suramin and \u03b1,\u03b2-methylene ATP indicate noradrenaline-ATP co-transmission in the response of the mouse vas deferens to single and low frequency pulses", "volume": "340", "author": "K\u00dcGELGEN", "year": "1989", "journal-title": "Naunyn-Schmied. Arch. Pharmacol."}, {"key": "10.1111/j.1476-5381.1995.tb13372.x-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.1016/0014-2999(79)90428-X", "article-title": "An attempt to differentiate the effects of angiotensin II, substance P and bradykinin on the field-stimulated guinea-pig vas deferens", "volume": "56", "author": "ZETLER", "year": "1979", "journal-title": "Eur. J. Pharmacol."}], "container-title": ["British Journal of Pharmacology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1476-5381.1995.tb13372.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 20]], "date-time": "2017-06-20T21:40:30Z", "timestamp": 1497994830000}, "score": 21.484262, "issued": {"date-parts": [[1995, 4]]}, "references-count": 42, "journal-issue": {"published-print": {"date-parts": [[1995, 4]]}, "issue": "7"}, "URL": "http://dx.doi.org/10.1111/j.1476-5381.1995.tb13372.x", "relation": {"cites": []}, "ISSN": ["0007-1188"], "issn-type": [{"value": "0007-1188", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T20:10:45Z", "timestamp": 1574280645563}, "reference-count": 83, "publisher": "Springer Science and Business Media LLC", "issue": "39", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2007, 3, 12]], "date-time": "2007-03-12T00:00:00Z", "timestamp": 1173657600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Oncogene"], "published-print": {"date-parts": [[2007, 8]]}, "DOI": "10.1038/sj.onc.1210383", "type": "journal-article", "created": {"date-parts": [[2007, 3, 12]], "date-time": "2007-03-12T12:50:47Z", "timestamp": 1173703847000}, "page": "5693-5701", "source": "Crossref", "is-referenced-by-count": 39, "title": ["EGFR kinase domain mutations \u2013 functional impact and relevance for lung cancer therapy"], "prefix": "10.1038", "volume": "26", "author": [{"given": "D", "family": "Irmer", "sequence": "first", "affiliation": []}, {"given": "J O", "family": "Funk", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Blaukat", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2007, 3, 12]]}, "reference": [{"key": "BF1210383_CR1", "first-page": "226", "volume": "65", "author": "J Amann", "year": "2005", "unstructured": "Amann J, Kalyankrishna S, Massion PP, Ohm JE, Girard L, Shigematsu H et al. (2005). Aberrant EGFR signalling and enhanced sensitivity to EGFR inhibitors in lung cancer. Cancer Res 65: 226\u2013235.", "journal-title": "Cancer Res"}, {"key": "BF1210383_CR2", "doi-asserted-by": "crossref", "first-page": "8872", "DOI": "10.1158/1078-0432.CCR-05-0811", "volume": "11", "author": "K Ando", "year": "2005", "unstructured": "Ando K, Ohmori T, Inoue F, Kadofuku T, Hosaka T, Ishida H et al. (2005). Enhancement of sensitivity to TNF\u03b1 in NSCLC cells with acquired resistance to gefitinib. Clin Cancer Res 11: 8872\u20138879.", "journal-title": "Clin Cancer Res"}, {"key": "BF1210383_CR3", "doi-asserted-by": "crossref", "first-page": "9101", "DOI": "10.1158/0008-5472.CAN-04-2360", "volume": "64", "author": "T Arao", "year": "2004", "unstructured": "Arao T, Fukumoto H, Takeda M, Tamura T, Saijo N, Nishio K . (2004). Small in-frame deletion in the EGFR as a target for ZD6474. Cancer Res 64: 9101\u20139104.", "journal-title": "Cancer Res"}, {"key": "BF1210383_CR4", "doi-asserted-by": "crossref", "first-page": "998", "DOI": "10.1038/sj.bjc.6603393", "volume": "95", "author": "H Asahina", "year": "2006", "unstructured": "Asahina H, Yamazaki K, Kinoshita I, Sukoh N, Harada M, Yokouchi H et al. (2006). A phase II trial of gefitinib as first-line therapy for advanced NSCLC with EGFR mutations. Br J Cancer 95: 998\u20131004.", "journal-title": "Br J Cancer"}, {"key": "BF1210383_CR5", "doi-asserted-by": "crossref", "first-page": "2883", "DOI": "10.1056/NEJM200412303512724", "volume": "351", "author": "TD Barber", "year": "2004", "unstructured": "Barber TD, Vogelstein B, Kinzler KW, Velculescu VE . (2004). Somatic mutations of EGFR in colorectal cancers and glioblastomas. N Engl J Med 351: 2883.", "journal-title": "N Engl J Med"}, {"key": "BF1210383_CR6", "doi-asserted-by": "crossref", "first-page": "1315", "DOI": "10.1038/ng1671", "volume": "37", "author": "DW Bell", "year": "2005", "unstructured": "Bell DW, Gore I, Okimoto RA, Godin-Heymann N, Sordella R, Mulloy R et al. (2005b). Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR. Nat Genet 37: 1315\u20131316.", "journal-title": "Nat Genet"}, {"key": "BF1210383_CR7", "doi-asserted-by": "crossref", "first-page": "8081", "DOI": "10.1200/JCO.2005.02.7078", "volume": "23", "author": "DW Bell", "year": "2005", "unstructured": "Bell DW, Lynch TJ, Haserlat SM, Harris PL, Okimoto RA, Brannigan BW et al. (2005a). EGFR mutations and gene amplification in NSCLC: molecular analysis of the IDEAL/INTACT gefitinib trials. J Clin Oncol 23: 8081\u20138092.", "journal-title": "J Clin Oncol"}, {"key": "BF1210383_CR8", "doi-asserted-by": "crossref", "first-page": "15435", "DOI": "10.1074/jbc.M211158200", "volume": "278", "author": "S Blencke", "year": "2003", "unstructured": "Blencke S, Ullrich A, Daub H . (2003). Mutation of threonine 766 in the EGFR reveals a hotspot for resistance formation against selective tyrosine kinase inhibitors. J Biol Chem 278: 15435\u201315440.", "journal-title": "J Biol Chem"}, {"key": "BF1210383_CR9", "doi-asserted-by": "crossref", "first-page": "2158", "DOI": "10.1200/JCO.2006.06.5961", "volume": "24", "author": "E Calvo", "year": "2006", "unstructured": "Calvo E, Baselga J . (2006). Ethnic differences in response to EGFR tyrosine kinase inhibitors. J Clin Oncol 24: 2158\u20132163.", "journal-title": "J Clin Oncol"}, {"key": "BF1210383_CR10", "doi-asserted-by": "crossref", "first-page": "643", "DOI": "10.1093/jnci/dji112", "volume": "97", "author": "F Cappuzzo", "year": "2005", "unstructured": "Cappuzzo F, Hirsch FR, Rossi E, Bartolini S, Ceresoli GL, Bemis L et al. (2005a). EGFR gene and protein and gefitinib sensitivity in NSCLC. J Natl Cancer Inst 97: 643\u2013655.", "journal-title": "J Natl Cancer Inst"}, {"key": "BF1210383_CR11", "doi-asserted-by": "crossref", "first-page": "1133", "DOI": "10.1093/jnci/djh217", "volume": "96", "author": "F Cappuzzo", "year": "2004", "unstructured": "Cappuzzo F, Magrini E, Ceresoli GL, Bartolini S, Rossi E, Ludovini V et al. (2004). Akt phosphorylation and gefitinib efficacy in patients with advanced NSCLC. J Natl Cancer Inst 96: 1133\u20131141.", "journal-title": "J Natl Cancer Inst"}, {"key": "BF1210383_CR12", "doi-asserted-by": "crossref", "first-page": "8163", "DOI": "10.1158/0008-5472.CAN-06-0453", "volume": "66", "author": "KD Carey", "year": "2006", "unstructured": "Carey KD, Garton AJ, Romero MS, Kahler J, Thomson S, Ross S et al. (2006). Kinetic analysis of EGFR somatic mutant proteins shows increased sensitivity to the EGFR tyrosine kinase inhibitor, erlotinib. Cancer Res 66: 8163\u20138171.", "journal-title": "Cancer Res"}, {"key": "BF1210383_CR13", "doi-asserted-by": "crossref", "first-page": "1205", "DOI": "10.1038/sj.onc.1209159", "volume": "25", "author": "YR Chen", "year": "2006", "unstructured": "Chen YR, Fu YN, Lin CH, Yang ST, Hu SF, Chen YT et al. (2006). Distinctive activation patterns in constitutively active and gefitinib-sensitive EGFR mutants. Oncogene 25: 1205\u20131215.", "journal-title": "Oncogene"}, {"key": "BF1210383_CR14", "doi-asserted-by": "crossref", "first-page": "50", "DOI": "10.1038/ncponc0400", "volume": "3", "author": "NW Choong", "year": "2006", "unstructured": "Choong NW, Dietrich S, Seiwert TY, Tretiakova MS, Nallasura V, Davies GC et al. (2006). Gefitinib response of erlotinib-refractory lung cancer involving meninges--role of EGFR mutation. Nat Clin Pract Oncol 3: 50\u201357.", "journal-title": "Nat Clin Pract Oncol"}, {"key": "BF1210383_CR15", "doi-asserted-by": "crossref", "first-page": "521", "DOI": "10.1158/1541-7786.MCR-06-0095", "volume": "4", "author": "CD Coldren", "year": "2006", "unstructured": "Coldren CD, Helfrich BA, Witta SE, Sugita M, Lapadat R, Zeng C et al. (2006). Baseline gene expression predicts sensitivity to gefitinib in NSCLC cell lines. Mol Cancer Res 4: 521\u2013528.", "journal-title": "Mol Cancer Res"}, {"key": "BF1210383_CR16", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1002/ijc.1572", "volume": "97", "author": "L Damstrup", "year": "2002", "unstructured": "Damstrup L, Wandahl PM, Bastholm L, Elling F, Skovgaard PH . (2002). EGFR mutation type III transfected into a SCLC cell line is predominantly localized at the cell surface and enhances the malignant phenotype. Int J Cancer 97: 7\u201314.", "journal-title": "Int J Cancer"}, {"key": "BF1210383_CR17", "doi-asserted-by": "crossref", "first-page": "5900", "DOI": "10.1200/JCO.2005.02.857", "volume": "23", "author": "DA Eberhard", "year": "2005", "unstructured": "Eberhard DA, Johnson BE, Amler LC, Goddard AD, Heldens SL, Herbst RS et al. (2005). Mutations in the EGFR and in KRAS are predictive and prognostic indicators in patients with NSCLC treated with chemotherapy alone and in combination with erlotinib. J Clin Oncol 23: 5900\u20135909.", "journal-title": "J Clin Oncol"}, {"key": "BF1210383_CR18", "doi-asserted-by": "crossref", "first-page": "3788", "DOI": "10.1073/pnas.0409773102", "volume": "102", "author": "JA Engelman", "year": "2005", "unstructured": "Engelman JA, Janne PA, Mermel C, Pearlberg J, Mukohara T, Fleet C et al. (2005). ErbB-3 mediates PI3K activity in gefitinib-sensitive NSCLC cell lines. Proc Natl Acad Sci USA 102: 3788\u20133793.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BF1210383_CR19", "doi-asserted-by": "crossref", "first-page": "2695", "DOI": "10.1172/JCI28656", "volume": "116", "author": "JA Engelman", "year": "2006", "unstructured": "Engelman JA, Mukohara T, Zejnullahu K, Lifshits E, Borras AM, Gale CM et al. (2006). Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer. J Clin Invest 116: 2695\u20132706.", "journal-title": "J Clin Invest"}, {"key": "BF1210383_CR20", "doi-asserted-by": "crossref", "first-page": "329", "DOI": "10.1038/nbt1068", "volume": "23", "author": "MA Fabian", "year": "2005", "unstructured": "Fabian MA, Biggs WH, Treiber DK, Atteridge CE, Azimioara MD, Benedetti MG et al. (2005). A small molecule-kinase interaction map for clinical kinase inhibitors. Nat Biotechnol 23: 329\u2013336.", "journal-title": "Nat Biotechnol"}, {"key": "BF1210383_CR21", "doi-asserted-by": "crossref", "first-page": "892", "DOI": "10.1136/thorax.58.10.892", "volume": "58", "author": "KM Fong", "year": "2003", "unstructured": "Fong KM, Sekido Y, Gazdar AF, Minna JD . (2003). Lung cancer. 9: Molecular biology of lung cancer: clinical implications. Thorax 58: 892\u2013900.", "journal-title": "Thorax"}, {"key": "BF1210383_CR22", "doi-asserted-by": "crossref", "first-page": "11478", "DOI": "10.1158/0008-5472.CAN-05-1977", "volume": "65", "author": "N Fujimoto", "year": "2005", "unstructured": "Fujimoto N, Wislez M, Zhang J, Iwanaga K, Dackor J, Hanna AE et al. (2005). High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of EGFR. Cancer Res 65: 11478\u201311485.", "journal-title": "Cancer Res"}, {"key": "BF1210383_CR23", "doi-asserted-by": "crossref", "first-page": "481", "DOI": "10.1016/j.molmed.2004.08.008", "volume": "10", "author": "AF Gazdar", "year": "2004", "unstructured": "Gazdar AF, Shigematsu H, Herz J, Minna JD . (2004). Mutations and addiction to EGFR: the Achilles \u2018heal\u2019 of lung cancers? Trends Mol Med 10: 481\u2013486.", "journal-title": "Trends Mol Med"}, {"key": "BF1210383_CR24", "doi-asserted-by": "crossref", "first-page": "6049", "DOI": "10.1158/1078-0432.CCR-06-0260", "volume": "12", "author": "G Giaccone", "year": "2006", "unstructured": "Giaccone G, Gallegos Ruiz M, Le Chevalier T, Thatcher N, Smit E, Rodriguez JA et al. (2006). Erlotinib for frontline treatment of advanced NSCLC: a phase II study. Clin Cancer Res 12: 6049\u20136055.", "journal-title": "Clin Cancer Res"}, {"key": "BF1210383_CR25", "doi-asserted-by": "crossref", "first-page": "e269", "DOI": "10.1371/journal.pmed.0020269", "volume": "2", "author": "CH Gow", "year": "2005", "unstructured": "Gow CH, Shih JY, Chang YL, Yu CJ . (2005). Acquired gefitinib-resistant mutation of EGFR in a chemo-naive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R. PLoS Med 2: e269.", "journal-title": "PLoS Med"}, {"key": "BF1210383_CR26", "doi-asserted-by": "crossref", "first-page": "e313", "DOI": "10.1371/journal.pmed.0020313", "volume": "2", "author": "H Greulich", "year": "2005", "unstructured": "Greulich H, Chen TH, Feng W, Janne PA, Alvarez JV, Zappaterra M et al. (2005). Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants. PLoS Med 2: e313.", "journal-title": "PLoS Med"}, {"key": "BF1210383_CR27", "doi-asserted-by": "crossref", "first-page": "689", "DOI": "10.1677/erc.1.00600", "volume": "11", "author": "PM Harari", "year": "2004", "unstructured": "Harari PM . (2004). EGFR inhibition strategies in oncology. Endocr Relat Cancer 11: 689\u2013708.", "journal-title": "Endocr Relat Cancer"}, {"key": "BF1210383_CR28", "doi-asserted-by": "crossref", "first-page": "4441s", "DOI": "10.1158/1078-0432.CCR-06-0286", "volume": "12", "author": "JV Heymach", "year": "2006", "unstructured": "Heymach JV, Nilsson M, Blumenschein G, Papadimitrakopoulou V, Herbst R . (2006). EGFR inhibitors in development for the treatment of NSCLC. Clin Cancer Res 12: 4441s\u20134445s.", "journal-title": "Clin Cancer Res"}, {"key": "BF1210383_CR29", "doi-asserted-by": "crossref", "first-page": "5034", "DOI": "10.1200/JCO.2006.06.3958", "volume": "24", "author": "FR Hirsch", "year": "2006", "unstructured": "Hirsch FR, Varella-Garcia M, Bunn Jr PA, Franklin WA, Dziadziuszko R, Thatcher N et al. (2006). Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced NSCLC. J Clin Oncol 24: 5034\u20135042.", "journal-title": "J Clin Oncol"}, {"key": "BF1210383_CR30", "doi-asserted-by": "crossref", "first-page": "7854", "DOI": "10.1158/0008-5472.CAN-06-1951", "volume": "66", "author": "M Inukai", "year": "2006", "unstructured": "Inukai M, Toyooka S, Ito S, Asano H, Ichihara S, Soh J et al. (2006). Presence of EGFR gene T790M mutation as a minor clone in NSCLC. Cancer Res 66: 7854\u20137858.", "journal-title": "Cancer Res"}, {"key": "BF1210383_CR31", "doi-asserted-by": "crossref", "first-page": "3908", "DOI": "10.1158/1078-0432.CCR-06-0462", "volume": "12", "author": "DM Jackman", "year": "2006", "unstructured": "Jackman DM, Yeap BY, Sequist LV, Lindeman N, Holmes AJ, Joshi VA . (2006). Exon 19 deletion mutations of EGFR are associated with prolonged survival in NSCLC patients treated with gefitinib or erlotinib. Clin Cancer Res 12: 3908\u20133914.", "journal-title": "Clin Cancer Res"}, {"key": "BF1210383_CR32", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1002/ijc.21290", "volume": "118", "author": "ML Janmaat", "year": "2006", "unstructured": "Janmaat ML, Rodriguez JA, Gallegos-Ruiz M, Kruyt FA, Giaccone G . (2006). Enhanced cytotoxicity induced by gefitinib and specific inhibitors of the Ras or PI3K pathways in NSCLC cells. Int J Cancer 118: 209\u2013214.", "journal-title": "Int J Cancer"}, {"key": "BF1210383_CR33", "doi-asserted-by": "crossref", "first-page": "3227", "DOI": "10.1200/JCO.2005.09.985", "volume": "23", "author": "PA Janne", "year": "2005", "unstructured": "Janne PA, Engelman JA, Johnson BE . (2005). EGFR mutations in NSCLC: implications for treatment and tumor biology. J Clin Oncol 23: 3227\u20133234.", "journal-title": "J Clin Oncol"}, {"key": "BF1210383_CR34", "doi-asserted-by": "crossref", "first-page": "485", "DOI": "10.1016/j.ccr.2006.04.022", "volume": "9", "author": "H Ji", "year": "2006", "unstructured": "Ji H, Li D, Chen L, Shimamura T, Kobayashi S, McNamara K et al. (2006). The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies. Cancer Cell 9: 485\u2013495.", "journal-title": "Cancer Cell"}, {"key": "BF1210383_CR35", "doi-asserted-by": "crossref", "first-page": "8968", "DOI": "10.1158/0008-5472.CAN-05-1829", "volume": "65", "author": "J Jiang", "year": "2005", "unstructured": "Jiang J, Greulich H, Janne PA, Sellers WR, Meyerson M, Griffin JD . (2005). EGF-independent transformation of Ba/F3 cells with cancer-derived EGFR mutants induces gefitinib-sensitive cell cycle progression. Cancer Res 65: 8968\u20138974.", "journal-title": "Cancer Res"}, {"key": "BF1210383_CR36", "doi-asserted-by": "crossref", "first-page": "6813", "DOI": "10.1200/JCO.2005.97.008", "volume": "23", "author": "BE Johnson", "year": "2005", "unstructured": "Johnson BE, Janne PA . (2005). Selecting patients for EGFR inhibitor treatment: A FISH story or a tale of mutations? J Clin Oncol 23: 6813\u20136816.", "journal-title": "J Clin Oncol"}, {"key": "BF1210383_CR37", "doi-asserted-by": "crossref", "first-page": "168", "DOI": "10.1038/nature04177", "volume": "439", "author": "RB Jones", "year": "2006", "unstructured": "Jones RB, Gordus A, Krall JA, MacBeath G . (2006). A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature 439: 168\u2013174.", "journal-title": "Nature"}, {"key": "BF1210383_CR38", "doi-asserted-by": "crossref", "first-page": "786", "DOI": "10.1056/NEJMoa044238", "volume": "352", "author": "S Kobayashi", "year": "2005", "unstructured": "Kobayashi S, Boggon TJ, Dayaram T, Janne PA, Kocher O, Meyerson M et al. (2005a). EGFR mutation and resistance of NSCLC to gefitinib. N Engl J Med 352: 786\u2013792.", "journal-title": "N Engl J Med"}, {"key": "BF1210383_CR39", "doi-asserted-by": "crossref", "first-page": "7096", "DOI": "10.1158/0008-5472.CAN-05-1346", "volume": "65", "author": "S Kobayashi", "year": "2005", "unstructured": "Kobayashi S, Ji H, Yuza Y, Meyerson M, Wong KK, Tenen DG et al. (2005b). An alternative inhibitor overcomes resistance caused by a mutation of the EGFR. Cancer Res 65: 7096\u20137101.", "journal-title": "Cancer Res"}, {"key": "BF1210383_CR40", "doi-asserted-by": "crossref", "first-page": "1711", "DOI": "10.1038/sj.bjc.6602559", "volume": "92", "author": "Y Kokubo", "year": "2005", "unstructured": "Kokubo Y, Gemma A, Noro R, Seike M, Kataoka K, Matsuda K et al. (2005). Reduction of PTEN protein and loss of EGFR gene mutation in lung cancer with natural resistance to gefitinib. Br J Cancer 92: 1711\u20131719.", "journal-title": "Br J Cancer"}, {"key": "BF1210383_CR41", "doi-asserted-by": "crossref", "first-page": "7665", "DOI": "10.1073/pnas.0502860102", "volume": "102", "author": "EL Kwak", "year": "2005", "unstructured": "Kwak EL, Sordella R, Bell DW, Godin-Heymann N, Okimoto RA, Brannigan BW et al. (2005). Irreversible inhibitors of the EGFR may circumvent acquired resistance to gefitinib. Proc Natl Acad Sci USA 102: 7665\u20137670.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BF1210383_CR42", "doi-asserted-by": "crossref", "first-page": "2879", "DOI": "10.1158/1078-0432.CCR-04-2029", "volume": "11", "author": "JW Lee", "year": "2005", "unstructured": "Lee JW, Soung YH, Kim SY, Nam HK, Park WS, Nam SW et al. (2005). Somatic mutations of EGFR gene in SCCHN. Clin Cancer Res 11: 2879\u20132882.", "journal-title": "Clin Cancer Res"}, {"key": "BF1210383_CR43", "doi-asserted-by": "crossref", "first-page": "2129", "DOI": "10.1056/NEJMoa040938", "volume": "350", "author": "TJ Lynch", "year": "2004", "unstructured": "Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW et al. (2004a). Activating mutations in the EGFR underlying responsiveness of NSCLC to gefitinib. N Engl J Med 350: 2129\u20132139.", "journal-title": "N Engl J Med"}, {"key": "BF1210383_CR44", "author": "TJ Lynch", "year": "2004", "unstructured": "Lynch TJ, Lilenbaum RC, Bonomi P, Ansari R, Govindan R, Janne PA et al. (2004b). A phase II trial of cetuximab as therapy for recurrent NSCLC. 40th Annual Meeting of the American Society of Clinical Oncology; 5\u20138 June 2004 New Orleans: USA.", "volume-title": "40th Annual Meeting of the American Society of Clinical Oncology"}, {"key": "BF1210383_CR45", "doi-asserted-by": "crossref", "first-page": "526", "DOI": "10.1056/NEJMc052564", "volume": "354", "author": "A Marchetti", "year": "2006", "unstructured": "Marchetti A, Felicioni L, Buttitta F . (2006). Assessing EGFR mutations. N Engl J Med 354: 526\u2013528.", "journal-title": "N Engl J Med"}, {"key": "BF1210383_CR46", "first-page": "1", "volume": "39", "author": "H Mellstedt", "year": "2003", "unstructured": "Mellstedt H . (2003). Monoclonal antibodies in human cancer. Drugs Today 39: 1\u201316.", "journal-title": "Drugs Today"}, {"key": "BF1210383_CR47", "doi-asserted-by": "crossref", "first-page": "2513", "DOI": "10.1200/JCO.2005.00.992", "volume": "23", "author": "T Mitsudomi", "year": "2005", "unstructured": "Mitsudomi T, Kosaka T, Endoh H, Horio Y, Hida T, Mori S et al. (2005). Mutations of the EGFR gene predict prolonged survival after gefitinib treatment in patients with NSCLC with postoperative recurrence. J Clin Oncol 23: 2513\u20132520.", "journal-title": "J Clin Oncol"}, {"key": "BF1210383_CR48", "first-page": "5536", "volume": "55", "author": "DK Moscatello", "year": "1995", "unstructured": "Moscatello DK, Holgado-Madruga M, Godwin AK, Ramirez G, Gunn G, Zoltick PW et al. (1995). Frequent expression of a mutant EGFR in multiple human tumors. Cancer Res 55: 5536\u20135539.", "journal-title": "Cancer Res"}, {"key": "BF1210383_CR49", "doi-asserted-by": "crossref", "first-page": "1185", "DOI": "10.1093/jnci/dji238", "volume": "97", "author": "T Mukohara", "year": "2005", "unstructured": "Mukohara T, Engelman JA, Hanna NH, Yeap BY, Kobayashi S, Lindeman N et al. (2005). Differential effects of gefitinib and cetuximab on NSCLC bearing EGFR mutations. J Natl Cancer Inst 97: 1185\u20131194.", "journal-title": "J Natl Cancer Inst"}, {"key": "BF1210383_CR50", "doi-asserted-by": "crossref", "first-page": "7276", "DOI": "10.1158/0008-5472.CAN-05-0331", "volume": "65", "author": "Y Nagai", "year": "2005", "unstructured": "Nagai Y, Miyazawa H, Huqun, Tanaka T, Udagawa K, Kato M et al. (2005). Genetic heterogeneity of the EGFR in NSCLC cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp. Cancer Res 65: 7276\u20137282.", "journal-title": "Cancer Res"}, {"key": "BF1210383_CR51", "doi-asserted-by": "crossref", "first-page": "64", "DOI": "10.1200/JCO.2005.02.5825", "volume": "24", "author": "S Niho", "year": "2006", "unstructured": "Niho S, Kubota K, Goto K, Yoh K, Ohmatsu H, Kakinuma R et al. (2006). First-line single agent treatment with gefitinib in patients with advanced NSCLC: a phase II study. J Clin Oncol 24: 64\u201369.", "journal-title": "J Clin Oncol"}, {"key": "BF1210383_CR52", "doi-asserted-by": "crossref", "first-page": "1800", "DOI": "10.1126/science.1095920", "volume": "303", "author": "ME Noble", "year": "2004", "unstructured": "Noble ME, Endicott JA, Johnson LN . (2004). Protein kinase inhibitors: insights into drug design from structure. Science 303: 1800\u20131805.", "journal-title": "Science"}, {"key": "BF1210383_CR53", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.2174/1389450053765879", "volume": "6", "author": "N Normanno", "year": "2005", "unstructured": "Normanno N, Bianco C, Strizzi L, Mancino M, Maiello MR, De Luca A et al. (2005). The ErbB receptors and their ligands in cancer: an overview. Curr Drug Targets 6: 243\u2013257.", "journal-title": "Curr Drug Targets"}, {"key": "BF1210383_CR54", "doi-asserted-by": "crossref", "first-page": "50", "DOI": "10.1111/j.1349-7006.2003.tb01351.x", "volume": "94", "author": "I Okamoto", "year": "2003", "unstructured": "Okamoto I, Kenyon LC, Emlet DR, Mori T, Sasaki J, Hirosako et al. (2003). Expression of constitutively activated EGFRvIII in NSCLC. Cancer Sci 94: 50\u201356.", "journal-title": "Cancer Sci"}, {"key": "BF1210383_CR55", "doi-asserted-by": "crossref", "first-page": "605", "DOI": "10.1517/14712598.6.6.605", "volume": "6", "author": "S Oliveira", "year": "2006", "unstructured": "Oliveira S, van Bergen en Henegouwen PM, Storm G, Schiffelers RM . (2006). Molecular biology of EGFR inhibition for cancer therapy. Expert Opin Biol Ther 6: 605\u2013617.", "journal-title": "Expert Opin Biol Ther"}, {"key": "BF1210383_CR56", "doi-asserted-by": "crossref", "first-page": "1497", "DOI": "10.1126/science.1099314", "volume": "304", "author": "JG Paez", "year": "2004", "unstructured": "Paez JG, Janne PA, Lee JC, Tracy S, Greulich H, Gabriel S et al. (2004). EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304: 1497\u20131500.", "journal-title": "Science"}, {"key": "BF1210383_CR57", "doi-asserted-by": "crossref", "first-page": "2556", "DOI": "10.1200/JCO.2005.07.799", "volume": "23", "author": "W Pao", "year": "2005", "unstructured": "Pao W, Miller VA . (2005). EGFR mutations, small-molecule kinase inhibitors, and NSCLC: current knowledge and future directions. J Clin Oncol 23: 2556\u20132568.", "journal-title": "J Clin Oncol"}, {"key": "BF1210383_CR58", "doi-asserted-by": "crossref", "first-page": "e73", "DOI": "10.1371/journal.pmed.0020073", "volume": "2", "author": "W Pao", "year": "2005", "unstructured": "Pao W, Miller VA, Politi KA, Riely GJ, Somwar R, Zakowski MF et al. (2005a). Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med 2: e73.", "journal-title": "PLoS Med"}, {"key": "BF1210383_CR59", "doi-asserted-by": "crossref", "first-page": "13306", "DOI": "10.1073/pnas.0405220101", "volume": "101", "author": "W Pao", "year": "2004", "unstructured": "Pao W, Miller V, Zakowski M, Doherty J, Politi K, Sarkaria I et al. (2004). EGFR gene mutations are common in lung cancers from \u2018never-smokers\u2019 and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 101: 13306\u201313311.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BF1210383_CR60", "doi-asserted-by": "crossref", "first-page": "e17", "DOI": "10.1371/journal.pmed.0020017", "volume": "2", "author": "W Pao", "year": "2005", "unstructured": "Pao W, Wang TY, Riely GJ, Miller VA, Pan Q, Ladanyi M et al. (2005b). KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib. PLoS Med 2: e17.", "journal-title": "PLoS Med"}, {"key": "BF1210383_CR61", "doi-asserted-by": "crossref", "first-page": "504", "DOI": "10.1016/S0962-8924(01)02154-7", "volume": "11", "author": "T Pawson", "year": "2001", "unstructured": "Pawson T, Gish GD, Nash P . (2001). SH2 domains, interaction modules and cellular wiring. Trends Cell Biol 11: 504\u2013511.", "journal-title": "Trends Cell Biol"}, {"key": "BF1210383_CR62", "author": "L Paz-Ares", "year": "2006", "unstructured": "Paz-Ares L, Sanchez JM, Garcia-Velasco A, Massuti B, Lopez-Vivanco G, Provencio M et al. (2006). A prospective phase II trail of erlotinib in advanced NSCLC patients with mutations in the TK domain of the EGFR. 42nd Annual Meeting of the American Society of Clinical Oncology; 2\u20136 June 2006 Atlanta: USA.", "volume-title": "42nd Annual Meeting of the American Society of Clinical Oncology"}, {"key": "BF1210383_CR63", "doi-asserted-by": "crossref", "first-page": "745", "DOI": "10.1023/A:1011177318162", "volume": "12", "author": "MW Pedersen", "year": "2001", "unstructured": "Pedersen MW, Meltorn M, Damstrup L, Poulsen HS . (2001). The type III EGFR mutation. Biological significance and potential target for anti-cancer therapy. Ann Oncol 12: 745\u2013760.", "journal-title": "Ann Oncol"}, {"key": "BF1210383_CR64", "doi-asserted-by": "crossref", "first-page": "40183", "DOI": "10.1074/jbc.M607958200", "volume": "281", "author": "M Perez-Torres", "year": "2006", "unstructured": "Perez-Torres M, Guix M, Gonzalez A, Arteaga CL . (2006). EGFR antibody downregulates mutant receptors and inhibits tumors expressing EGFR mutations. J Biol Chem 281: 40183\u201340192.", "journal-title": "J Biol Chem"}, {"key": "BF1210383_CR65", "doi-asserted-by": "crossref", "first-page": "1496", "DOI": "10.1101/gad.1417406", "volume": "20", "author": "K Politi", "year": "2006", "unstructured": "Politi K, Zakowski MF, Fan PD, Schonfeld EA, Pao W, Varmus HE . (2006). Lung adenocarcinomas induced in mice by mutant EGFR found in human lung cancers respond to a tyrosine kinase inhibitor or to downregulation of the receptors. Genes Dev 20: 1496\u20131510.", "journal-title": "Genes Dev"}, {"key": "BF1210383_CR66", "doi-asserted-by": "crossref", "first-page": "445", "DOI": "10.1002/path.2004", "volume": "209", "author": "JS Reis-Filho", "year": "2006", "unstructured": "Reis-Filho JS, Pinheiro C, Lambros MB, Milanezi F, Carvalho S, Savage K et al. (2006). EGFR amplification and lack of activating mutations in metaplastic breast carcinomas. J Pathol 209: 445\u2013453.", "journal-title": "J Pathol"}, {"key": "BF1210383_CR67", "doi-asserted-by": "crossref", "first-page": "839", "DOI": "10.1158/1078-0432.CCR-05-1846", "volume": "12", "author": "GJ Riely", "year": "2006", "unstructured": "Riely GJ, Pao W, Pham D, Li AR, Rizvi N, Venkatraman ES et al. (2006). Clinical course of patients with NSCLC and EGFR exon 19 and exon 21 mutations treated with gefitinib or erlotinib. Clin Cancer Res 12: 839\u2013844.", "journal-title": "Clin Cancer Res"}, {"key": "BF1210383_CR68", "author": "J Robertson", "year": "2003", "unstructured": "Robertson J, Gutteridge E, Cheung KR, Owers MK, Hamilton L, Gee J et al. (2003). 39th Annual Meeting of the American Society of Clinical Oncology; 31 May-3 June 2003 Chicago: USA.", "volume-title": "39th Annual Meeting of the American Society of Clinical Oncology"}, {"key": "BF1210383_CR69", "doi-asserted-by": "crossref", "first-page": "1014", "DOI": "10.1182/blood.V100.3.1014", "volume": "100", "author": "C Roche-Lestienne", "year": "2002", "unstructured": "Roche-Lestienne C, Soenen-Cornu V, Grardel-Duflos N, Lai JL, Philippe N, Facon T et al. (2002). Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment. Blood 100: 1014\u20131018.", "journal-title": "Blood"}, {"key": "BF1210383_CR70", "first-page": "511", "volume": "1", "author": "JD Sato", "year": "1983", "unstructured": "Sato JD, Kawamoto T, Le AD, Mendelsohn J, Polikoff J, Sato GH . (1983). Biological effects in vitro of monoclonal antibodies to human EGFR. Mol Biol Med 1: 511\u2013529.", "journal-title": "Mol Biol Med"}, {"key": "BF1210383_CR71", "doi-asserted-by": "crossref", "first-page": "1219", "DOI": "10.1200/JCO.2005.04.4420", "volume": "24", "author": "FA Shepherd", "year": "2006", "unstructured": "Shepherd FA, Tsao MS . (2006). Unraveling the mystery of prognostic and predictive factors in EGFR therapy. J Clin Oncol 24: 1219\u20131220.", "journal-title": "J Clin Oncol"}, {"key": "BF1210383_CR72", "doi-asserted-by": "crossref", "first-page": "339", "DOI": "10.1093/jnci/dji055", "volume": "97", "author": "H Shigematsu", "year": "2005", "unstructured": "Shigematsu H, Lin L, Takahashi T, Nomura M, Suzuki M, Wistuba II et al. (2005a). Clinical and biological features associated with EGFR gene mutations in lung cancers. J Natl Cancer Inst 97: 339\u2013346.", "journal-title": "J Natl Cancer Inst"}, {"key": "BF1210383_CR73", "doi-asserted-by": "crossref", "first-page": "6401", "DOI": "10.1158/0008-5472.CAN-05-0933", "volume": "65", "author": "T Shimamura", "year": "2005", "unstructured": "Shimamura T, Lowell AM, Engelman JA, Shapiro GI . (2005). EGFR harboring kinase domain mutations associate with the Hsp90 chaperone and are destabilized following exposure to geldanamycins. Cancer Res 65: 6401\u20136408.", "journal-title": "Cancer Res"}, {"key": "BF1210383_CR74", "doi-asserted-by": "crossref", "first-page": "976", "DOI": "10.1007/s00109-005-0699-4", "volume": "83", "author": "H Sihto", "year": "2005", "unstructured": "Sihto H, Puputti M, Pulli L, Tynninen O, Koskinen W, Aaltonen LM et al. (2005). EGFR domain II, IV, and kinase domain mutations in human solid tumors. J Mol Med 83: 976\u2013983.", "journal-title": "J Mol Med"}, {"key": "BF1210383_CR75", "doi-asserted-by": "crossref", "first-page": "1183", "DOI": "10.1016/j.cellsig.2005.03.026", "volume": "17", "author": "AB Singh", "year": "2005", "unstructured": "Singh AB, Harris RC . (2005). Autocrine, paracrine and juxtacrine signaling by EGFR ligands. Cell Signal 17: 1183\u20131193.", "journal-title": "Cell Signal"}, {"key": "BF1210383_CR76", "doi-asserted-by": "crossref", "first-page": "1163", "DOI": "10.1126/science.1101637", "volume": "305", "author": "R Sordella", "year": "2004", "unstructured": "Sordella R, Bell DW, Haber DA, Settleman J . (2004). Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. Science 305: 1163\u20131167.", "journal-title": "Science"}, {"key": "BF1210383_CR77", "doi-asserted-by": "crossref", "first-page": "6829", "DOI": "10.1200/JCO.2005.01.0793", "volume": "23", "author": "T Takano", "year": "2005", "unstructured": "Takano T, Ohe Y, Sakamoto H, Tsuta K, Matsuno Y, Tateishi U et al. (2005). EGFR gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent NSCLC. J Clin Oncol 23: 6829\u20136837.", "journal-title": "J Clin Oncol"}, {"key": "BF1210383_CR78", "doi-asserted-by": "crossref", "first-page": "2136", "DOI": "10.1056/NEJM200505193522019", "volume": "352", "author": "S Toyooka", "year": "2005", "unstructured": "Toyooka S, Kiura K, Mitsudomi T . (2005). EGFR mutation and response of lung cancer to gefitinib. N Engl J Med 352: 2136.", "journal-title": "N Engl J Med"}, {"key": "BF1210383_CR79", "doi-asserted-by": "crossref", "first-page": "7241", "DOI": "10.1158/0008-5472.CAN-04-1905", "volume": "64", "author": "S Tracy", "year": "2004", "unstructured": "Tracy S, Mukohara T, Hansen M, Meyerson M, Johnson BE, Janne PA . (2004). Gefitinib induces apoptosis in the EGFR-L858R NSCLC cell line H3255. Cancer Res 64: 7241\u20137244.", "journal-title": "Cancer Res"}, {"key": "BF1210383_CR80", "doi-asserted-by": "crossref", "first-page": "133", "DOI": "10.1056/NEJMoa050736", "volume": "353", "author": "MS Tsao", "year": "2005", "unstructured": "Tsao MS, Sakurada A, Cutz JC, Zhu CQ, Kamel-Reid S, Squire J et al. (2005). Erlotinib in lung cancer \u2013 molecular and clinical predictors of outcome. N Engl J Med 353: 133\u2013144.", "journal-title": "N Engl J Med"}, {"key": "BF1210383_CR81", "doi-asserted-by": "crossref", "first-page": "208", "DOI": "10.1056/NEJM200507143530218", "volume": "353", "author": "Z Tsuchihashi", "year": "2005", "unstructured": "Tsuchihashi Z, Khambata-Ford S, Hanna N, Janne PA . (2005). Responsiveness to cetuximab without mutations in EGFR. N Engl J Med 353: 208\u2013209.", "journal-title": "N Engl J Med"}, {"key": "BF1210383_CR82", "doi-asserted-by": "crossref", "first-page": "8865", "DOI": "10.1074/jbc.274.13.8865", "volume": "274", "author": "R Worthylake", "year": "1999", "unstructured": "Worthylake R, Opresko LK, Wiley HS . (1999). ErbB-2 amplification inhibits downregulation and induces constitutive activation of both ErbB-2 and EGFR. J Biol Chem 274: 8865\u20138874.", "journal-title": "J Biol Chem"}, {"key": "BF1210383_CR83", "doi-asserted-by": "crossref", "first-page": "S3", "DOI": "10.1016/S0959-8049(01)00230-1", "volume": "37", "author": "Y Yarden", "year": "2001", "unstructured": "Yarden Y . (2001). The EGFR family and its ligands in human cancer signalling mechanisms and therapeutic opportunities. Eur J Cancer 37: S3\u2013S8.", "journal-title": "Eur J Cancer"}], "container-title": ["Oncogene"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/1210383.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1210383", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1210383.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 19]], "date-time": "2019-04-19T16:37:49Z", "timestamp": 1555691869000}, "score": 21.327116, "issued": {"date-parts": [[2007, 3, 12]]}, "references-count": 83, "journal-issue": {"published-print": {"date-parts": [[2007, 8]]}, "issue": "39"}, "alternative-id": ["BF1210383"], "URL": "http://dx.doi.org/10.1038/sj.onc.1210383", "relation": {"cites": []}, "ISSN": ["0950-9232", "1476-5594"], "issn-type": [{"value": "0950-9232", "type": "print"}, {"value": "1476-5594", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T14:52:54Z", "timestamp": 1574520774003}, "reference-count": 51, "publisher": "Springer Science and Business Media LLC", "issue": "4", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2012, 12, 7]], "date-time": "2012-12-07T00:00:00Z", "timestamp": 1354838400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Invest New Drugs"], "published-print": {"date-parts": [[2013, 8]]}, "DOI": "10.1007/s10637-012-9907-6", "type": "journal-article", "created": {"date-parts": [[2012, 12, 6]], "date-time": "2012-12-06T10:06:43Z", "timestamp": 1354788403000}, "page": "812-822", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Functional and molecular characterization of kinin B1 and B2 receptors in human bladder cancer: implication of the PI3K\u03b3 pathway"], "prefix": "10.1007", "volume": "31", "author": [{"given": "V.", "family": "Sgnaolin", "sequence": "first", "affiliation": []}, {"given": "T. C. B.", "family": "Pereira", "sequence": "additional", "affiliation": []}, {"given": "M. R.", "family": "Bogo", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Zanin", "sequence": "additional", "affiliation": []}, {"given": "A. M. O.", "family": "Battastini", "sequence": "additional", "affiliation": []}, {"given": "F. B.", "family": "Morrone", "sequence": "additional", "affiliation": []}, {"given": "M. M.", "family": "Campos", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2012, 12, 7]]}, "reference": [{"key": "9907_CR1", "doi-asserted-by": "crossref", "first-page": "277", "DOI": "10.3322/caac.20073", "volume": "60", "author": "A Jemal", "year": "2010", "unstructured": "Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277\u2013300", "journal-title": "CA Cancer J Clin"}, {"key": "9907_CR2", "doi-asserted-by": "crossref", "first-page": "1573", "DOI": "10.1016/S0022-5347(05)65157-9", "volume": "167", "author": "MS Soloway", "year": "2002", "unstructured": "Soloway MS, Sofer M, Vaidya A (2002) Contemporary management of stage T1 transitional cell carcinoma of the bladder. J Urol 167:1573\u20131583", "journal-title": "J Urol"}, {"key": "9907_CR3", "doi-asserted-by": "crossref", "first-page": "369", "DOI": "10.1046/j.1464-4096.2001.01699.x", "volume": "89", "author": "A Saad", "year": "2002", "unstructured": "Saad A, Hanbury DC, McNicholas TA, Boustead GB, Morgan S, Woodman AC (2002) A study comparing various noninvasive methods of detecting bladder cancer in urine. BJU Int 89:369\u2013373", "journal-title": "BJU Int"}, {"key": "9907_CR4", "doi-asserted-by": "crossref", "first-page": "1964", "DOI": "10.1016/S0022-5347(05)64273-5", "volume": "168", "author": "RJ Sylvester", "year": "2002", "unstructured": "Sylvester RJ, Van Der MA, Lamm DL (2002) Intravesical bacillus calmette-guerin reduces the risk of progression in patients with superficial bladder cancer: a metaanalysis of the published results of randomized clinical trials. J Urol 168:1964\u20131970", "journal-title": "J Urol"}, {"key": "9907_CR5", "doi-asserted-by": "crossref", "first-page": "2766", "DOI": "10.1002/1097-0142(19871201)60:11<2766::AID-CNCR2820601129>3.0.CO;2-0", "volume": "60", "author": "AM Jordan", "year": "1987", "unstructured": "Jordan AM, Weingarten J, Murphy WM (1987) Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading? Cancer 60:2766\u20132774", "journal-title": "Cancer"}, {"key": "9907_CR6", "first-page": "2893", "volume": "28", "author": "A Lopez-Beltran", "year": "2008", "unstructured": "Lopez-Beltran A, Cheng L, Mazzucchelli R, Bianconi M, Blanca A, Scarpelli M, Montironi R (2008) Morphological and molecular profiles and pathways in bladder neoplasms. Anticancer Res 28:2893\u20132900", "journal-title": "Anticancer Res"}, {"key": "9907_CR7", "doi-asserted-by": "crossref", "first-page": "455", "DOI": "10.1016/j.humpath.2010.07.007", "volume": "42", "author": "L Cheng", "year": "2011", "unstructured": "Cheng L, Zhang S, Maclennan GT, Williamson SR, Lopez-Beltran A, Montironi R (2011) Bladder cancer: translating molecular genetic insights into clinical practice. Hum Pathol 42:455\u2013481", "journal-title": "Hum Pathol"}, {"key": "9907_CR8", "doi-asserted-by": "crossref", "first-page": "445", "DOI": "10.1007/s00345-006-0123-x", "volume": "24", "author": "DJ Golijanin", "year": "2006", "unstructured": "Golijanin DJ, Kakiashvili D, Madeb RR, Messing EM, Lerner SP (2006) Chemoprevention of bladder cancer. World J Urol 24:445\u2013472", "journal-title": "World J Urol"}, {"key": "9907_CR9", "doi-asserted-by": "crossref", "first-page": "346", "DOI": "10.1023/A:1018453104303", "volume": "8", "author": "P Vineis", "year": "1997", "unstructured": "Vineis P, Pirastu R (1997) Aromatic amines and cancer. Cancer Causes Control 8:346\u2013355", "journal-title": "Cancer Causes Control"}, {"key": "9907_CR10", "doi-asserted-by": "crossref", "first-page": "244", "DOI": "10.3322/caac.20077", "volume": "60", "author": "BL Jacobs", "year": "2010", "unstructured": "Jacobs BL, Lee CT, Montie JE (2010) Bladder cancer in 2010: how far have we come? CA Cancer J Clin 60:244\u2013272", "journal-title": "CA Cancer J Clin"}, {"key": "9907_CR11", "doi-asserted-by": "crossref", "first-page": "646", "DOI": "10.1016/j.tips.2006.10.007", "volume": "27", "author": "MM Campos", "year": "2006", "unstructured": "Campos MM, Leal PC, Nunes RA, Calixto JB (2006) Non-peptide antagonists for kinin B1 receptors: new insight sinto their therapeutic potential for the management of inflammation and pain. Trends Pharmacol Sci 27:646\u2013651", "journal-title": "Trends Pharmacol Sci"}, {"key": "9907_CR12", "first-page": "1", "volume": "32", "author": "D Regoli", "year": "1980", "unstructured": "Regoli D, Barabe J (1980) Pharmacology of bradykinin and related kinins. Pharmacol Rev 32:1\u201346", "journal-title": "Pharmacol Rev"}, {"key": "9907_CR13", "doi-asserted-by": "crossref", "first-page": "803", "DOI": "10.1038/sj.bjp.0706012", "volume": "143", "author": "JB Calixto", "year": "2004", "unstructured": "Calixto JB, Medeiros R, Fernandes ES, Ferreira J, Cabrini DA, Campos MM (2004) Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes. Br J Pharmacol 143:803\u2013818", "journal-title": "Br J Pharmacol"}, {"key": "9907_CR14", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1124/pr.57.1.2", "volume": "57", "author": "LM Leeb-Lundberg", "year": "2005", "unstructured": "Leeb-Lundberg LM, Marceau F, M\u00fcller-Esterl W, Pettibone DJ, Zuraw BL (2005) International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 57:27\u201377", "journal-title": "Pharmacol Rev"}, {"key": "9907_CR15", "unstructured": "Ehrenfeld P, Figueroa CD, Bhoola KD (2011) Kinin: kallikreins and kinins in cancer. In: Bader M, editor. Kinin. De Gruyter. pp. 217\u2013245", "DOI": "10.1515/9783110252354.217", "doi-asserted-by": "crossref"}, {"key": "9907_CR16", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1016/S0163-7258(00)00080-2", "volume": "88", "author": "R Mahabeer", "year": "2000", "unstructured": "Mahabeer R, Bhoola KD (2000) Kallikrein and kinin receptor genes. Pharmacol Ther 88:77\u201389", "journal-title": "Pharmacol Ther"}, {"key": "9907_CR17", "doi-asserted-by": "crossref", "first-page": "2036", "DOI": "10.2174/1381612033454171", "volume": "9", "author": "JM Stewart", "year": "2003", "unstructured": "Stewart JM (2003) Bradykinin antagonists as anti-cancer agents. Curr Pharm Des 9:2036\u20132042", "journal-title": "Curr Pharm Des"}, {"key": "9907_CR18", "doi-asserted-by": "crossref", "first-page": "299", "DOI": "10.1517/14728222.2012.662957", "volume": "16", "author": "CD Figueroa", "year": "2012", "unstructured": "Figueroa CD, Ehrenfeld P, Bhoola KD (2012) Kinin receptors as targets for cancer therapy. Expert Opin Ther Targets 16:299\u2013312", "journal-title": "Expert Opin Ther Targets"}, {"key": "9907_CR19", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1515/BC.2001.013", "volume": "382", "author": "K Bhoola", "year": "2001", "unstructured": "Bhoola K, Ramsaroop R, Plendl J, Cassim B, Dlamini Z, Naicker S (2001) Kallikrein and kinin receptor expression in inflammation and cancer. Biol Chem 382:77\u201389", "journal-title": "Biol Chem"}, {"key": "9907_CR20", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1159/000050011", "volume": "55", "author": "JW Wang", "year": "2001", "unstructured": "Wang JW, Su W, Law YP, Lu CH, Chen YC, Wang JL, Chang HJ, Chen WC, Jan CR (2001) Mechanism of bradykinin-induced Ca2+ mobilization in MG63 human osteosarcoma cells. Horm Res 55:265\u2013270", "journal-title": "Horm Res"}, {"key": "9907_CR21", "doi-asserted-by": "crossref", "first-page": "318", "DOI": "10.1254/jjp.87.318", "volume": "87", "author": "K Ishihara", "year": "2001", "unstructured": "Ishihara K, Hayash I, Yamashina S, Majima M (2001) A potential role of bradykinin in angiogenesis and growth of S-180 mouse tumors. Jpn J Pharmacol 87:318\u2013326", "journal-title": "Jpn J Pharmacol"}, {"key": "9907_CR22", "doi-asserted-by": "crossref", "first-page": "499", "DOI": "10.1016/S1567-5769(01)00193-X", "volume": "2", "author": "K Ishihara", "year": "2002", "unstructured": "Ishihara K, Kamata M, Hayashi I, Yamashina S, Majima M (2002) Roles of bradykinin in vascular permeability and angiogenesis in solid tumor. Int Immunopharmacol 2:499\u2013509", "journal-title": "Int Immunopharmacol"}, {"key": "9907_CR23", "doi-asserted-by": "crossref", "first-page": "255", "DOI": "10.1016/S0162-3109(99)00097-1", "volume": "43", "author": "DM Raidoo", "year": "1999", "unstructured": "Raidoo DM, Sawant S, Mahabeer R, Bhoola KD (1999) Kinin receptors are expressed in human astrocytic tumour cells. Immunopharmacology 43:255\u2013263", "journal-title": "Immunopharmacology"}, {"key": "9907_CR24", "first-page": "2037", "volume": "63", "author": "JS Taub", "year": "2003", "unstructured": "Taub JS, Guo R, Leeb-Lundberg LM, Madden JF, Daaka Y (2003) Bradykinin receptor subtype 1 expression and function in prostate cancer. Cancer Res 63:2037\u20132041", "journal-title": "Cancer Res"}, {"key": "9907_CR25", "doi-asserted-by": "crossref", "first-page": "289", "DOI": "10.1016/j.intimp.2007.06.006", "volume": "8", "author": "L Gera", "year": "2008", "unstructured": "Gera L, Stewart JM, Fortin JP, Morissette G, Marceau F (2008) Structural modification of the highly potent peptide bradykinin B1 receptor antagonist B9958. Int Immunopharmacol 8:289\u2013292", "journal-title": "Int Immunopharmacol"}, {"key": "9907_CR26", "doi-asserted-by": "crossref", "first-page": "322", "DOI": "10.1080/02688690500305555", "volume": "19", "author": "Y Zhao", "year": "2005", "unstructured": "Zhao Y, Xue Y, Liu Y, Fu W, Jiang N, An P, Wang P, Yang Z, Wang Y (2005) Study of correlation between expression of bradykinin B2 receptor and pathological grade in human gliomas. Br J Neurosurg 19:322\u2013326", "journal-title": "Br J Neurosurg"}, {"key": "9907_CR27", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1002/ijc.10142", "volume": "98", "author": "J Wu", "year": "2002", "unstructured": "Wu J, Akaike T, Hayashida K, Miyamoto Y, Nakagawa T, Miyakawa K, M\u00fcller-Esterl W, Maeda H (2002) Identification of bradykinin receptors in clinical cancer specimens and murine tumor tissues. Int J Cancer 98:29\u201335", "journal-title": "Int J Cancer"}, {"key": "9907_CR28", "doi-asserted-by": "crossref", "first-page": "260", "DOI": "10.1016/j.urolonc.2009.01.035", "volume": "28", "author": "J Stella", "year": "2010", "unstructured": "Stella J, Bavaresco L, Braganhol E, Rockenbach L, Farias PF, Wink MR, Azambuja AA, Barrios CH, Morrone FB, Oliveira-Battastini AM (2010) Differential ectonucleotidase expression in human bladder cancer cell lines. Urol Oncol 28:260\u2013267", "journal-title": "Urol Oncol"}, {"key": "9907_CR29", "doi-asserted-by": "crossref", "first-page": "499", "DOI": "10.1007/s10549-009-0314-4", "volume": "118", "author": "L Molina", "year": "2009", "unstructured": "Molina L, Matus CE, Astroza A, Pavicic F, Tapia E, Toledo C, Perez JA, Nualart F, Gonzalez CB, Burgos RA, Figueroa CD, Ehrenfeld P, Poblete MT (2009) Stimulation of the bradykinin B1 receptor induces the proliferation of estrogen-sensitive breast cancer cells and activates the ERK 1/2 signaling pathway. Breast Cancer Res Treat 118:499\u2013510", "journal-title": "Breast Cancer Res Treat"}, {"key": "9907_CR30", "doi-asserted-by": "crossref", "first-page": "661", "DOI": "10.1124/jpet.103.059527", "volume": "309", "author": "J Gougat", "year": "2004", "unstructured": "Gougat J, Ferrari B, Sarran L, Planchenault C, Poncelet M, Maruani J, Alonso R, Cudennec A, Croci T, Guagnini F, Urban-Szabo K, Martinolle JP, Soubri\u00e9 P, Finance O, Le Fur G (2004) SSR240612 [(2R)-2-[((3R)-3-(1,3-Benzodioxol-5-yl)-3-{[(6-methoxy-2-naphthyl)sulfonyl]amino}propanoyl) amino]-3-(4-{[2R,6S)-2,6-dimethylpiperidinyl]methyl}phenyl)-N-isopropyl-nmethylpropanamide hydrochloride], a New nonpeptide antagonist of the bradykinin B1 receptor: biochemical and pharmacological characterization. J Pharmacol Exp Ther 309:661\u2013669", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9907_CR31", "doi-asserted-by": "crossref", "first-page": "238", "DOI": "10.1016/j.peptides.2009.12.003", "volume": "31", "author": "T Andoh", "year": "2010", "unstructured": "Andoh T, Akira A, Saiki I, Kuraishi Y (2010) Bradykinin increases the secretion and expression of endothelin-1 through kinin B2 receptors in melanoma cells. Peptides 31:238\u2013241", "journal-title": "Peptides"}, {"key": "9907_CR32", "doi-asserted-by": "crossref", "first-page": "3857", "DOI": "10.1021/jm0601598", "volume": "49", "author": "V Pomel", "year": "2006", "unstructured": "Pomel V, Klicic J, Covini D, Church DD, Shaw JP, Roulin K, Burgat-Charvillon F, Valognes D, Camps M, Chabert C, Gillieron C, Fran\u00e7on B, Perrin D, Leroy D, Gretener D, Nichols A, Vitte PA, Carboni S, Rommel C, Schwarz MK, R\u00fcckle T (2006) Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase gamma. J Med Chem 49:3857\u20133871", "journal-title": "J Med Chem"}, {"key": "9907_CR33", "doi-asserted-by": "crossref", "first-page": "240", "DOI": "10.1186/1471-2407-10-240", "volume": "10", "author": "HW Rho", "year": "2010", "unstructured": "Rho HW, Lee BC, Choi ES, Choi IJ, Lee YS, Goh SH (2010) Identification of valid reference genes for gene expression studies of human stomach cancer by reverse transcription-qPCR. BMC Cancer 10:240", "journal-title": "BMC Cancer"}, {"key": "9907_CR34", "doi-asserted-by": "crossref", "first-page": "1862", "DOI": "10.1016/j.intimp.2007.07.012", "volume": "7", "author": "C Bertram", "year": "2007", "unstructured": "Bertram C, Misso N, Fogel-Petrovic M, Figueroa C, Thompson PJ, Bhoola KD (2007) Comparison of kinin B1 and B2 receptor expression in neutrophils of asthmatic and non-asthmatic subjects. Int Immunopharmacol 7:1862\u20131868", "journal-title": "Int Immunopharmacol"}, {"key": "9907_CR35", "doi-asserted-by": "crossref", "first-page": "419", "DOI": "10.4067/S0716-97602004000300007", "volume": "37", "author": "V Velarde", "year": "2004", "unstructured": "Velarde V, de La Cerda PM, Duarte C, Arancibia F, Abbott E, Gonz\u00e1lez A, Moreno F, Jaffa AA (2004) Role of reactive oxygen species in bradykinininduced proliferation of vascular smooth muscle cells. Biol Res 37:419\u2013430", "journal-title": "Biol Res"}, {"key": "9907_CR36", "doi-asserted-by": "crossref", "first-page": "84", "DOI": "10.1002/jcp.20052", "volume": "201", "author": "S Greco", "year": "2004", "unstructured": "Greco S, Muscella A, Elia MG, Romano S, Storelli C, Marsigliante S (2004) Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells. J Cell Physiol 201:84\u201396", "journal-title": "J Cell Physiol"}, {"key": "9907_CR37", "doi-asserted-by": "crossref", "first-page": "146", "DOI": "10.1016/j.ejphar.2009.03.001", "volume": "613", "author": "DY Lu", "year": "2009", "unstructured": "Lu DY, Tang CH, Yeh WL, Wong KL, Lin CP, Chen YH, Lai CH, Chen YF, Leung YM, Fu WM (2009) SDF-1alpha up-regulates interleukin-6 through CXCR4, PI3K/AKT, ERK, and NF-kappaB-dependent pathway in microglia. Eur J Pharmacol 613:146\u2013154", "journal-title": "Eur J Pharmacol"}, {"key": "9907_CR38", "first-page": "462", "volume": "8", "author": "KD Bhoola", "year": "2007", "unstructured": "Bhoola KD, Misso N, Naran A, Thompson PJ (2007) Current status of tissue kallikrein inhibitors: importance in cancer. Curr Opin Investig Drugs 8:462\u2013468", "journal-title": "Curr Opin Investig Drugs"}, {"key": "9907_CR39", "doi-asserted-by": "crossref", "first-page": "275", "DOI": "10.1139/y02-030", "volume": "80", "author": "JM Stewart", "year": "2002", "unstructured": "Stewart JM, Gera L, Chan DC, Bunn PA Jr, York EJ, Simkeviciene V, Helfrich B (2002) Bradykinin-related compounds as new drugs for cancer and inflammation. Can J Physiol Pharmacol 80:275\u2013280", "journal-title": "Can J Physiol Pharmacol"}, {"key": "9907_CR40", "doi-asserted-by": "crossref", "first-page": "5146", "DOI": "10.1111/j.1742-4658.2010.07928.x", "volume": "277", "author": "S Jutras", "year": "2010", "unstructured": "Jutras S, Bachvarova M, Keita M, Bascands JP, Mes-Masson AM, Stewart JM, Bachvarov D (2010) Strong cytotoxic effect of the bradykinin antagonist BKM-570 in ovarian cancer cells \u2013 analysis of the molecular mechanisms of its antiproliferative action. FEBS J 277:5146\u20135160", "journal-title": "FEBS J"}, {"key": "9907_CR41", "doi-asserted-by": "crossref", "first-page": "44", "DOI": "10.1016/j.jns.2007.02.031", "volume": "258", "author": "YB Wang", "year": "2007", "unstructured": "Wang YB, Peng C, Liu YH (2007) Low dose of bradykinin selectively increases intracellular calcium in glioma cells. J Neurol Sci 258:44\u201351", "journal-title": "J Neurol Sci"}, {"key": "9907_CR42", "doi-asserted-by": "crossref", "first-page": "997", "DOI": "10.1016/j.intimp.2006.01.016", "volume": "6", "author": "W Zelawski", "year": "2006", "unstructured": "Zelawski W, Machnik G, Nowaczyk G, Plewka D, Lorenc Z, Sosada K, Stadnicki A (2006) Expression and localisation of kinin receptors in colorectal polyps. Int Immunopharmacol 6:997\u20131002", "journal-title": "Int Immunopharmacol"}, {"key": "9907_CR43", "doi-asserted-by": "crossref", "first-page": "375", "DOI": "10.1515/BC.2005.045", "volume": "386", "author": "R Moodley", "year": "2005", "unstructured": "Moodley R, Snyman C, Odhav B, Bhoola KD (2005) Visualisation of transforming growth factor-beta 1, tissue kallikrein, and kinin and transforming growth factor-beta receptors on human clear-cell renal carcinoma cells. Biol Chem 386:375\u2013382", "journal-title": "Biol Chem"}, {"key": "9907_CR44", "first-page": "357", "volume": "50", "author": "F Marceau", "year": "1998", "unstructured": "Marceau F, Hess JF, Bachvarov DR (1998) The B1 receptors for kinins. Pharmacol Rev 50:357\u2013386", "journal-title": "Pharmacol Rev"}, {"key": "9907_CR45", "doi-asserted-by": "crossref", "first-page": "1655", "DOI": "10.1126/science.296.5573.1655", "volume": "296", "author": "LC Cantley", "year": "2002", "unstructured": "Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296:1655\u20131657", "journal-title": "Science"}, {"key": "9907_CR46", "doi-asserted-by": "crossref", "first-page": "257", "DOI": "10.1016/S1535-6108(03)00248-4", "volume": "4", "author": "J Luo", "year": "2003", "unstructured": "Luo J, Manning BD, Cantley LC (2003) Targeting the PI3K-AKT pathway in human cancer: rationale and promise. Cancer Cell 4:257\u2013262", "journal-title": "Cancer Cell"}, {"key": "9907_CR47", "doi-asserted-by": "crossref", "first-page": "424", "DOI": "10.1038/nature04869", "volume": "25", "author": "RJ Shaw", "year": "2006", "unstructured": "Shaw RJ, Cantley LC (2006) Ras, PI3K and mTOR signalling controls tumour cell growth. Nature 25:424\u2013430", "journal-title": "Nature"}, {"key": "9907_CR48", "doi-asserted-by": "crossref", "first-page": "1881", "DOI": "10.1007/s00432-010-0847-2", "volume": "136", "author": "V Spitzenberg", "year": "2010", "unstructured": "Spitzenberg V, K\u00f6nig C, Ulm S, Marone R, R\u00f6pke L, M\u00fcller JP, Gr\u00fcn M, Bauer R, Rubio I, Wymann MP, Voigt A, Wetzker R (2010) Targeting PI3K in neuroblastoma. J Cancer Res Clin Oncol 136:1881\u20131890", "journal-title": "J Cancer Res Clin Oncol"}, {"key": "9907_CR49", "doi-asserted-by": "crossref", "first-page": "305", "DOI": "10.1007/s10555-009-9198-3", "volume": "28", "author": "MA Knowles", "year": "2009", "unstructured": "Knowles MA, Platt FM, Ross RL, Hurst CD (2009) Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer. Cancer Metastasis Rev 28:305\u2013316", "journal-title": "Cancer Metastasis Rev"}, {"key": "9907_CR50", "doi-asserted-by": "crossref", "first-page": "291", "DOI": "10.1677/joe.1.06052", "volume": "186", "author": "S Greco", "year": "2005", "unstructured": "Greco S, Elia MG, Muscella A, Romano S, Storelli C (2005) Bradykinin stimulates cell proliferation through an extracellularregulated kinase 1 and 2-dependent mechanism in breast cancer cells in primary culture. J Endocrinol 186:291\u2013301", "journal-title": "J Endocrinol"}, {"key": "9907_CR51", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1677/joe.1.06433", "volume": "188", "author": "S Greco", "year": "2006", "unstructured": "Greco S, Storelli C, Marsigliante S (2006) Protein kinase C (PKC)-delta/-epsilon mediate the PKC/AKT-dependent phosphorylation of extracellular signal-regulated kinases 1 and 2 in MCF-7 cells stimulated by bradykinin. J Endocrinol 188:79\u201389", "journal-title": "J Endocrinol"}], "container-title": ["Investigational New Drugs"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s10637-012-9907-6.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s10637-012-9907-6/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s10637-012-9907-6", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 30]], "date-time": "2019-05-30T20:08:03Z", "timestamp": 1559246883000}, "score": 20.654, "issued": {"date-parts": [[2012, 12, 7]]}, "references-count": 51, "journal-issue": {"published-print": {"date-parts": [[2013, 8]]}, "issue": "4"}, "alternative-id": ["9907"], "URL": "http://dx.doi.org/10.1007/s10637-012-9907-6", "relation": {"cites": []}, "ISSN": ["0167-6997", "1573-0646"], "issn-type": [{"value": "0167-6997", "type": "print"}, {"value": "1573-0646", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T03:57:53Z", "timestamp": 1574135873826}, "reference-count": 27, "publisher": "Elsevier BV", "issue": "13-14", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2002, 12, 1]], "date-time": "2002-12-01T00:00:00Z", "timestamp": 1038700800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["International Immunopharmacology"], "published-print": {"date-parts": [[2002, 12]]}, "DOI": "10.1016/s1567-5769(02)00188-1", "type": "journal-article", "created": {"date-parts": [[2002, 12, 2]], "date-time": "2002-12-02T19:16:37Z", "timestamp": 1038856597000}, "page": "1771-1779", "source": "Crossref", "is-referenced-by-count": 17, "title": ["Diabetes modulates the expression of glomerular kinin receptors"], "prefix": "10.1016", "volume": "2", "author": [{"given": "Julie", "family": "Christopher", "sequence": "first", "affiliation": []}, {"given": "Ayad A", "family": "Jaffa", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["International Immunopharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1567576902001881?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1567576902001881?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 9]], "date-time": "2019-04-09T01:51:25Z", "timestamp": 1554774685000}, "score": 20.597734, "issued": {"date-parts": [[2002, 12]]}, "references-count": 27, "journal-issue": {"published-print": {"date-parts": [[2002, 12]]}, "issue": "13-14"}, "alternative-id": ["S1567576902001881"], "URL": "http://dx.doi.org/10.1016/s1567-5769(02)00188-1", "ISSN": ["1567-5769"], "issn-type": [{"value": "1567-5769", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T07:02:53Z", "timestamp": 1575097373372}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1995, 1, 1]], "date-time": "1995-01-01T00:00:00Z", "timestamp": 788918400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pharmacological Research"], "published-print": {"date-parts": [[1995, 1]]}, "DOI": "10.1016/1043-6618(95)87238-8", "type": "journal-article", "created": {"date-parts": [[2003, 10, 11]], "date-time": "2003-10-11T09:00:14Z", "timestamp": 1065862814000}, "page": "245", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Functional characterization of vasopressin receptors in human uterine artery"], "prefix": "10.1016", "volume": "31", "author": [{"given": "L.", "family": "Grbovi\u0107", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Jovanovi\u0107", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Pharmacological Research"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:1043661895872388?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:1043661895872388?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 20]], "date-time": "2019-02-20T19:23:08Z", "timestamp": 1550690588000}, "score": 20.374954, "issued": {"date-parts": [[1995, 1]]}, "references-count": 0, "alternative-id": ["1043661895872388"], "URL": "http://dx.doi.org/10.1016/1043-6618(95)87238-8", "ISSN": ["1043-6618"], "issn-type": [{"value": "1043-6618", "type": "print"}], "subject": ["Pharmacology"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T03:07:01Z", "timestamp": 1574132821101}, "reference-count": 61, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1995, 5, 1]], "date-time": "1995-05-01T00:00:00Z", "timestamp": 799286400000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "https://www.elsevier.com/open-access/userlicense/1.0/", "start": {"date-parts": [[2013, 7, 17]], "date-time": "2013-07-17T00:00:00Z", "timestamp": 1374019200000}, "delay-in-days": 6652, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuron"], "published-print": {"date-parts": [[1995, 5]]}, "DOI": "10.1016/0896-6273(95)90341-0", "type": "journal-article", "created": {"date-parts": [[2004, 7, 21]], "date-time": "2004-07-21T18:22:43Z", "timestamp": 1090434163000}, "page": "1029-1038", "source": "Crossref", "is-referenced-by-count": 85, "title": ["Heterologous expression of metabotropic glutamate receptors in adult rat sympathetic neurons: Subtype-specific coupling to ion channels"], "prefix": "10.1016", "volume": "14", "author": [{"given": "Stephen R", "family": "Ikeda", "sequence": "first", "affiliation": []}, {"given": "David M", "family": "Lovinger", "sequence": "additional", "affiliation": []}, {"given": "Brian A", "family": "McCool", "sequence": "additional", "affiliation": []}, {"given": "Deborah L", "family": "Lewis", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Neuron"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0896627395903410?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0896627395903410?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 5]], "date-time": "2019-02-05T17:54:40Z", "timestamp": 1549389280000}, "score": 20.348597, "issued": {"date-parts": [[1995, 5]]}, "references-count": 61, "journal-issue": {"published-print": {"date-parts": [[1995, 5]]}, "issue": "5"}, "alternative-id": ["0896627395903410"], "URL": "http://dx.doi.org/10.1016/0896-6273(95)90341-0", "ISSN": ["0896-6273"], "issn-type": [{"value": "0896-6273", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T17:41:34Z", "timestamp": 1575222094603}, "reference-count": 25, "publisher": "American Society for Pharmacology & Experimental Therapeutics (ASPET)", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Mol Pharmacol"], "published-print": {"date-parts": [[1997, 5, 1]]}, "DOI": "10.1124/mol.51.5.711", "type": "journal-article", "created": {"date-parts": [[2018, 1, 8]], "date-time": "2018-01-08T20:26:41Z", "timestamp": 1515443201000}, "page": "711-720", "source": "Crossref", "is-referenced-by-count": 99, "title": ["Subtype-Specific Intracellular Trafficking of \u03b12-Adrenergic Receptors"], "prefix": "10.1124", "volume": "51", "author": [{"given": "David A.", "family": "Daunt", "sequence": "first", "affiliation": []}, {"given": "Carl", "family": "Hurt", "sequence": "additional", "affiliation": []}, {"given": "Lutz", "family": "Hein", "sequence": "additional", "affiliation": []}, {"given": "Jaana", "family": "Kallio", "sequence": "additional", "affiliation": []}, {"given": "Felix", "family": "Feng", "sequence": "additional", "affiliation": []}, {"given": "Brian K.", "family": "Kobilka", "sequence": "additional", "affiliation": []}], "member": "36", "published-online": {"date-parts": [[1997, 5, 1]]}, "reference": [{"key": "2019092416585355000_51.5.711.1", "DOI": "10.1016/0165-6147(88)90254-4", "doi-asserted-by": "publisher"}, {"key": "2019092416585355000_51.5.711.2", "first-page": "600", "article-title": "\u03b1-2A and \u03b1-2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtype.", "volume": "245", "author": "Bylund", "year": "1988", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "2019092416585355000_51.5.711.3", "DOI": "10.1021/bi00227a024", "doi-asserted-by": "publisher"}, {"key": "2019092416585355000_51.5.711.4", "first-page": "9852", "article-title": "Factors determining the specificity of signal transduction by guanine nucleotide-binding protein-coupled receptors. II. Preferential coupling of the \u03b12C-adrenergic receptor to the guanine nucleotide-binding protein, Go.", "volume": "267", "author": "Coupry", "year": "1992", "journal-title": "J. Biol. Chem."}, {"key": "2019092416585355000_51.5.711.5", "first-page": "9844", "article-title": "Factors determining the specificity of signal transduction by guanine nucleotide-binding protein-coupled receptors. I. Coupling of \u03b12-adrenergic receptor subtypes to distinct G-proteins.", "volume": "267", "author": "Duzic", "year": "1992", "journal-title": "J. Biol. Chem."}, {"key": "2019092416585355000_51.5.711.6", "first-page": "15795", "article-title": "Simultaneous coupling of \u03b12-adrenergic receptors to two G-proteins with opposing effects: subtype-selective coupling of \u03b12C10, \u03b12C4, and \u03b12C2 adrenergic receptors to Gi and Gs.", "volume": "267", "author": "Eason", "year": "1992", "journal-title": "J. Biol. Chem."}, {"key": "2019092416585355000_51.5.711.7", "first-page": "696", "article-title": "Contribution of ligand structure to activation of \u03b12-adrenergic receptor subtype coupling to Gs.", "volume": "45", "author": "Eason", "year": "1994", "journal-title": "Mol. Pharmacol."}, {"key": "2019092416585355000_51.5.711.8", "DOI": "10.1016/0922-4106(94)90106-6", "doi-asserted-by": "publisher"}, {"key": "2019092416585355000_51.5.711.9", "first-page": "24045", "article-title": "Factors determining the specificity of signal transduction by guanine nucleotide-binding protein-coupled receptors. III. Coupling of \u03b12-adrenergic receptor subtypes in a cell type-specific manner.", "volume": "267", "author": "Duzic", "year": "1992", "journal-title": "J. Biol. Chem."}, {"key": "2019092416585355000_51.5.711.10", "first-page": "63", "article-title": "Multiple second messenger pathways of \u03b1-adrenergic receptor subtypes expressed in eukaryotic cells.", "volume": "265", "author": "Cotecchia", "year": "1990", "journal-title": "J. Biol. Chem."}, {"key": "2019092416585355000_51.5.711.11", "DOI": "10.1126/science.1354394", "doi-asserted-by": "publisher"}, {"key": "2019092416585355000_51.5.711.12", "first-page": "25473", "article-title": "Subtype-selective desensitization of \u03b12-adrenergic receptors: different mechanisms control short and long term agonist-promoted desensitization of \u03b12C10, \u03b12C4, and \u03b12C2.", "volume": "267", "author": "Eason", "year": "1992", "journal-title": "J. Biol. Chem."}, {"key": "2019092416585355000_51.5.711.13", "DOI": "10.1006/bbrc.1993.1626", "doi-asserted-by": "publisher"}, {"key": "2019092416585355000_51.5.711.14", "DOI": "10.1074/jbc.270.9.4681", "doi-asserted-by": "publisher"}, {"key": "2019092416585355000_51.5.711.15", "first-page": "4740", "article-title": "Sites in the third intracellular loop of the \u03b12A-adrenergic receptor confer short term agonist-promoted desensitization: evidence for a receptor kinase-mediated mechanism.", "volume": "267", "author": "Liggett", "year": "1992", "journal-title": "J. Biol. Chem."}, {"key": "2019092416585355000_51.5.711.16", "first-page": "763", "article-title": "Subtype-specific differences in the intracellular sorting of G protein-coupled receptors.", "volume": "268", "author": "von", "year": "1993", "journal-title": "J. Biol. Chem."}, {"key": "2019092416585355000_51.5.711.17", "DOI": "10.1074/jbc.271.9.5017", "doi-asserted-by": "publisher"}, {"key": "2019092416585355000_51.5.711.18", "first-page": "27719", "article-title": "Intracellular targeting and trafficking of thrombin receptors: a novel mechanism for resensitization of a G protein-coupled receptor.", "volume": "269", "author": "Hein", "year": "1994", "journal-title": "J. Biol. Chem."}, {"key": "2019092416585355000_51.5.711.19", "first-page": "9780", "article-title": "Kinetics of thrombin receptor cleavage on intact cells: relation to signaling.", "volume": "268", "author": "Ishii", "year": "1993", "journal-title": "J. Biol. Chem."}, {"key": "2019092416585355000_51.5.711.20", "DOI": "10.1016/0092-8674(91)90261-V", "doi-asserted-by": "publisher"}, {"key": "2019092416585355000_51.5.711.21", "first-page": "15488", "article-title": "A point mutation in the seventh hydrophobic domain of the \u03b12 adrenergic receptor increases its affinity for a family of beta receptor antagonists.", "volume": "266", "author": "Suryanarayana", "year": "1991", "journal-title": "J. Biol. Chem."}, {"key": "2019092416585355000_51.5.711.22", "first-page": "666", "article-title": "Sequestration and recycling of \u03b22-adrenergic receptors permit receptor resensitization.", "volume": "47", "author": "Pippig", "year": "1995", "journal-title": "Mol. Pharmacol."}, {"key": "2019092416585355000_51.5.711.23", "DOI": "10.1126/science.271.5247.363", "doi-asserted-by": "publisher"}, {"key": "2019092416585355000_51.5.711.24", "DOI": "10.1073/pnas.91.23.11178", "doi-asserted-by": "publisher"}, {"key": "2019092416585355000_51.5.711.25", "DOI": "10.1038/333129a0", "doi-asserted-by": "publisher"}], "container-title": ["Molecular Pharmacology"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1124/mol.51.5.711", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 25]], "date-time": "2019-09-25T00:02:47Z", "timestamp": 1569369767000}, "score": 20.348597, "issued": {"date-parts": [[1997, 5, 1]]}, "references-count": 25, "journal-issue": {"published-online": {"date-parts": [[1997, 5, 1]]}, "published-print": {"date-parts": [[1997, 5, 1]]}, "issue": "5"}, "alternative-id": ["10.1124/mol.51.5.711"], "URL": "http://dx.doi.org/10.1124/mol.51.5.711", "relation": {"cites": []}, "ISSN": ["0026-895X", "1521-0111"], "issn-type": [{"value": "0026-895X", "type": "print"}, {"value": "1521-0111", "type": "electronic"}], "subject": ["Molecular Medicine", "Pharmacology"]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T09:24:48Z", "timestamp": 1575105888190}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "6-7", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1999, 1, 1]], "date-time": "1999-01-01T00:00:00Z", "timestamp": 915148800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Life Sciences"], "published-print": {"date-parts": [[1999, 1]]}, "DOI": "10.1016/s0024-3205(99)90478-2", "type": "journal-article", "created": {"date-parts": [[2003, 11, 17]], "date-time": "2003-11-17T14:20:04Z", "timestamp": 1069078804000}, "page": "561", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Characterization of the subtype selectivity of the allosteric modulator, C7/3-phth, at cloned muscarinic acetylcholine receptors"], "prefix": "10.1016", "volume": "64", "author": [{"given": "E.E.", "family": "El-Fakahany", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Christopoulos", "sequence": "additional", "affiliation": []}, {"given": "J.L.", "family": "Sorman", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Mitchelson", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Life Sciences"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0024320599904782?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0024320599904782?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 17]], "date-time": "2019-02-17T01:28:13Z", "timestamp": 1550366893000}, "score": 20.147888, "issued": {"date-parts": [[1999, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1999, 1]]}, "issue": "6-7"}, "alternative-id": ["S0024320599904782"], "URL": "http://dx.doi.org/10.1016/s0024-3205(99)90478-2", "ISSN": ["0024-3205"], "issn-type": [{"value": "0024-3205", "type": "print"}], "subject": ["General Pharmacology, Toxicology and Pharmaceutics", "General Biochemistry, Genetics and Molecular Biology", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T07:08:59Z", "timestamp": 1574320139669}, "publisher-location": "Totowa, NJ", "reference-count": 89, "publisher": "Humana Press", "isbn-type": [{"value": "9781607611851", "type": "print"}, {"value": "9781607611868", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2009]]}, "DOI": "10.1007/978-1-60761-186-8_11", "type": "book-chapter", "created": {"date-parts": [[2009, 8, 31]], "date-time": "2009-08-31T17:18:24Z", "timestamp": 1251739104000}, "page": "135-150", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Kinin Receptors and ACE Inhibitors: An Interrelationship"], "prefix": "10.1007", "author": [{"given": "Ervin G.", "family": "Erd\u00f6s", "sequence": "first", "affiliation": []}, {"given": "Fulong", "family": "Tan", "sequence": "additional", "affiliation": []}, {"given": "Randal A.", "family": "Skidgel", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2009, 8, 5]]}, "reference": [{"key": "11_CR1", "doi-asserted-by": "publisher", "first-page": "569", "DOI": "10.1016/0024-3205(67)90090-2", "volume": "6", "author": "E. G. Erd\u00f6s", "year": "1967", "unstructured": "Erd\u00f6s, E. G., and Yang, H. Y. T. (1967) An enzyme in microsomal fraction of kidney that inactivates bradykinin, Life Sci 6, 569\u2013574.", "journal-title": "Life Sci"}, {"key": "11_CR2", "first-page": "291", "volume": "177", "author": "H. Y. Yang", "year": "1971", "unstructured": "Yang, H. Y., Erd\u00f6s, E. G., and Levin, Y. (1971) Characterization of a dipeptide hydrolase (kininase II: angiotensin I converting enzyme), J Pharmacol Exp Ther 177, 291\u2013300.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "11_CR3", "doi-asserted-by": "publisher", "first-page": "1402", "DOI": "10.1038/2151402a0", "volume": "215", "author": "H. Y. T. Yang", "year": "1967", "unstructured": "Yang, H. Y. T., and Erd\u00f6s, E. G. (1967) Second kininase in human blood plasma, Nature 215, 1402\u20131403.", "journal-title": "Nature"}, {"key": "11_CR4", "doi-asserted-by": "crossref", "first-page": "374", "DOI": "10.1016/0005-2795(70)90017-6", "volume": "214", "author": "H. Y. T. Yang", "year": "1970", "unstructured": "Yang, H. Y. T., Erd\u00f6s, E. G., and Levin, Y. (1970) A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin, Biochim. Biophys. Acta 214, 374\u2013376.", "journal-title": "Biochim. Biophys. Acta"}, {"key": "11_CR5", "doi-asserted-by": "publisher", "first-page": "295", "DOI": "10.1084/jem.103.3.295", "volume": "103", "author": "L. T. Skeggs Jr", "year": "1956", "unstructured": "Skeggs, L. T., Jr., Kahn, J. R., and Shumway, N. P. (1956) The preparation and function of the hypertensin-converting enzyme, J Exp Med 103, 295\u2013299.", "journal-title": "J Exp Med"}, {"key": "11_CR6", "doi-asserted-by": "publisher", "first-page": "H1796", "DOI": "10.1152/ajpheart.00781.2005", "volume": "289", "author": "O. A. Carretero", "year": "2005", "unstructured": "Carretero, O. A. (2005) Novel mechanism of action of ACE and its inhibitors, Am J Physiol Heart Circ Physiol 289, H1796\u2013H1797.", "journal-title": "Am J Physiol Heart Circ Physiol"}, {"key": "11_CR7", "doi-asserted-by": "publisher", "first-page": "2436", "DOI": "10.1161/CIRCULATIONAHA.104.528695", "volume": "112", "author": "H. Peng", "year": "2005", "unstructured": "Peng, H., Carretero, O. A., Vuljaj, N., Liao, T. D., Motivala, A., Peterson, E. L., and Rhaleb, N. E. (2005) Angiotensin-converting enzyme inhibitors: a new mechanism of action, Circulation 112, 2436\u20132445.", "journal-title": "Circulation"}, {"key": "11_CR8", "doi-asserted-by": "crossref", "first-page": "770", "DOI": "10.1161/01.CIR.58.5.770", "volume": "58", "author": "H. P. Gavras", "year": "1978", "unstructured": "Gavras, H. P., Faxon, D. P., Berkoben, J., Brunner, H. R., and Ryan, T. J. (1978) Angiotensin converting enzyme inhibition in patients with congestive heart failure, Circulation 58, 770\u2013776.", "journal-title": "Circulation"}, {"key": "11_CR9", "doi-asserted-by": "publisher", "first-page": "3310", "DOI": "10.1073/pnas.79.10.3310", "volume": "79", "author": "J. M. Pfeffer", "year": "1982", "unstructured": "Pfeffer, J. M., Pfeffer, M. A., Mirsky, I., and Braunwald, E. (1982) Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat, Proc Natl Acad Sci USA 79, 3310\u20133314.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "11_CR10", "doi-asserted-by": "publisher", "first-page": "26", "DOI": "10.1161/CIRCULATIONAHA.105.592733", "volume": "114", "author": "S. D. Solomon", "year": "2006", "unstructured": "Solomon, S. D., Rice, M. M., Jablonski, K. A., Jose, P., Domanski, M., Sabatine, M., Gersh, B. J., Rouleau, J., Pfeffer, M. A., and Braunwald, E. (2006) Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial, Circulation 114, 26\u201331.", "journal-title": "Circulation"}, {"key": "11_CR11", "doi-asserted-by": "crossref", "first-page": "H2021", "DOI": "10.1152/ajpheart.00647.2006", "volume": "291", "author": "M. A. Pfeffer", "year": "2006", "unstructured": "Pfeffer, M. A., and Frohlich, E. D. (2006) Improvements in clinical outcomes with the use of angiotensin converting enzyme inhibitors: cross-fertilization between clinical and basic investigation, Am J Physiol Heart Circ Physiol 291: H2021\u20132025.", "journal-title": "Am J Physiol Heart Circ Physiol"}, {"key": "11_CR12", "doi-asserted-by": "publisher", "first-page": "145", "DOI": "10.1056/NEJM200001203420301", "volume": "342", "author": "S. Yusuf", "year": "2000", "unstructured": "Yusuf, S., Sleight, P., Pogue, J., Bosch, J., Davies, R., and Dagenais, G. (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators, N Engl J Med 342, 145\u2013153.", "journal-title": "N Engl J Med"}, {"key": "11_CR13", "doi-asserted-by": "crossref", "first-page": "238", "DOI": "10.1111/j.1476-5381.1994.tb14050.x", "volume": "111", "author": "M. Hecker", "year": "1994", "unstructured": "Hecker, M., Porsti, I., Bara, A. T., and Busse, R. (1994) Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level, Br J Pharmacol 111, 238\u2013244.", "journal-title": "Br J Pharmacol"}, {"key": "11_CR14", "doi-asserted-by": "publisher", "first-page": "312", "DOI": "10.1093/cvr/27.2.312", "volume": "27", "author": "W. Auch-Schwelk", "year": "1993", "unstructured": "Auch-Schwelk, W., Bossaller, C., Claus, M., Graf, K., Grafe, M., and Fleck, E. (1993) ACE inhibitors are endothelium dependent vasodilators of coronary arteries during submaximal stimulation with bradykinin, Cardiovasc Res 27, 312\u2013317.", "journal-title": "Cardiovasc Res"}, {"key": "11_CR15", "first-page": "91", "volume": "20", "author": "I. Fleming", "year": "2005", "unstructured": "Fleming, I., Kohlstedt, K., and Busse, R. (2005) New fACEs to the renin-angiotensin system, Physiology (Bethesda) 20, 91\u201395.", "journal-title": "Physiology (Bethesda)"}, {"key": "11_CR16", "doi-asserted-by": "publisher", "first-page": "1034", "DOI": "10.1096/fj.06-0602ufm", "volume": "20", "author": "E. G. Erd\u00f6s", "year": "2006", "unstructured": "Erd\u00f6s, E. G. (2006) The ACE and I: how ACE inhibitors came to be, Faseb J 20, 1034\u20131038.", "journal-title": "Faseb J"}, {"key": "11_CR17", "doi-asserted-by": "publisher", "first-page": "223", "DOI": "10.1016/S1043-2760(99)00156-3", "volume": "10", "author": "E. G. Erd\u00f6s", "year": "1999", "unstructured": "Erd\u00f6s, E. G., Deddish, P. A., and Marcic, B. M. (1999) Potentiation of bradykinin actions by ACE inhibitors, Trends Endocrinol Metab 10, 223\u2013229.", "journal-title": "Trends Endocrinol Metab"}, {"key": "11_CR18", "doi-asserted-by": "publisher", "first-page": "159", "DOI": "10.1515/BC.2006.021", "volume": "387", "author": "R. A. Skidgel", "year": "2006", "unstructured": "Skidgel, R. A., Stanisavljevic, S., and Erd\u00f6s, E. G. (2006) Kinin- and angiotensin-converting enzyme (ACE) inhibitor-mediated nitric oxide production in endothelial cells, Biol Chem 387, 159\u2013165.", "journal-title": "Biol Chem"}, {"key": "11_CR19", "first-page": "1", "volume": "32", "author": "D. Regoli", "year": "1980", "unstructured": "Regoli, D., and Barabe, J. (1980) Pharmacology of bradykinin and related kinins, Pharmacol Rev 32, 1\u201346.", "journal-title": "Pharmacol Rev"}, {"key": "11_CR20", "doi-asserted-by": "publisher", "first-page": "7994", "DOI": "10.1074/jbc.M709837200", "volume": "283", "author": "X. Zhang", "year": "2008", "unstructured": "Zhang, X., Tan, F., Zhang, Y., and Skidgel, R. A. (2008) Carboxypeptidase M and kinin B1 receptors interact to facilitate efficient B1 signaling from B2 agonists, J Biol Chem 283, 7994\u20138004.", "journal-title": "J Biol Chem"}, {"key": "11_CR21", "doi-asserted-by": "publisher", "first-page": "299", "DOI": "10.1016/0165-6147(88)90015-6", "volume": "9", "author": "R. A. Skidgel", "year": "1988", "unstructured": "Skidgel, R. A. (1988) Basic carboxypeptidases: regulators of peptide hormone activity, Trends Pharmacol Sci 9, 299\u2013304.", "journal-title": "Trends Pharmacol Sci"}, {"key": "11_CR22", "doi-asserted-by": "publisher", "first-page": "1888", "DOI": "10.1016/j.intimp.2007.07.014", "volume": "7", "author": "R. A. Skidgel", "year": "2007", "unstructured": "Skidgel, R. A., and Erd\u00f6s, E. G. (2007) Structure and function of human plasma carboxypeptidase N, the anaphylatoxin inactivator, Int Immunopharmacol 7, 1888\u20131899.", "journal-title": "Int Immunopharmacol"}, {"key": "11_CR23", "doi-asserted-by": "publisher", "first-page": "1310", "DOI": "10.1124/mol.104.001990", "volume": "66", "author": "T. Ignjatovic", "year": "2004", "unstructured": "Ignjatovic, T., Stanisavljevic, S., Brovkovych, V., Skidgel, R. A., and Erd\u00f6s, E. G. (2004) Kinin B1 receptors stimulate nitric oxide production in endothelial cells: signaling pathways activated by angiotensin I-converting enzyme inhibitors and peptide ligands, Mol Pharmacol 66, 1310\u20131316.", "journal-title": "Mol Pharmacol"}, {"key": "11_CR24", "unstructured": "Ignjatovic, T., Stanisavljevic, S., Brovkovych, V., Tan, F., Skidgel, R. A., and Erd\u00f6s, E. G. (2006) ACE inhibitors directly activate bradykinin B1 receptors to release NO, in Renin-Angiotensin-Aldosterone System (Frohlich, E. D., and Re, R. N., Eds.), pp. 163\u2013176, Springer Science + Business Media, New York.", "DOI": "10.1007/0-387-27826-5_13", "doi-asserted-by": "crossref"}, {"key": "11_CR25", "doi-asserted-by": "publisher", "first-page": "16847", "DOI": "10.1074/jbc.M200355200", "volume": "277", "author": "T. Ignjatovic", "year": "2002", "unstructured": "Ignjatovic, T., Tan, F., Brovkovych, V., Skidgel, R. A., and Erd\u00f6s, E. G. (2002) Novel mode of action of angiotensin I converting enzyme inhibitors. Direct activation of bradykinin B1 receptor, J Biol Chem 277, 16847\u201316852.", "journal-title": "J Biol Chem"}, {"key": "11_CR26", "doi-asserted-by": "publisher", "first-page": "27", "DOI": "10.1124/pr.57.1.2", "volume": "57", "author": "L. M. Leeb-Lundberg", "year": "2005", "unstructured": "Leeb-Lundberg, L. M., Marceau, F., Muller-Esterl, W., Pettibone, D. J., and Zuraw, B. L. (2005) International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences, Pharmacol Rev 57, 27\u201377.", "journal-title": "Pharmacol Rev"}, {"key": "11_CR27", "doi-asserted-by": "publisher", "first-page": "1153", "DOI": "10.1124/jpet.105.093849", "volume": "316", "author": "S. Stanisavljevic", "year": "2006", "unstructured": "Stanisavljevic, S., Ignjatovic, T., Deddish, P. A., Brovkovych, V., Zhang, K., Erd\u00f6s, E. G., and Skidgel, R. A. (2006) Angiotensin I-converting enzyme inhibitors block protein kinase C epsilon by activating bradykinin B1 receptors in human endothelial cells, J Pharmacol Exp Ther 316, 1153\u20131158.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "11_CR28", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/S0014-2999(00)00046-7", "volume": "392", "author": "P. B. Simpson", "year": "2000", "unstructured": "Simpson, P. B., Woollacott, A. J., Hill, R. G., and Seabrook, G. R. (2000) Functional characterization of bradykinin analogues on recombinant human bradykinin B(1) and B(2) receptors, Eur J Pharmacol 392, 1\u20139.", "journal-title": "Eur J Pharmacol"}, {"key": "11_CR29", "doi-asserted-by": "publisher", "first-page": "276", "DOI": "10.1016/j.intimp.2007.10.001", "volume": "8", "author": "R. Zubakova", "year": "2008", "unstructured": "Zubakova, R., Gille, A., Faussner, A., and Hilgenfeldt, U. (2008) Ca2+ signalling of kinins in cells expressing rat, mouse and human B1/B2-receptor, Int Immunopharmacol 8, 276\u2013281.", "journal-title": "Int Immunopharmacol"}, {"key": "11_CR30", "doi-asserted-by": "crossref", "first-page": "332", "DOI": "10.1016/B978-0-12-079611-3.50090-2", "volume-title": "Handbook of Proteolytic Enzymes", "author": "P. Corvol", "year": "2004", "unstructured": "Corvol, P., Eyries, M., and Soubrier, F. (2004) Peptidyl-dipeptidase A/angiotensin I-converting enzyme, in Handbook of Proteolytic Enzymes (Barrett, A. J., Rawlings, N. D., and Woessner, J. F., Eds.) 2nd ed., pp. 332\u2013346, Academic Press, San Diego, CA.", "edition": "2"}, {"key": "11_CR31", "doi-asserted-by": "publisher", "first-page": "515", "DOI": "10.1124/jpet.106.108803", "volume": "319", "author": "S. Donnini", "year": "2006", "unstructured": "Donnini, S., Solito, R., Giachetti, A., Granger, H. J., Ziche, M., and Morbidelli, L. (2006) Fibroblast growth factor-2 mediates Angiotensin-converting enzyme inhibitor-induced angiogenesis in coronary endothelium, J Pharmacol Exp Ther 319, 515\u2013522.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "11_CR32", "doi-asserted-by": "publisher", "first-page": "3281", "DOI": "10.1161/01.CIR.0000147274.83071.68", "volume": "110", "author": "J. J. McMurray", "year": "2004", "unstructured": "McMurray, J. J., Pfeffer, M. A., Swedberg, K., and Dzau, V. J. (2004) Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction? Circulation 110, 3281\u20133288.", "journal-title": "Circulation"}, {"key": "11_CR33", "doi-asserted-by": "publisher", "first-page": "424", "DOI": "10.1161/01.RES.0000138299.85648.92", "volume": "95", "author": "P. H. Goldspink", "year": "2004", "unstructured": "Goldspink, P. H., Montgomery, D. E., Walker, L. A., Urboniene, D., McKinney, R. D., Geenen, D. L., Solaro, R. J., and Buttrick, P. M. (2004) Protein kinase Cepsilon overexpression alters myofilament properties and composition during the progression of heart failure, Circ Res 95, 424\u2013432.", "journal-title": "Circ Res"}, {"key": "11_CR34", "doi-asserted-by": "crossref", "first-page": "H1959", "DOI": "10.1152/ajpheart.00036.2003", "volume": "284", "author": "S. Sangsree", "year": "2003", "unstructured": "Sangsree, S., Brovkovych, V., Minshall, R. D., and Skidgel, R. A. (2003) Kininase I-type carboxypeptidases enhance nitric oxide production in endothelial cells by generating bradykinin B1 receptor agonists, Am J Physiol Heart Circ Physiol 284, H1959\u2013H1968.", "journal-title": "Am J Physiol Heart Circ Physiol"}, {"key": "11_CR35", "doi-asserted-by": "publisher", "first-page": "257", "DOI": "10.1016/j.jmb.2004.02.058", "volume": "338", "author": "D. Reverter", "year": "2004", "unstructured": "Reverter, D., Maskos, K., Tan, F., Skidgel, R. A., and Bode, W. (2004) Crystal structure of human carboxypeptidase M, a membrane-bound enzyme that regulates peptide hormone activity, J Mol Biol 338, 257\u2013269.", "journal-title": "J Mol Biol"}, {"key": "11_CR36", "doi-asserted-by": "crossref", "first-page": "851", "DOI": "10.1016/B978-0-12-079611-3.50260-3", "volume-title": "Handbook of Proteolytic Enzymes", "author": "R. A. Skidgel", "year": "2004", "unstructured": "Skidgel, R. A. (2004) Carboxypeptidase M, in Handbook of Proteolytic Enzymes (Barrett, A. J., Rawlings, N. D., and Woessner, J. F., Eds.) 2nd ed., pp. 851\u2013854, Elsevier Academic Press, San Diego.", "edition": "2"}, {"key": "11_CR37", "doi-asserted-by": "publisher", "first-page": "129", "DOI": "10.1111/j.1600-065X.1998.tb01577.x", "volume": "161", "author": "R. A. Skidgel", "year": "1998", "unstructured": "Skidgel, R. A., and Erd\u00f6s, E. G. (1998) Cellular carboxypeptidases, Immunol Rev 161, 129\u2013141.", "journal-title": "Immunol Rev"}, {"key": "11_CR38", "author": "C. E. Odya", "first-page": "287", "year": "1979", "unstructured": "Odya, C. E., and Goodfriend, T. L. (1979) Bradykinin Receptors, in Bradykinin, Kallidin and Kallikrein (Erd\u00f6s, E. G., Ed.), pp 287\u2013300, Springer-Verlag, Heidelberg, Germany.", "volume-title": "Bradykinin, Kallidin and Kallikrein", "DOI": "10.1007/978-3-642-67301-6_7", "doi-asserted-by": "crossref"}, {"key": "11_CR39", "doi-asserted-by": "publisher", "first-page": "1975", "DOI": "10.1021/bi00460a002", "volume": "29", "author": "R. A. Roberts", "year": "1990", "unstructured": "Roberts, R. A., and Gullick, W. J. (1990) Bradykinin receptors undergo ligand-induced desensitization, Biochemistry 29, 1975\u20131979.", "journal-title": "Biochemistry"}, {"key": "11_CR40", "doi-asserted-by": "publisher", "first-page": "16110", "DOI": "10.1074/jbc.M909490199", "volume": "275", "author": "B. Marcic", "year": "2000", "unstructured": "Marcic, B., Deddish, P. A., Skidgel, R. A., Erd\u00f6s, E. G., Minshall, R. D., and Tan, F. (2000) Replacement of the transmembrane anchor in angiotensin I-converting enzyme (ACE) with a glycosylphosphatidylinositol tail affects activation of the B2 bradykinin receptor by ACE inhibitors, J Biol Chem 275, 16110\u201316118.", "journal-title": "J Biol Chem"}, {"key": "11_CR41", "doi-asserted-by": "publisher", "first-page": "173", "DOI": "10.1016/0006-2952(78)90297-6", "volume": "27", "author": "C. E. Odya", "year": "1978", "unstructured": "Odya, C. E., Levin, Y., Erd\u00f6s, E. G., and Robinson, C. J. (1978) Soluble dextran complexes of kallikrein. Bradykinin and enzyme inhibitors, Biochem Pharmacol 27, 173\u2013179.", "journal-title": "Biochem Pharmacol"}, {"key": "11_CR42", "doi-asserted-by": "publisher", "first-page": "2261", "DOI": "10.1096/fj.06-6113com", "volume": "20", "author": "Z. Chen", "year": "2006", "unstructured": "Chen, Z., Deddish, P. A., Minshall, R. D., Becker, R. P., Erd\u00f6s, E. G., and Tan, F. (2006) Human ACE and bradykinin B2 receptors form a complex at the plasma membrane, FASEB J 20, 2261\u20132270.", "journal-title": "FASEB J"}, {"key": "11_CR43", "doi-asserted-by": "publisher", "first-page": "193", "DOI": "10.1016/0014-2999(88)90423-2", "volume": "155", "author": "G. Drapeau", "year": "1988", "unstructured": "Drapeau, G., Rhaleb, N. E., Dion, S., Jukic, D., and Regoli, D. (1988) [Phe8 psi(CH2-NH)Arg9]bradykinin, a B2 receptor selective agonist which is not broken down by either kininase I or kininase II, Eur J Pharmacol 155, 193\u2013195.", "journal-title": "Eur J Pharmacol"}, {"key": "11_CR44", "doi-asserted-by": "publisher", "first-page": "551", "DOI": "10.1038/nature01370", "volume": "421", "author": "R. Natesh", "year": "2003", "unstructured": "Natesh, R., Schwager, S. L., Sturrock, E. D., and Acharya, K. R. (2003) Crystal structure of the human angiotensin-converting enzyme-lisinopril complex, Nature 421, 551\u2013554.", "journal-title": "Nature"}, {"key": "11_CR45", "doi-asserted-by": "publisher", "first-page": "1741", "DOI": "10.1016/S1567-5769(02)00166-2", "volume": "2", "author": "E. G. Erd\u00f6s", "year": "2002", "unstructured": "Erd\u00f6s, E. G., and Deddish, P. A. (2002) The kinin system: suggestions to broaden some prevailing concepts, Int Immunopharmacol 2, 1741\u20131746.", "journal-title": "Int Immunopharmacol"}, {"key": "11_CR46", "doi-asserted-by": "publisher", "first-page": "132A", "DOI": "10.1016/S0002-9149(97)00468-2", "volume": "80", "author": "R. D. Minshall", "year": "1997", "unstructured": "Minshall, R. D., Erd\u00f6s, E. G., and Vogel, S. M. (1997) Angiotensin I-converting enzyme inhibitors potentiate bradykinin\u2019s inotropic effects independently of blocking its inactivation, Am J Cardiol 80, 132A-136A.", "journal-title": "Am J Cardiol"}, {"key": "11_CR47", "doi-asserted-by": "crossref", "first-page": "835", "DOI": "10.1161/01.HYP.33.3.835", "volume": "33", "author": "B. Marcic", "year": "1999", "unstructured": "Marcic, B., Deddish, P. A., Jackman, H. L., and Erd\u00f6s, E. G. (1999) Enhancement of bradykinin and resensitization of its B2 receptor, Hypertension 33, 835\u2013843.", "journal-title": "Hypertension"}, {"key": "11_CR48", "first-page": "605", "volume": "294", "author": "B. M. Marcic", "year": "2000", "unstructured": "Marcic, B. M., and Erd\u00f6s, E. G. (2000) Protein kinase C and phosphatase inhibitors block the ability of angiotensin I-converting enzyme inhibitors to resensitize the receptor to bradykinin without altering the primary effects of bradykinin, J Pharmacol Exp Ther 294, 605\u2013612.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "11_CR49", "doi-asserted-by": "publisher", "first-page": "719", "DOI": "10.1515/BC.2008.083", "volume": "389", "author": "M. Koch", "year": "2008", "unstructured": "Koch, M., Bonaventura, K., Spillmann, F., Dendorfer, A., Schultheiss, H. P., and Tschope, C. (2008) Attenuation of left ventricular dysfunction by an ACE inhibitor after myocardial infarction in a kininogen-deficient rat model, Biol Chem 389, 719\u2013723.", "journal-title": "Biol Chem"}, {"key": "11_CR50", "doi-asserted-by": "publisher", "first-page": "1368", "DOI": "10.1161/01.HYP.0000188905.20884.63", "volume": "46", "author": "Z. Chen", "year": "2005", "unstructured": "Chen, Z., Tan, F., Erd\u00f6s, E. G., and Deddish, P. A. (2005) Hydrolysis of angiotensin peptides by human angiotensin I-converting enzyme and the resensitization of B2 kinin receptors, Hypertension 46, 1368\u20131373.", "journal-title": "Hypertension"}, {"key": "11_CR51", "doi-asserted-by": "publisher", "first-page": "2583", "DOI": "10.1021/bi00815a005", "volume": "9", "author": "S. H. Ferreira", "year": "1970", "unstructured": "Ferreira, S. H., Bartelt, D. C., and Greene, L. J. (1970) Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom, Biochemistry 9, 2583\u20132593.", "journal-title": "Biochemistry"}, {"key": "11_CR52", "doi-asserted-by": "publisher", "first-page": "817", "DOI": "10.1056/NEJM197410172911603", "volume": "291", "author": "H. Gavras", "year": "1974", "unstructured": "Gavras, H., Brunner, H. R., Laragh, J. H., Sealey, J. E., Gavras, I., and Vukovich, R. A. (1974) An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients, N Engl J Med 291, 817\u2013821.", "journal-title": "N Engl J Med"}, {"key": "11_CR53", "first-page": "177", "volume": "8", "author": "R. Vogel", "year": "1970", "unstructured": "Vogel, R., Werle, E., and Zickgraf-Rudel, G. (1970) Current aspects of kinin research. I. Potentiation and blocking of biological kinin activity, Z Klin Chem Klin Biochem 8, 177\u2013185.", "journal-title": "Z Klin Chem Klin Biochem"}, {"key": "11_CR54", "doi-asserted-by": "publisher", "first-page": "1235", "DOI": "10.1016/j.peptides.2005.03.046", "volume": "26", "author": "S. Mueller", "year": "2005", "unstructured": "Mueller, S., Gothe, R., Siems, W. D., Vietinghoff, G., Paegelow, I., and Reissmann, S. (2005) Potentiation of bradykinin actions by analogues of the bradykinin potentiating nonapeptide BPP9alpha, Peptides 26, 1235\u20131247.", "journal-title": "Peptides"}, {"key": "11_CR55", "doi-asserted-by": "publisher", "first-page": "1257", "DOI": "10.1016/S0196-9781(00)00267-9", "volume": "21", "author": "R. D. Minshall", "year": "2000", "unstructured": "Minshall, R. D., Nedumgottil, S. J., Igic, R., Erd\u00f6s, E. G., and Rabito, S. F. (2000) Potentiation of the effects of bradykinin on its receptor in the isolated guinea pig ileum, Peptides 21, 1257\u20131264.", "journal-title": "Peptides"}, {"key": "11_CR56", "doi-asserted-by": "publisher", "first-page": "40431", "DOI": "10.1074/jbc.M107024200", "volume": "276", "author": "A. Blaukat", "year": "2001", "unstructured": "Blaukat, A., Pizard, A., Breit, A., Wernstedt, C., Alhenc-Gelas, F., Muller-Esterl, W., and Dikic, I. (2001) Determination of bradykinin B2 receptor in vivo phosphorylation sites and their role in receptor function, J Biol Chem 276, 40431\u201340440.", "journal-title": "J Biol Chem"}, {"key": "11_CR57", "doi-asserted-by": "publisher", "first-page": "43", "DOI": "10.1515/BC.2001.007", "volume": "382", "author": "E. G. Erd\u00f6s", "year": "2001", "unstructured": "Erd\u00f6s, E. G., and Marcic, B. M. (2001) Kinins, receptors, kininases and inhibitors\u2013where did they lead us? Biol Chem 382, 43\u201347.", "journal-title": "Biol Chem"}, {"key": "11_CR58", "doi-asserted-by": "crossref", "first-page": "848", "DOI": "10.1161/01.RES.81.5.848", "volume": "81", "author": "R. D. Minshall", "year": "1997", "unstructured": "Minshall, R. D., Tan, F., Nakamura, F., Rabito, S. F., Becker, R. P., Marcic, B., and Erd\u00f6s, E. G. (1997) Potentiation of the actions of bradykinin by angiotensin I converting enzyme (ACE) inhibitors. The role of expressed human bradykinin B2 receptors and ACE in CHO cells, Circul. Res. 81, 848\u2013856.", "journal-title": "Circul. Res"}, {"key": "11_CR59", "doi-asserted-by": "publisher", "first-page": "2699", "DOI": "10.1021/bi051674v", "volume": "45", "author": "S. Michineau", "year": "2006", "unstructured": "Michineau, S., Alhenc-Gelas, F., and Rajerison, R. M. (2006) Human bradykinin B2 receptor sialylation and N-glycosylation participate with disulfide bonding in surface receptor dimerization, Biochemistry 45, 2699\u20132707.", "journal-title": "Biochemistry"}, {"key": "11_CR60", "doi-asserted-by": "publisher", "first-page": "7807", "DOI": "10.1073/pnas.91.16.7807", "volume": "91", "author": "P. A. Deddish", "year": "1994", "unstructured": "Deddish, P. A., Wang, J., Michel, B., Morris, P. W., Davidson, N. O., Skidgel, R. A., and Erd\u00f6s, E. G. (1994) Naturally occurring active N-domain of human angiotensin I-converting enzyme, Proc Natl Acad Sci USA 91, 7807\u20137811.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "11_CR61", "doi-asserted-by": "publisher", "first-page": "254", "DOI": "10.1016/j.intimp.2007.09.013", "volume": "8", "author": "B. M. Redublo Quinto", "year": "2008", "unstructured": "Redublo Quinto, B. M., Camargo de Andrade, M. C., Ronchi, F. A., Santos, E. L., Alves Correa, S. A., Shimuta, S. I., Pesquero, J. B., Mortara, R. A., and Casarini, D. E. (2008) Expression of angiotensin I-converting enzymes and bradykinin B2 receptors in mouse inner medullary-collecting duct cells, Int Immunopharmacol 8, 254\u2013260.", "journal-title": "Int Immunopharmacol"}, {"key": "11_CR62", "doi-asserted-by": "publisher", "first-page": "429", "DOI": "10.2119/2007-00112.Fernandes", "volume": "14", "author": "F. B. Fernandes", "year": "2008", "unstructured": "Fernandes, F. B., Plavnik, F. L., Teixeira, A. M., Christofalo, D. M., Ajzen, S. A., Higa, E. M., Ronchi, F. A., Sesso, R. C., and Casarini, D. E. (2008) Association of urinary N-domain Angiotensin I-converting enzyme with plasma inflammatory markers and endothelial function, Mol Med 14, 429\u2013435.", "journal-title": "Mol Med"}, {"key": "11_CR63", "author": "R. A. Skidgel", "first-page": "pp 10.11\u201310.10", "year": "1993", "unstructured": "Skidgel, R. A., and Erd\u00f6s, E. G. (1993) Biochemistry of angiotensin converting enzyme, in The Renin-Angiotensin System. (Robertson, J. I. S., and Nicholls, M. G., Eds.), pp 10.11\u201310.10, Gower Medical Publishers, London, England.", "volume-title": "The Renin-Angiotensin System"}, {"key": "11_CR64", "doi-asserted-by": "publisher", "first-page": "1580", "DOI": "10.1021/pr060658x", "volume": "6", "author": "I. V. Balyasnikova", "year": "2007", "unstructured": "Balyasnikova, I. V., Skirgello, O. E., Binevski, P. V., Nesterovitch, A. B., Albrecht, R. F., 2nd, Kost, O. A., and Danilov, S. M. (2007) Monoclonal Antibodies 1G12 and 6A12 to the N-domain of human angiotensin-converting enzyme: fine epitope mapping and antibody-based detection of ACE inhibitors in human blood, J Proteome Res 6, 1580\u20131594.", "journal-title": "J Proteome Res"}, {"key": "11_CR65", "doi-asserted-by": "publisher", "first-page": "84", "DOI": "10.1016/S0014-5793(03)00825-1", "volume": "550", "author": "P. V. Binevski", "year": "2003", "unstructured": "Binevski, P. V., Sizova, E. A., Pozdnev, V. F., and Kost, O. A. (2003) Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin-converting enzyme, FEBS Lett 550, 84\u201388.", "journal-title": "FEBS Lett"}, {"key": "11_CR66", "doi-asserted-by": "publisher", "first-page": "12654", "DOI": "10.1021/bi061146z", "volume": "45", "author": "J. M. Watermeyer", "year": "2006", "unstructured": "Watermeyer, J. M., Sewell, B. T., Schwager, S. L., Natesh, R., Corradi, H. R., Acharya, K. R., and Sturrock, E. D. (2006) Structure of testis ACE glycosylation mutants and evidence for conserved domain movement, Biochemistry 45, 12654\u201312663.", "journal-title": "Biochemistry"}, {"key": "11_CR67", "doi-asserted-by": "publisher", "first-page": "32453", "DOI": "10.1074/jbc.M706242200", "volume": "282", "author": "Y. Zhang", "year": "2007", "unstructured": "Zhang, Y., Brovkovych, V., Brovkovych, S., Tan, F., Lee, B. S., Sharma, T., and Skidgel, R. A. (2007) Dynamic receptor-dependent activation of inducible nitric-oxide synthase by ERK-mediated phosphorylation of Ser745, J Biol Chem 282, 32453\u201332461.", "journal-title": "J Biol Chem"}, {"key": "11_CR68", "doi-asserted-by": "publisher", "first-page": "E268", "DOI": "10.1152/ajpendo.00382.2005", "volume": "291", "author": "A. Duka", "year": "2006", "unstructured": "Duka, A., Duka, I., Gao, G., Shenouda, S., Gavras, I., and Gavras, H. (2006) Role of bradykinin B1 and B2 receptors in normal blood pressure regulation, Am J Physiol Endocrinol Metab 291, E268\u2013E274.", "journal-title": "Am J Physiol Endocrinol Metab"}, {"key": "11_CR69", "doi-asserted-by": "publisher", "first-page": "747", "DOI": "10.1161/01.HYP.0000153322.04859.81", "volume": "45", "author": "J. Xu", "year": "2005", "unstructured": "Xu, J., Carretero, O. A., Sun, Y., Shesely, E. G., Rhaleb, N. E., Liu, Y. H., Liao, T. D., Yang, J. J., Bader, M., and Yang, X. P. (2005) Role of the B1 kinin receptor in the regulation of cardiac function and remodeling after myocardial infarction, Hypertension 45, 747\u2013753.", "journal-title": "Hypertension"}, {"key": "11_CR70", "doi-asserted-by": "crossref", "first-page": "837", "DOI": "10.1016/B978-0-12-079611-3.50255-X", "volume-title": "Handbook of Proteolytic Enzymes", "author": "R. A. Skidgel", "year": "2004", "unstructured": "Skidgel, R. A., and Erd\u00f6s, E. G. (2004) Lysine carboxypeptidase, in Handbook of Proteolytic Enzymes (Barret, A. J., Rawlings, N. D., and Woessner, J.F Eds.) 2nd ed., pp. 837\u2013839, Academic Press, San Diego, CA.", "edition": "2"}, {"key": "11_CR71", "doi-asserted-by": "publisher", "first-page": "F82", "DOI": "10.1152/ajprenal.00139.2006", "volume": "292", "author": "H. A. Shaltout", "year": "2007", "unstructured": "Shaltout, H. A., Westwood, B. M., Averill, D. B., Ferrario, C. M., Figueroa, J. P., Diz, D. I., Rose, J. C., and Chappell, M. C. (2007) Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II, Am J Physiol Renal Physiol 292, F82\u2013F91.", "journal-title": "Am J Physiol Renal Physiol"}, {"key": "11_CR72", "first-page": "1936", "volume-title": "Handbook of Proteolytic Enzymes", "author": "F. Tan", "year": "2004", "unstructured": "Tan, F., and Erd\u00f6s, E. G. (2004) Lysosomal Pro-X carboxypeptidase, in Handbook of Proteolytic Enzymes, (Barrett, A. J., Rawlings, N. D., and Woessner, J. F., Eds.) 2nd ed, pp. 1936\u20131937, Academic Press, San Diego, CA.", "edition": "2"}, {"key": "11_CR73", "doi-asserted-by": "publisher", "first-page": "3265", "DOI": "10.1021/bi00282a035", "volume": "22", "author": "J. T. Gafford", "year": "1983", "unstructured": "Gafford, J. T., Skidgel, R. A., Erd\u00f6s, E. G., and Hersh, L. B. (1983) Human kidney \u201cenkephalinase\u201d, a neutral metalloendopeptidase that cleaves active peptides, Biochemistry 22, 3265\u20133271.", "journal-title": "Biochemistry"}, {"key": "11_CR74", "first-page": "564", "volume": "132", "author": "A. R. Johnson", "year": "1985", "unstructured": "Johnson, A. R., Ashton, J., Schulz, W. W., and Erd\u00f6s, E. G. (1985) Neutral metalloendopeptidase in human lung tissue and cultured cells, Am Rev Respir Dis 132, 564\u2013568.", "journal-title": "Am Rev Respir Dis"}, {"key": "11_CR75", "first-page": "1262", "volume": "132", "author": "A. R. Johnson", "year": "1985", "unstructured": "Johnson, A. R., Coalson, J. J., Ashton, J., Larumbide, M., and Erd\u00f6s, E. G. (1985) Neutral endopeptidase in serum samples from patients with adult respiratory distress syndrome. Comparison with angiotensin-converting enzyme, Am Rev Respir Dis 132, 1262\u20131267.", "journal-title": "Am Rev Respir Dis"}, {"key": "11_CR76", "doi-asserted-by": "crossref", "first-page": "377", "DOI": "10.1042/bj2140377", "volume": "214", "author": "N. S. Gee", "year": "1983", "unstructured": "Gee, N. S., Matsas, R., and Kenny, A. J. (1983) A monoclonal antibody to kidney endopeptidase-24.11. Its application in immunoadsorbent purification of the enzyme and immunofluorescent microscopy of kidney and intestine, Biochem J 214, 377\u2013386.", "journal-title": "Biochem J"}, {"key": "11_CR77", "doi-asserted-by": "publisher", "first-page": "619", "DOI": "10.1161/hy0202.103298", "volume": "39", "author": "P. A. Deddish", "year": "2002", "unstructured": "Deddish, P. A., Marcic, B. M., Tan, F., Jackman, H. L., Chen, Z., and Erd\u00f6s, E. G. (2002) Neprilysin inhibitors potentiate effects of bradykinin on B2 receptor, Hypertension 39, 619\u2013623.", "journal-title": "Hypertension"}, {"key": "11_CR78", "doi-asserted-by": "publisher", "first-page": "8737", "DOI": "10.1073/pnas.82.24.8737", "volume": "82", "author": "J. C. Connelly", "year": "1985", "unstructured": "Connelly, J. C., Skidgel, R. A., Schulz, W. W., Johnson, A. R., and Erd\u00f6s, E. G. (1985) Neutral endopeptidase 24.11 in human neutrophils: Cleavage of chemotactic peptide, Proc Natl Acad Sci USA 82, 8737\u20138741.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "11_CR79", "first-page": "188", "volume-title": "Hypertension Primer: The Essentials of High BLood Pressure, Basic Science, Population Science and Clinical Management", "author": "E. Frohlich", "year": "2008", "unstructured": "Frohlich, E. (2008) Pathogenesis of Hypertensive Left Ventricular Hypertrophy and Diastolic Dysfunction, in Hypertension Primer: The Essentials of High BLood Pressure, Basic Science, Population Science and Clinical Management (Izzo, J. L., Sica, D. A., and Black, H. R., Eds.) 4th ed., pp. 188\u2013190, Lippincott Williams and Wilkins Philadelphia.", "edition": "4"}, {"key": "11_CR80", "doi-asserted-by": "publisher", "first-page": "3667", "DOI": "10.1161/01.CIR.0000149806.01354.BF", "volume": "110", "author": "M. P. Tokmakova", "year": "2004", "unstructured": "Tokmakova, M. P., Skali, H., Kenchaiah, S., Braunwald, E., Rouleau, J. L., Packer, M., Chertow, G. M., Moye, L. A., Pfeffer, M. A., and Solomon, S. D. (2004) Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study, Circulation 110, 3667\u20133673.", "journal-title": "Circulation"}, {"key": "11_CR81", "doi-asserted-by": "crossref", "first-page": "851", "DOI": "10.1042/bj2320851", "volume": "232", "author": "Y. Takada", "year": "1985", "unstructured": "Takada, Y., Skidgel, R. A., and Erd\u00f6s, E. G. (1985) Purification of human urinary prokallikrein. Identification of the site of activation by the metalloproteinase thermolysin, Biochem J 232, 851\u2013858.", "journal-title": "Biochem J"}, {"key": "11_CR82", "doi-asserted-by": "crossref", "first-page": "484", "DOI": "10.1161/01.RES.84.4.484", "volume": "84", "author": "W. B. Campbell", "year": "1999", "unstructured": "Campbell, W. B., and Harder, D. R. (1999) Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone, Circ. Res. 84, 484\u2013488.", "journal-title": "Circ. Res"}, {"key": "11_CR83", "doi-asserted-by": "publisher", "first-page": "2323", "DOI": "10.1111/j.1538-7836.2007.02770.x", "volume": "5", "author": "A. H. Schmaier", "year": "2007", "unstructured": "Schmaier, A. H., and McCrae, K. R. (2007) The plasma kallikrein-kinin system: its evolution from contact activation, J Thromb Haemost 5, 2323\u20132329.", "journal-title": "J Thromb Haemost"}, {"key": "11_CR84", "doi-asserted-by": "publisher", "first-page": "715", "DOI": "10.1161/HYPERTENSIONAHA.108.114587", "volume": "52", "author": "J. Chao", "year": "2008", "unstructured": "Chao, J., Yin, H., Gao, L., Hagiwara, M., Shen, B., Yang, Z. R., and Chao, L. (2008) Tissue kallikrein elicits cardioprotection by direct kinin B2 receptor activation independent of kinin formation, Hypertension 52, 715\u2013720.", "journal-title": "Hypertension"}, {"key": "11_CR85", "doi-asserted-by": "publisher", "first-page": "H1244", "DOI": "10.1152/ajpheart.00934.2005", "volume": "290", "author": "D. Biyashev", "year": "2006", "unstructured": "Biyashev, D., Tan, F., Chen, Z., Zhang, K., Deddish, P. A., Erd\u00f6s, E. G., and Hecquet, C. (2006) Kallikrein activates bradykinin B2 receptors in absence of kininogen, Am J Physiol Heart Circ Physiol 290, H1244\u2013H1250.", "journal-title": "Am J Physiol Heart Circ Physiol"}, {"key": "11_CR86", "doi-asserted-by": "crossref", "first-page": "828", "DOI": "10.1124/mol.58.4.828", "volume": "58", "author": "C. Hecquet", "year": "2000", "unstructured": "Hecquet, C., Tan, F., Marcic, B. M., and Erd\u00f6s, E. G. (2000) Human bradykinin B2 receptor is activated by kallikrein and other serine proteases, Mol Pharmacol 58, 828\u2013836.", "journal-title": "Mol Pharmacol"}, {"key": "11_CR87", "doi-asserted-by": "publisher", "first-page": "1970", "DOI": "10.1161/CIRCULATIONAHA.108.791533", "volume": "118", "author": "M. B. West", "year": "2008", "unstructured": "West, M. B., Rokosh, G., Obal, D., Velayutham, M., Xuan, Y. T., Hill, B. G., Keith, R. J., Schrader, J., Guo, Y., Conklin, D. J., Prabhu, S. D., Zweier, J. L., Bolli, R., and Bhatnagar, A. (2008) Cardiac myocyte-specific expression of inducible nitric oxide synthase protects against ischemia/reperfusion injury by preventing mitochondrial permeability transition, Circulation 118, 1970\u20131978.", "journal-title": "Circulation"}, {"key": "11_CR88", "first-page": "263", "volume": "294", "author": "L. J. Murphey", "year": "2000", "unstructured": "Murphey, L. J., Hachey, D. L., Oates, J. A., Morrow, J. D., and Brown, N. J. (2000) Metabolism of bradykinin In vivo in humans: identification of BK1-5 as a stable plasma peptide metabolite, J Pharmacol Exp Ther 294, 263\u2013269.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "11_CR89", "doi-asserted-by": "publisher", "first-page": "1903", "DOI": "10.1016/S0196-9781(00)00348-X", "volume": "21", "author": "C. Blais Jr", "year": "2000", "unstructured": "Blais, C., Jr., Marceau, F., Rouleau, J. L., and Adam, A. (2000) The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins, Peptides 21, 1903\u20131940.", "journal-title": "Peptides"}], "container-title": ["Renin Angiotensin System and Cardiovascular Disease"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-60761-186-8_11", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 22]], "date-time": "2019-05-22T08:49:55Z", "timestamp": 1558514995000}, "score": 20.026535, "issued": {"date-parts": [[2009]]}, "ISBN": ["9781607611851", "9781607611868"], "references-count": 89, "URL": "http://dx.doi.org/10.1007/978-1-60761-186-8_11", "relation": {"cites": []}}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}